{"title": "PDF", "author": "PDF", "url": "https://repository.urosario.edu.co/bitstream/10336/19876/1/GarzonOspina-DiegoEdison-2019.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "1 Identificaci\u00f3n de se\u00f1ales de selecci\u00f3n natural en genes de Plasmodium vivax que codifican prote\u00ednas involucradas en el proceso de invasi\u00f3n para determinar su potencial uso en una vacuna antimal\u00e1rica. Diego Edison Garz\u00f3n Ospina Tesis Doctoral presentada como requisito para optar al t\u00edtulo de Doctor en Ciencias Biom\u00e9dicas y Biol\u00f3gicas de la Universidad del Rosario Bogot\u00e1, 2018 2 Identificaci\u00f3n de se\u00f1ales de selecci\u00f3n natural en genes de Plasmodium vivax que codifican prote\u00ednas involucradas en el proceso de invasi\u00f3n para determinar su potencial uso en una vacuna antimal\u00e1rica. Estudiante Diego Edison Garz\u00f3n Ospina Bi\u00f3logo, Universidad INCCA de Colombia Magister en Ciencias -Microbiolog\u00eda, Universidad Nacional de Colombia Director Manuel Alfonso Patarroyo Guti\u00e9rrez M.D., Dr.Sc. Jefe del Departamento de Biolog\u00eda Molecular e Inmu nolog\u00eda Fundaci\u00f3n Instituto de Inmunolog\u00eda de Colombia (FIDIC) Profesor Titular, Escuela de Medicina y Ciencias de la Salud Universidad del Rosario DOCTORADO EN CIENCIAS BIOM\u00c9DICAS Y BIOL\u00d3GICAS UNIVERSIDAD DEL ROSARIO Bogot\u00e1, 2018 3 AGRADECIMIENTOS Quiero dar mis agradecimientos y dedicar este trabajo a mi madre : Martha Ospina Vargas , y a mis hermanos : Yamile Garz\u00f3n Ospina y Juli\u00e1n David Escobar Ospina , quienes me han acompa\u00f1ado y apoyado en todo momento. A Sindy Paola Buitrago Puentes por su acompa\u00f1a miento y apoyo durante este tiempo . Tambi\u00e9n agradecer a l Dr. Manuel Alfonso Patarroyo Guti\u00e9rrez , por haberme acogido en su equipo de trabajo y por apoyarme a lo largo de todos estos a\u00f1os . Quiero agrade cer y reconocer la labor de: Andrea Estefan\u00eda Ramos, Darwin Andr \u00e9s Heidy Daniela Ortiz Suarez, Lady Johanna Forero Alejandra Ricaurte Contreras , Leidy Paola Reyes , Luis Alfredo Baquero, Paola Andrea Camargo Ayala, Sindy Paola Buitrago Puentes, Ricar do De Le\u00f3n Montero y Yimara Grosso Paz , quienes aportaron su tiempo, dedicaci\u00f3n y esfuerzo, permitiendo la culminaci\u00f3n de este trabajo. Y finalmente, mis agradecimientos a l Doctorado , a la Universidad del Rosario y a los Jurados de tesis, quienes amabl emente aceptaron la revisi\u00f3n de este trabajo , por su s enriquecedores comentarios y por su tiempo . 4 CONTENIDO LISTA DE TABLAS ................................ ................................ LISTA DE DE vacuna. ................................ ................................ ................................ ........ 19 Gen\u00e9tica y evoluci\u00f3n, herramientas para el dise\u00f1o de vacunas. ................................ ....... 20 HIPOTESIS ................................ ................................ .... 27 An\u00e1lisis de las relaciones filogen\u00e9ticas ................................ ................................ ................................ ................. 27 An\u00e1lisis de diversidad gen\u00e9tica e inferencia de se\u00f1ales de selecci\u00f3n natural . .............. 28 Resul 41 Resultados y discusi\u00f3n ................................ ................................ ................................ ...... 46 Estructura gen\u00e9tica y relaciones filogen\u00e9ticas de la regi\u00f3n msp7 en Plasmodium spp. 46 Relaciones filogen\u00e9ticas de los miembros de msp7 en Plasmodium ............................ 46 Selecci\u00f3n positiva integridad del ADN. ................................ ................................ ........ 51 Determinaci\u00f3n de la presencia de infecciones \u00fanicas por P. vivax y de diferentes genotipos en las muestra s utilizadas ................................. ................................ ............. 52 Dise\u00f1o de iniciadores y amplificaci\u00f3n por PCR ................................ ........................... 53 Purificaci\u00f3n y Secuenciaci\u00f3n de los fragmentos amplificados. ................................ .... 53 An\u00e1lisis de la diversidad gen\u00e9tica y de las fuerzas evolutivas en los loci seleccionados. ................................ ................................ ................................ ............... 91 7 LISTA DE TABLAS Tabla 1. Total de muertes causadas por agentes parasitarios en 2013. ................................ 15 Tabla 2. Estimadores de la diversidad gen\u00e9tica en 59 genes de P. vivax . ............................ 30 Tabla 3. Raz\u00f3n diversidad nucleot\u00eddica/divergencia ( /), \u00edndice de neutralidad de la prueba McDonald -Kreitman (NI) y tasas de sustituci\u00f3n no sin\u00f3nima (d N) y sin\u00f3nima (d S) para algunos genes de P. vivax evaluados. ................................ ................................ ........... 34 ................................ gen\u00e9tica ................................ ................................ ........ 57 Tabla 6. Tasas de divergencia no -sin\u00f3nima (K N) y sin\u00f3nima (K S) ................................ ...... 57 Tabla 7. Estimadores de diversidad ................................ ................................ ...................... 67 8 LISTA DE FIGURAS Figura 1. El merozo\u00edto y su estructura interna. ................................ ................................ ..... 16 Figura 2. Ciclo de vida de Plasmodium spp. ................................ ................................ ........ 16 Figura 3. Filogenia (A) y tiempos de divergencia (B) de algunas especies del g\u00e9nero Plasmodium . ................................ ................................ ................................ 1 ................................ ................................ ................... 29 Figura 5. Distribuci\u00f3n del polimorfismo dentro de los 59 genes Plasmodium vivax estudiados. ................................ ................................ ................................ ............................ 33 Figura 6. Ventana deslizante de la tasa en la regi\u00f3n C -terminal de PvMSP -1 ................. 36 Figura 7. Metodolog\u00eda del Cap\u00edtulo 2 ................................ ................................ ................... 42 Figura 8. Filogenia de la familia de genes msp7 inferida por el modelo evo lutivo DLTRS 42 Figura 9. Representaci\u00f3n esquem\u00e1tica de los loci msp7 en 13 genomas de Plasmodium .... 44 Figura 10. Filogenias de msp7s analizadas por el m\u00e9todo Branch -site REL ........................ 48 Figura 11. Lugar de procedencia de las muestras de ADN parasitario en Colombia ........... 52 Figura 12. Metodolog\u00eda del Cap\u00edtulo 3 ................................ ................................ ................. 54 Figura 13. Patrones de PCR -RFLPs ................................ ................................ ..................... 56 Figura 14. Ventanas deslizantes 8 ant\u00edg enos de P. vivax ................................ ...... 58 Figura 15. Ventanas deslizantes de la tasa entre especies ................................ ................ 59 Figura 16. Metodolog\u00eda del Cap\u00edtulo 4 ................................ ................................ ................. 66 Figura 17. Ventana deslizante para el locus pvgama ................................ ............................ 69 Figura 18. Ventana deslizante locus pvrbsa ................................ ............................. 70 Figura 19 . Actividad de uni\u00f3n de fragmentos de PvGAMA y PvRBSA ............................. 71 Figura 20. Ensayos de inhibici\u00f3n de la uni\u00f3n con p\u00e9ptidos de PvCelTOS .......................... 71 Figura 21. Ventana deslizante para el locus pvceltos ................................ ........................... 72 Figura 22. Flujo de trabajo a seguir para seleccionar ant\u00edgenos promisorios a incluir en el dise\u00f1o de vacunas contra agentes infecciosos ................................ ................................ ...... 75 9 LISTA DE ANEXOS Anexo 1 \u00c1rbol filogen\u00e9tico de la familia msp3 ................................ ................................ .. 87 Anexo 2 . Ventanas deslizantes la tasa (d N/dS o K N/KS) ................................ .............. 88 Anexo 3 . Filogenia de la familia msp7 inferida por el m\u00e9todo de m\u00e1xima verosimilitud .. 89 Anexo 4. Ventana deslizante del gen pvron4 ................................ ................................ ...... 90 10 LISTA , MA. Size and Garz\u00f3n Natural Selection . Front Genet. 2018 Jan 25;9:10. doi:10.3389/fgene.2018.00010. Publicaci\u00f3n 9: Camargo PA, Garz\u00f3n -Ospina D Moreno -P\u00e9rez DA , Ricaurte - Contreras LA, Noya O and Patarroyo MA. On the 10.3389/fgene.2018.00372 11 ABREVIATURAS : diversidad nucleot\u00eddica por sitio : diversidad nucleot\u00eddica dN: tasas de sustituci\u00f3n no -sin\u00f3nima por sitio no -sin\u00f3nimo dS: la tasa de sustituci\u00f3n sin\u00f3nima por sitio sin\u00f3nimo KN: divergencia no -sin\u00f3nima por sitio no -sin\u00f3nimo KS: divergencia sin\u00f3nima po r sitio sin\u00f3nimo : tasa evolutiva (omega) = d N/dS o K N/KS n: Numero se secuencias analizadas Sitios: total de sitios analizados, excluyendo gaps Ss: n\u00famero de sitios segregantes (polim\u00f3rficos) S: n\u00famero de singleton Ps: n\u00famero de sitios parsimoni osos SD: desviaci\u00f3n est\u00e1ndar NI: \u00edndice de neutralidad de la prueba McDonald -Kreitman (NI) ORF: marco abierto de lectura MK: prueba de McDonald -Kreitman Pn: polimorfismo no -sin\u00f3nimo Ps: BY: bayesiano malERA: Malaria Eradication Research Agenda 12 Identificaci\u00f3n de se\u00f1ales de selecci\u00f3n natural en genes de Plasmodium vivax que codifican prote\u00ednas involucradas en el proceso de invasi\u00f3n para determinar su potenc ial uso en una vacuna antimal\u00e1rica. RESUMEN Plasmodium vivax , es un endopar\u00e1sito de origen Asi\u00e1tico que se dispers\u00f3 alrededor del mundo y, actualmente, es predominante en las regiones tropicales y subtropicales del planeta que se encuentran entre los 15 y 16 \u00b0 C. P. vivax , presenta una importancia biom\u00e9dica dado que es el segundo agente responsable de malaria en humanos . Aunque numerosos esfuerzos se han realizado para disminuir el impacto de esta enfermedad, las condiciones sociales y econ\u00f3micas de los lugares m\u00e1s afectados , sumado a los conflictos sociales y pol\u00edticos en varias \u00e1reas end\u00e9micas , hacen del control y eliminaci\u00f3n de est e par\u00e1sito una tarea nada f\u00e1cil. Como si esto no fuera suficiente, la aparici\u00f3n de resistencia a los insecticidas por parte del vector trasmisor , as\u00ed como de par\u00e1sitos resistentes a los antimal\u00e1ricos, podr\u00eda provocar una recurrencia de esta enfermedad . Teniendo en cuenta lo anterior , nuevas estrategias que permitan disminuir la incidencia de malaria por P. vivax se hacen prior itarias. Una de las alternativas que podr\u00eda ayudar al control de la malaria es el desarrollo de una vacuna contra los pat\u00f3genos que la causan . Sin embargo, la elevada diversidad gen\u00e9tica que P. vivax presenta , ha generado uno de los retos a afrontar para el dise\u00f1o de una vacuna completamente efectiva. Actualmente, se han descrito varios ant\u00edgenos potenciales candidatos a vacuna contra P. vivax . No obstante, la diversidad gen\u00e9tica de un reducido n\u00famero de estos ant\u00edgenos ha sido evaluada , debido a los req uerimientos de tiempo y recursos econ\u00f3micos . Adicion almente, poco se sabe acerca del rol real de estos ant\u00edgenos durante el proceso de invasi\u00f3n de este parasito a las c\u00e9lulas hospederas. Es por esto , que nuevos enfoqu es, que permitan en un menor tiempo y a bajo costo identificar las regiones de estos ant\u00edgenos conservadas por selecci\u00f3n natural (usualmente asociadas con regiones funcionales) se hacen necesarios. Estos nuevos enfoques podr\u00edan entonces servir como 13 punto de partida para la identificaci\u00f3n o prio rizaci\u00f3n de nuevos y promisorios candidatos vacu nales . Este trabajo presenta los resultados un enfoque alternativo que permite hacer un acercamiento a la diversidad gen\u00e9tica de ant\u00edgenos de P. vivax , determinando regiones bajo selecci\u00f3n negativa , para s er consideradas durante el dise\u00f1o de una vacuna completamente efectiva. Aunque e ste enfoque se utiliz\u00f3 para P. vivax , este podr\u00eda tambi\u00e9n ser aplicado en otros organismos. 14 Identificaci\u00f3n de se\u00f1ales de selecci\u00f3n natural en genes de Plasmodium vivax que codifican prote\u00ednas involucradas en el proceso de invasi\u00f3n para determinar su potencial uso en una vacuna antimal\u00e1rica. ABSTRACT Plasmodium vivax , an endoparasite that arose world , has biomedical impor tance given -malaria parasite . Although efforts have been made to reduce the impact of this disease, the social and economic conditions of the most affected places, together with social and political conflicts in several endemic areas, make the parasite control . The the disease have become a priority. An a ntimalarial vaccine development against the causal pathogens has been proposed as a cost-effective intervention which would P. genetic remains one of the challenges to overcome for the design of a genetic small number of them has been assessed , due to the high amount of time and economic resources required . Additionally, there is a modest knowl edge about real role of these antigens during the invasion process of target with functional importance , might be used as a starting point for the identificat ion or prioritization of new potentia l vaccine candidates. This work presents a new for design ing a fully effective vaccine. This approach is not limi ted to P. vivax and could be useful in other microorganisms . 15 INTRODUCCI\u00d3N GENERAL Los par\u00e1sitos representan una gran proporci\u00f3n de los organismos vivos del planeta y son de importancia biom\u00e9dica debido a su impacto en la salud humana (1). De todas las enfermedades parasitarias que afectan al ser humano, la malaria es la que produce m\u00e1 s muertes alrededor del mundo (2, 3) (Tabla 1). Tabla 1. Total de muertes causadas por agentes parasitarios en 2013. Parasitosis Muertes globales en 2013 Malaria 854.600 Leishmaniasis 62.500 Criptosporidiosis Ascariasis 4.500 Equinococo sis 2.200 Cisticercosis 700 Total de muertes por parasitosis 1.000.700 Modificada de: Hotez, P., Herricks, J., 2015. PLOS Medicine Pathogens Neglected Tropical Diseases (2). Esta enfermedad es causa da por par\u00e1sitos intracelulares obligados que pertenecen al Phylum Apicomplexa, orden Haemosporidia y g\u00e9nero Plasmodium . Miembros de este Phylum se caracteriza n por la presencia de organelos apicales (roptrias, micronemas y gr\u00e1nulos densos, Figura 1) impor tante s durante el proceso de invasi\u00f3n a las c\u00e9lulas hospederas . Plasmodium spp tiene un ciclo de vida complejo (Figura 2) , desarroll\u00e1ndose en dos hospederos diferentes; uno intermediario (vertebrados terrestres como reptiles, aves y mam\u00edferos (4-6)), donde se desarrolla la fase asexual y un hospedero definitivo y trasmisor del par \u00e1sito (mosquitos del genero Anopheles ), donde se lleva a cabo la fase sexual . 16 Figur a 1. El merozo\u00edto y su estructura interna. Modificada de: Cowman A F y Crabb B S., 2006. Cell (7). Figura 2. Ciclo de vida de Plasmodium spp. Modificad a de: Galinski M , Meyer E, Barnwell J., 2013 . Adv Parasitol (8). A la fecha, solo cinco especies de Plasmodium son capaces de infectar a l ser P. 9) y P. knowlesi (10). P. falciparu m, filogen\u00e9ticamente relacionado con P. reichenowi (11, 12), divergi\u00f3 aproximadamente al mismo tiempo en q ue lo hicieron los humanos de los grandes simios Africanos (13) (Figura 3B). Por su parte, P. vivax , de origen Asi\u00e1tico ( Figura 3A, aunque un origen Africano es 17 probable (14)), divergi\u00f3 de par\u00e1sitos que infecta n primates no humanos , hace unos 2 - 2,5 millones de a\u00f1os (11), mediante un evento conocido como cambio de hospedero (15). Por lo tanto, P. falciparum y P. vivax , a pesar de infectar seres humanos, presentan diferentes historias evolutivas. Figura 3. Filogenia (A) y tiempos de divergencia (B) de algunas especies del g \u00e9nero Plasmodium . Modificado de : Pacheco, 2011. BMC Evol Biol (11) y Silva, 2015. Mol Biol Evol (13). La incidencia de P. vivax ha disminuido desde 2010. Cerca de 6 a 11 millones de casos se atribuyeron a este par\u00e1sito en 2016, alrededor de 7 millones menos que en 2010 (16). A pesar de es to, la carga social y econ\u00f3mica causada por la malaria en los pa\u00edses end\u00e9micos (17) sigue siendo grande . Aunque las medidas de control contra este par\u00e1sito parecen ser \u00fatiles, la eliminaci\u00f3n de P. vivax (as\u00ed c omo la eliminaci\u00f3n de la malaria) no es una tarea sencilla . Las condiciones sociales y econ\u00f3micas de los lugares m\u00e1s afectados por esta enfermedad, as\u00ed como los conflictos sociales y pol\u00edticos en varias \u00e1reas end\u00e9micas , representan los principales desaf\u00edos para eliminar la malaria (16). Esto, junto con la dispersi\u00f3n de mosquitos resistentes a los insecticidas y de par\u00e1sitos resistent es a los medicamentos, podr\u00eda empeorar el panorama , generando una recurrencia de la enfermedad 18 (18-20). Por lo tanto, nuevas intervenciones como el dise\u00f1o de una vacuna , se hacen necesarios (21). As\u00ed, las intervenciones existentes junto con las nuevas estrategias podr\u00edan contribu ir a un mundo libre de malaria (21, 22). Dado que P. falciparum es el agente m\u00e1s letal de la enfermedad , el dise\u00f1o de una vacuna se centr \u00f3 durante mucho tiempo en este par\u00e1si to. Sin embargo, dado que en los \u00faltimos a\u00f1os la infecci\u00f3n por P. vivax est\u00e1 presentando complicaciones cl\u00ednicas y fallas terap\u00e9uticas , la malERA (del ingl\u00e9s , Mala ria Eradication Research Agenda ), en 2013 , reconoci\u00f3 la necesidad de desarrollar una vacuna c ontra este par\u00e1sito (23). A pesar de esto, el desarrollo de una vacuna contra P. vivax se encuentra retrasad o con respecto a P. falciparum (24), esto debid o a que l os aspectos de la biolog\u00eda de P. vivax son generalmente dif\u00edciles de estudiar de forma directa , dada la predilecci\u00f3n de este par\u00e1 sito por los reticulocitos (9). Sin embargo, datos gen\u00f3micos, trascript\u00f3micos, p rote\u00f3 micos, de marcadores moleculares o estudios de gen\u00e9tica de poblaciones , podr\u00edan ser cruciales para la predicci\u00f3n y evaluaci\u00f3n de drogas y vacunas (1, 25). En los \u00faltimos a\u00f1os, utilizando este tipo de datos ( \u00f3micos) , se han c aracterizado nuevos ant\u00edgenos que podr\u00edan ser considerados como candidatos a vacuna (24, 26-28). No obstante, esta caracterizaci\u00f3n es tan s\u00f3lo el primer paso . Debido a la alta diversidad ( variabilidad) gen\u00e9tica que exhibe P. vivax (25, 29), una vacuna dise\u00f1ada a partir de estos ant\u00edgenos podr\u00eda ser poco eficaz, dadas las respuestas inmunes alelo-espec\u00edfica s que el polimorfismo dentro de estos ant\u00edgenos podr\u00eda generar (30-34). As\u00ed, con el fin de dise\u00f1ar una vacuna completamente efectiva, se hace necesari o centrar su desarrollo en regiones conservadas o dominios funcionales (35). No obstante, los dominios funcionales (por ejemplo, aquellos involucrado s en la interacci\u00f3n pat\u00f3geno -hospedero) de ant\u00edgenos de P. vivax , no ha n podido ser dilucidad os sino en un muy reducido grupo de ello s (36-38). Las r egiones funcionales de l as prote\u00ednas , por ser cr\u00edtic as para llevar a cabo diferentes procesos celulares , evolucionan lentamente , observ\u00e1ndose una correlaci\u00f3n entre la conservaci\u00f3n de un fragmento de la mol\u00e9cula con su importancia funcional (39, 40). Por lo tanto, determinar estas regiones podr\u00eda ser un punto de partida para dise\u00f1ar una vacuna 19 completamente efectiva , ya que se evitar\u00edan as\u00ed , las respuestas inmunes alelo -espec \u00edficas. Recientemente, se ha producido un i ncremento de los datos gen\u00f3micos (29, 41), trascript\u00f3 micos (42) y prote \u00f3micos (43, 44) de P. vivax y especies filogen \u00e9ticamente relaciona das (10, 45). \u00c9stos, sumados a los estudio s de variaci\u00f3n gen\u00e9tica en las poblaciones natu rales , puede n dar acceso a informaci\u00f3n clave sobre la biolog\u00eda, ecolog\u00eda y evoluci\u00f3n del par\u00e1sito , usando un conjunto cada vez mayor de herramientas de gen\u00e9tica de poblaciones y evoluci\u00f3n molecular. As\u00ed, la generaci\u00f3n o uso de este tipo de datos y herramie ntas, podr\u00eda ser el punto de partida para la priorizaci\u00f3n o selecci\u00f3n de los mejores ant\u00edgenos para dise\u00f1ar una vacuna completamente eficaz contra P. vivax . Candidatos a vacuna . El esporozo\u00edto y el merozo\u00ed to son las formas extracelulares infectivas de Plasmodium spp, por lo tanto, son blancos del sistema inmune. Numerosas prote\u00ednas, tanto de superficie como de los organelos apicales del par\u00e1sito, participan activamente durante la invasi\u00f3n a la c\u00e9lula hospedera. Por lo tanto, e stas mol\u00e9culas son los princi pales blancos a incluir en una vacuna, ya que respuestas inmunes dirigidas hacia ellas podr\u00eda n inhibir la invasi\u00f3n (46-48). A pesar de la existencia de m\u00faltiples ant\u00edgenos , no todos son considerados candidatos promisorios. Para su inclusi\u00f3n en una vacuna, los candidatos deben cumplir con ciertas caracter\u00edstica s (35, 49): 1) estar involucrad os en el proceso de invasi\u00f3n a la c\u00e9lula hospedera 2) deben ser accesibles a l sistema inmune del hospedero 3) inducir respuestas inmunes protectoras , y 4) carecer de variabilidad gen\u00e9tica o por lo menos tener una variabilidad baja (5). A pesar de que ya se cuenta con un n\u00famero signifi cativo de ant\u00edgenos en P. vivax descritos (24, 50-58), la diversidad gen\u00e9tica de solo algunos de estos ant\u00ed genos ha sido evaluada . Esto debido a que los estudios usados para tal fin implican , no solo tiempo , sino tambi\u00e9n la disponibilidad de recursos econ\u00f3micos, convirti\u00e9ndose en una limitante para el desarrollo de una vacuna. A\u00fan m\u00e1s, dada la predilecci\u00f3n de P. vivax por los reticulocitos, el papel que 20 estos ant\u00edgenos tiene n durante la invasi\u00f3n no ha podido ser del todo descrit o, dadas las dificultades t\u00e9cnicas para evaluar la interacci\u00f3n pat\u00f3geno ( P. vivax ) - hospedero (reticulocitos). Gen\u00e9tica y evoluci\u00f3n, herramientas para el dise\u00f1o de vacunas . La diversidad gen\u00e9tica en los ant\u00edgenos parasitarios puede ser, en parte, consecuencia de presiones selectivas impuestas por el sistema inmune del hospedero , lo que per mite la fijaci\u00f3n o acumulaci\u00f3n de variantes (mutaciones) en la poblaci\u00f3n parasitaria . Esta presi\u00f3n selectiva , puede entonces, incrementa r la diversidad del par\u00e1sito, l o cual genera el problema de las respuestas inmunes alelo -espec\u00edficas (49, 59) que disminu yen la eficacia de las vacunas (34, 60). Estudios poblaciones han permitido , no solo evaluar la diversidad de los ant\u00edgenos , sino tambi\u00e9n identificar las fuerzas evolutivas responsables de generar el patr\u00f3n de variaci\u00f3n observado (61-71). Usualmente, los ant\u00edgenos sobre la superficie del par\u00e1sito est\u00e1n expuestos al sistema inmune del hospedero, lo que genera una presi\u00f3n selectiva sobre el ant\u00edgeno. Teniendo en cuenta que las mutaciones en este grupo de par\u00e1sitos se producen a un ritmo mayor que la tasa de mutaci\u00f3n de l\u00ednea base (49), la aparici\u00f3n de una variante, que permita la evasi\u00f3n de la respuesta inmune, se puede presentar a una tasa elevada. Es a mutaci\u00f3n (o algunas ya presentes) se fijar\u00e1 en la poblaci\u00f3n, dada la ventaja adaptativa que la variante tendr\u00eda, y en este caso , la selecci\u00f3n actuar\u00e1 hacia una direcci\u00f3n, manteniendo el mutante ventajoso (selecci\u00f3n positiva). Sin embargo, muchas mutacion es no alcanzan a fijarse en la poblaci\u00f3n. \u00c9stas se mantienen circulando en la poblaci\u00f3n , manteniendo frecuencias intermedias o alternando sus frecuencias con el tiempo (selecci\u00f3n balanceante y selecci\u00f3n dependiente de frecuencia). En este caso, la selecci\u00f3 n act\u00faa manteniendo las diferentes variantes, ya que un alto n\u00famero de alelos circulando, se convierte en un mecanismo de evasi\u00f3n de la respuesta inmune. Por lo tanto, se ha sugerido que ant\u00edgenos o region es con estos tipos de selecci\u00f3n, podr\u00edan ser dianas de la respuesta inmune y por consiguiente ser evaluados como candidatos a vacuna (72, 73). No obstante, est os candidatos n o necesariamente son las dianas ideales, debido a su alta diversidad gen\u00e9tica. 21 Por otro lado, algunas variantes (mutaciones que alteren la secuencia de la prote\u00edna) podr\u00edan tener un efecto contrario a las variantes fijadas /mantenidas por selecci\u00f3n positiva o balanceante. Por ejemplo, si una variante es reconocida f\u00e1cilmente por el sistema inmune, \u00e9sta ser\u00e1 eliminada de la poblaci\u00f3n parasitaria . As\u00ed mismo, muchas de las mutaciones que se generan suelen ser eliminadas \"r\u00e1pidamente \" debido a que alteran la funci\u00f3n o estructura de la prote\u00edna. Esta eliminaci\u00f3n se debe a la selecci\u00f3n negativa (a veces llamada purifica nte), que elimina todas aquellas variantes que tengan un efecto negativo en el organismo (74). Dado que la selecci\u00f3n negativa mantendr\u00e1 conservadas porciones de la prote\u00edna donde esta est\u00e1 actuando, l a detecci\u00f3n de este tipo de selecci\u00f3n podr\u00eda entonces ser utilizado para la identif icaci\u00f3n de potenciales candidatos a vacunas, ya que estos , al ser conservados , evitar\u00e1 n respuestas inmunes alelo -espec\u00edfica s. (68, 74-76). A\u00fan m\u00e1s, la inferencia de este tipo de selecci\u00f3n podr\u00eda ayudar a delimitar regiones funcionales dentro de los ant\u00edgenos , debido a que los dominios funcionales suelen estar restringid os funcional o estructuralmente (39, 40), evolucionando m\u00e1s lentamente . En consecuencia, la regi\u00f3n o ant\u00edgeno bajo selecci\u00f3n negativa se mantendr\u00e1 conser vado (a nivel de la secuencia de prote\u00edna) y as\u00ed, si las respuestas inmunes se dirigen hacia estas regiones (y son protectoras) , se obtendr \u00eda una respuesta completamente efectiva . Ya que los ant\u00edgenos invol ucrados en el proceso de invasi\u00f3n podr\u00edan ser rec onocidos por el sistema inmune de hospedero, estos podr\u00edan presentar una alta diversidad gen\u00e9tica. Sin embargo, las partes funcionalmente importantes de la prote\u00edna ( por ejemplo , las regiones implicadas en la interacci\u00f3n par\u00e1sito -hospedero ) debe n estar restringidas funcionalmente , manteni\u00e9ndose conservadas por selecci\u00f3n negativa , dentro y entre las especies (40). En consecuencia, inferir este tipo de selecci\u00f3n en ant\u00edgenos de P. vivax (u otro pat\u00f3geno) podr\u00eda usarse para pred ecir regiones bajo restricci\u00f3n funcional , que luego podr\u00edan usarse como potenciales candidatas a vacunas. El presente trabajo est\u00e1 dividido en tres partes, la primera (Capitulo 1 y 2) donde se analiz\u00f3 los datos gen\u00f3micos disponibles en bases de datos con el fin de generar un flujo de trabajo que permitiese hacer una selecci\u00f3n preliminar de los ant\u00edgenos parasitarios m\u00e1s promisorios para el dise\u00f1o de una vacuna contra P. vivax que evite las respuestas inmunes alelo -22 espec\u00edficas . La segunda parte (Capitulo 3 ) analiz\u00f3 por an\u00e1lisis poblaciones, la diversidad gen\u00e9tica de 8 ant\u00edgenos parasitarios, contrastando los resultados obtenidos en los Cap\u00edtulos 1 y 3 . La \u00faltima parte (Capitulo 4) , demuestra el potencial uso de esta metodolog\u00eda para la selecci\u00f3n de ant\u00edgeno s (o regiones dentro de \u00e9stos) promisorios para el dise\u00f1o de una vacuna contra P. vivax . 23 HIPOTESIS DE INVESTIGACI\u00d3N La diversidad gen\u00e9tica observada en P. vivax es mayor a la de P. falciparum (25, 29), posiblemente debido a que P. vivax no ha experimentado cuellos de botella durante su historia evolutiva como P. falciparum (77-80). As\u00ed, gran parte del polimorfismo observado en esta especie podr\u00eda ser ancestral y muchas de las variantes al\u00e9licas podr\u00edan haber surgi do antes de la dispersi\u00f3n del parasi to por el mundo (81). Por lo tanto, el an\u00e1lisis de un n\u00famero reducido de secuencias de cepas parasitarias de diferentes regiones del mundo podr\u00eda reflejar la diversidad gen\u00e9tica un determinado ant\u00edgeno. Si el an\u00e1lisis de pocas secuencias provenientes de diferentes regiones del mundo refleja la diversidad gen\u00e9tica de un determinado ant\u00edgeno , entonces estos resultados ser\u00e1n concordantes a los obtenidos analizando un mayor n\u00famero de secuencias , y as\u00ed, podr\u00edan seleccionase ant\u00edgenos con baja diversidad en un menor tiempo, postul\u00e1ndolos como potenciales ant\u00edgenos a ser incluidos en una vacuna contra P. vivax . Por otra parte, d ado que l os ant\u00edgenos parasitarios involucrados en el proceso de invasi\u00f3n podr\u00edan ser blancos del sistema inmune de hospedero, \u00e9stos pueden presentan una alta diversidad gen\u00e9tica (61, 64, 65, 67, 70, 71, 90, 128, 129). Sin embargo, las partes funcionalmente importantes de la prote\u00edna ( por ejemplo , aquellas regiones implicadas en la interacci\u00f3n par\u00e1sito -hospedero) podr\u00edan estar restringidas funcionalmente , manteni\u00e9ndose conservadas dentro y entre especies por la acci\u00f3n de la selecci\u00f3n negativa . Por lo tanto , si las regiones conservadas entre especies de un determinado ant\u00edgeno son el resultado de la acci\u00f3n de la selecci\u00f3n negativa , entonces estas regiones ser\u00edan funcionalmente importantes y podr\u00edan estar involucradas , por ejemplo, en la interacci\u00f3n pat\u00f3geno -hosped ero y as\u00ed ser consideradas como promisorias para ser incluidas durante el dise\u00f1o de una vacuna contra P. vivax . 24 OBJETIVOS Objetivo general Inferir se\u00f1ales de selecci\u00f3n natural en ant\u00edgenos de Plasmodium vivax para identificar y seleccionar los candid atos/regiones a vacuna m\u00e1s promisorios para el dise\u00f1o de una vacuna completamente efectiva contra P. vivax . Objetivos espec\u00edficos Analizar 59 genes de P. vivax previamente reportados como potenciales candidatos a vacuna a partir de los datos gen\u00f3micos de 5 aislados parasitarios y 2 especies filogen\u00e9ticamente relacionas depositados en el GenBank. Calcular varios par\u00e1metros de diversidad gen\u00e9tica y detectar se\u00f1ales de selecci\u00f3n natural para cada uno de los 59 genes a partir de los datos gen\u00f3micos obtenidos. Seleccionar los ant\u00edgenos m\u00e1s promisorios a incluir en el dise\u00f1o de vacuna antimal\u00e1rica contra P. vivax a partir de los datos obtenidos. Identificar la presencia de infecciones \u00fanicas y la presencia de diferentes genotipos de P. vivax en muestras de ADN de aislados naturales obtenidas en diferentes regiones de Colombia . Evaluar la diversidad gen\u00e9tica de 8 ant\u00edgenos de P. vivax y determinar las fuerzas evolutivas que generan el patr\u00f3n de variaci\u00f3n observado , a partir de secuencias obtenidas de aislados parasitarios de la poblaci\u00f3n Colombiana . Implementar la metodolog\u00eda propuesta en este trabajo durante la caracterizaci\u00f3n de nuevo s ant\u00edgeno s de P. vivax . 25 CAPITULO 1 Un enfoque alternativo para la selecci\u00f3n de candidatos promisorios a vacuna 26 Introducci\u00f3n El desarrollo de una vacuna contra P. vivax se encuentra retrasado con respecto a P. falciparum , y pocos candidatos a vacuna han sido propuestos hasta la fecha (21). En P. vivax , la caracterizaci\u00f3n de nuevos potenciales candidatos involucra la b\u00fasqueda de secuencias con un alto porcentaje de similitud con los ant\u00edgenos previamente descritos en P. falciparum (24). Adicionalmente, o tras alternativas (82) han permitido por m\u00e9todos bioinform\u00e1tico s predecir prote\u00ednas de P. vivax que podr\u00edan tener un papel durante el proceso de invasi\u00f3 n. Estos estudios han permitido describir cerca de 60 ant\u00edgenos de P. vivax que podr\u00edan ser considerados durante el dise\u00f1o de una vacuna. Sin embargo, la diversidad gen\u00e9tica y las fuerzas evolutivas de estas mol\u00e9culas deben ser evaluadas para dise\u00f1ar una vacuna completamente efectiva (21, 83). An\u00e1lisis poblacion ales y de evoluci\u00f3n molecu lar son las principales estrategias para tal fin. Estas alternativas requieren la secuenciaci\u00f3n de varias muestras parasitarias, por lo tanto, realizar tales estudios para todos estos genes implicar\u00eda tiempo y recursos econ\u00f3micos . No obstante , Cornejo et al. (84), utilizando un tama\u00f1o de muestra limitado ( los genomas de 5 aislamientos) han identificado genes con se\u00f1ales de selecci\u00f3n natural . Este tipo de an\u00e1lisis podr\u00eda ser un punto de partida para detectar posi bles nuevos candidatos a vacuna (73), similar a previos enfoque s adoptado s en P. falciparum (72, 85). La primera parte de este trabajo utiliz\u00f3 tres pruebas diferentes para detectar se\u00f1ales de selecci\u00f3n en 59 ant\u00edgenos de l merozo\u00edto de P. vivax previamente caracte rizados . Para este fin, la informaci\u00f3n disponible en GenBank de cinco genomas de aislados de P. vivax de diferentes regiones del mundo y de dos especies estrechamente relacionadas (P. cynomolgi y P. knowlesi ) fue analizada . Los resultados obtenidos pueden ser utilizados para determinar qu\u00e9 ant\u00edgenos deber\u00edan ser priorizados y evaluados en estudios adicionales dirigidos al dise\u00f1o de una vacuna completamente efectiva contra P. vivax . 27 Metodolog\u00eda Obtenci\u00f3n de secuencias y alineamientos . Secuencias de 59 gen es (de la cepa adaptada a primates no humanos Sal -I) previamente sugeridos como potenciales candidatos a vacuna (24, 26-28, 50-58, 82, 86-89), fueron descargadas de la base de datos PlasmoDB (www.plasmodb.org/plasmo/ ). Cuarenta y ocho de estos genes no hab\u00edan sido analizados previamente por an\u00e1lisis poblacion ales, mientras 11, ya han sido evaluados por esta metodolog\u00eda (61-63, 68, 90). Posteriormente, estas secuencias fueron utilizadas con el fin de obtener las hom\u00f3logas de estos 59 genes de cuatro cepas de P. vivax adaptada s a primates no humanos (Brasil-I, India -VII, Mauritania -I y Corea del Norte (29)) de dos espe filogen\u00e9ticamente relacionadas ( Plasmodium cynomolgi (10)), mediante una b\u00fasqueda por tBlasn (29). Adicionalmente, s e realiz \u00f3 una b\u00fasqueda en la base de datos GenBank para obtener secuencias report adas para otras cepas de P. vivax (VCG -I, Bele m o Corea del Sur). An\u00e1lisis de las relaciones filogen\u00e9ticas de los genes pertenecientes a las familias multig\u00e9nicas . Algunos genes incluidos en el an\u00e1lisis pertenecen a familias multig\u00e9nicas, por lo tanto, previo a los an\u00e1lisis de diversidad gen\u00e9tica y de selecci\u00f3n natural, se realiz \u00f3 la identificaci\u00f3n de las relaciones de ortolog\u00eda dentro de cada familia multig\u00e9nica. Una combinaci\u00f3n de 3 criterios fue utiliz ada para esta identificaci\u00f3n, e stos incluyen: a. una se\u00f1al filogen\u00e9tica (topo log\u00eda de un \u00e1rbol filogen\u00e9tico) b. similitud de secuencia (distancia gen\u00e9tica) , y c. sintenia (posic i\u00f3n gen\u00f3mica similar) como ha sido previamente descrito (91-94). Las secuencias de P. vivax , P. cynomolgi y knowlesi de msp3, msp7, clag, Pfam A y Pfam d, fueron alineadas independientemente con todos los miembros de sus respectivas familias utilizando el m\u00e9todo MUSCLE (95). El mejor modelo evolutivo para 28 cada familia fue seleccionado por el criterio de informaci\u00f3n bayesiano, utilizando el programa MEGA v.5 (96) y fue utilizado para inferir \u00e1rboles filogen\u00e9ticos mediante el m\u00e9todo de M\u00e1xima verosimilitud (ML). Gaps y regiones repetitivas no fueron tenidos en cuenta para los an\u00e1 lisis. La confiabilidad de la topolog\u00eda fue evaluada por bootstrap (1.000 repeticiones). Las distancias gen\u00e9ticas fueron calculadas usando el programa MEGA v.5 y la sintenia fue determinada teniendo en cuenta estudios previos (91, 92, 94) y la informaci\u00f3n disponible en PlasmoDB ( www.plasmodb.org/plasmo/ ). An\u00e1lisis de diversidad gen\u00e9tica e inferencia de se\u00f1ales de selecci\u00f3n natural . Ya con la identificaci\u00f3n de los genes ort\u00f3logos putativos de las familias multig\u00e9nicas , se realiz aron alineamientos m\u00faltiples para todos los 59 genes , usando las secuencias disponibles de cepas de P. vivax adaptadas a primates y las secuencias ort\u00f3logas de dos especies filogen\u00e9ticamente relacionadas. A partir de estas secuencias de ADN , se infiri \u00f3 la secuencia de prote\u00ednas, las c uales fueron alineadas con el m\u00e9todo MUSCLE (95). A partir de este alineamiento , se infiri \u00f3 el alineamiento de ADN (por c odones) usando el programa Pal2Nal (97). Para todos los an\u00e1lisis , se utiliz \u00f3 la anotaci\u00f3n de la cepa Sal -I como referencia. A partir de los alineamientos obtenidos , se estim aron varias medidas de la diversidad gen\u00e9tica, utilizando el programa DnaSP v.5 (98). Recientemente, Cornejo et al ., (84) identificaron patrones consistentes con selecci\u00f3n natural en el genoma de P. vivax usando la prueba de Hudson, Kreitman y Aguade, la versi\u00f3n gen\u00f3mica de la prueba de McDonald -Kreitman (MK) y el estimador D de Tajima (84); sin embargo, no se reportaron se\u00f1ales de selecci\u00f3n positiva en los genes del merozo\u00edto implicados en la invasi\u00f3n. En el presente trabajo , se evaluar on se\u00f1ales de la selecci\u00f3n natural (positiva, balanceante y negativa) mediante la utilizaci\u00f3n de pruebas de comparaci\u00f3n de datos de diferentes especies (99) tales como: la prueba convencional de MK (100) y la raz\u00f3n / (diversidad nu cleot\u00eddica /divergencia nucleot \u00eddica) (72, 85). La prueba MK se realiz \u00f3 teniendo en cuenta la correcci\u00f3n de di vergencia de Jukes -Cantor (101), mediante el uso del s ervidor web http://mkt.uab.es/mkt/MKT.asp (102). La raz\u00f3n / fue evaluada para la identificaci\u00f3n de genes con valores mayores a 0 ,1, lo cual es esperad o en genes bajo selecci\u00f3n balanceante (72, 85). 29 Figura 4. Metodolog\u00eda del Cap\u00edtulo 1 30 El programa MEGA v.5 (103) fue utili zado para evaluar se\u00f1ales de selecci\u00f3n natural dentro de P. vivax , mediante el c\u00e1lculo de las tasas de sustituci\u00f3n no -sin\u00f3nima por sitio no - sin\u00f3nimo (d N) y la tasa de sustituci\u00f3n sin\u00f3nima por sitio sin\u00f3nimo (d S), utilizando el m\u00e9todo modificado de Nei -Gojo bori (104). As\u00ed mismo, pa ra inferir patrones de selecci\u00f3n natural que podr\u00eda n haber prevalecido durante la historia evolutiva de Plasmodium , se calcular on la diferencia entre el n\u00famero promedio de la divergencia no -sin\u00f3nima por sitio no-sin\u00f3nimo y el n\u00famero promedio de la divergen cia sin\u00f3nima por sitio sin\u00f3nimo (K N-KS, adecuado para detectar selecci\u00f3n pasada (99)), utilizando el m\u00e9todo modificado de Nei - Gojobori con la correcci\u00f3n de Jukes -Cantor. Diferencias significativas entre d N y dS (o K N y KS) fueron evaluadas por la prueba Z-test o la prueba exacta de Fisher. Adicionalmente, se realiz \u00f3 una ventana deslizante de la tasa ( omega = dN/dS o K N/KS) para determinar regiones espec\u00edficas afectadas por tipos particulares de selecci\u00f3n natural. Regiones con gaps o regiones repetitivas , no fueron tenidas en cuenta para los an\u00e1lisis. La Figura 4 esquematiza la metodolog\u00eda realizada. Resultados y Discusi\u00f3n Secuencias de 59 genes de P. vivax (obtenidas de al menos 5 cepas adaptadas a primates), que codifican potenciales candidatos a vacuna, fueron analizados con respecto a su diversidad gen\u00e9tica y se\u00f1ales de selecci\u00f3n natural (Publicaci\u00f3n 1). Los c\u00e1lculos de los estimadores de diversidad mostraron 16 genes altamente polim\u00f3rficos ( > 0,01), 35 con un polimorfismo intermedio (0 ,009 < > 0,001) y 8 que mostraron una baja diversidad gen\u00e9tica ( < 0,001) (Tabla 2 ). La Figura 5, muestra la distribuci\u00f3 n de los polimorfismo s dentro de cada uno de los 59 genes. Tabla 2. Estimadores de la diversidad gen\u00e9tica en 59 genes de P. vivax . # ID Gen n Sitios Ss S Ps (SD) Genes sin estudios previos de gen\u00e9tic a de poblaciones 1 PVX_000945 pvron -1 6 2340 5 3 2 0,0096 (0 ,0001) 2 PVX_000995 pv41 6 1086 ,0013) 3 PVX_002510 nucleosomal binding protein (0,0003) 4 PVX_003800 Pvsera 5 3033 4 5 PVX_003805 pvsera , putative ,0014) 7 PVX_003825 pvsera -4 4 (0 ,0072) 8 PVX_003830 pvsera -5 6 (0 ,0222) 9 PVX_003850 pvsera -2 6 10 PVX_080305 hypothetical protein, conserved 5 11 PVX_081810 hypothetical protein, conserved PVX_081845 hypothetical protein 5 14 PVX_086850 pvvir -35, putative 4 19 21 0,0360 (0 ,0090) 15 PVX_086930 pvrhopH1/clag 5 3978 38 30 8 0,0043 (0,0010) 16 PVX_090075 pv34 6 1092 1 1 0 0,0003 (0 ,0003) 17 PVX_090210 Pvarp 7 82 6 5 0,0029 (0 ,0007) 18 PVX_091434 pvron -4 6 19 PVX_092425 hypothetical conserved PVX_092975 erythrocyte binding hypothetical conserved ,0001) 23 PVX_096990 Pv-fam-d protein 5 1136 24 PVX_097565 Plasmodium exported protein ,0003) 25 PVX_097670 pvmsp -3, putative 6 0,1408 (0 ,0154) 26 PVX_097675 pvmsp -3, putative 5 ,0229) 27 PVX_097695 pvmsp -3, putative 28 pvmsp putative 29 pvmsp putative 30 pvmsp putative ,0185) 31 PVX_097715 pvmsp -3, putative 5 42 7 0,0163 (0 ,0034) 32 PVX_097960 pv38 6 1065 33 pvrbp -1, putative 34 pvrhopH3 PVX_101555 hypothetical 5 ) 37 PVX_101605 hypothetical protein 0,0031 (0 ,0030) 38 PVX_109280 pvfam -a 7 753 (0 ,0003) 39 PVX_112665 tryptophan -rich antigen 0,0018 (0 ,0004) 40 PVX_113775 pv12 7 942 4 0,0014 (0 ,0006) PVX_117230 pvser/thr -2 45 PVX_121920 pvrbp -2, like PVX_123105 hypothetical 5 32 47 PVX_123550 hypothetical protein, conserved PVX_123575 thrombospondin -related protein 3 6 966 3 2 1 0,0012 (0 ,0004) Genes con estudios previos de gen\u00e9tica de poblaciones 1 PVX_003905 pv230 , putative 5 pvmsp putative ,0006) 3 PVX_085930 pvrap -1, putative 5 2 0 0,0003 (0 ,0002) 4 PVX_092275 pvama -1 6 1683 31 13 0,0080 (0 ,0010) 5 PVX_097590 pvrap -2, putative 5 1203 0 0 0 0,000 (0 ,000) 6 PVX_097625 pvmsp -8 6 1320 6 3 3 0,0021 (0 ,0006) 7 PVX_097720 pvmsp -3 6 2016 154 72 82 0,0349 (0 ,0158) 8 PVX_097680 pvmsp -3 6 2007 329 165 164 0,0747 (0 ,0094) 9 PVX_099980 pvmsp -1 6 (0 10 PVX_110810 Pvdbp ,0010) PVX_114145 pvmsp n: N\u00fa mero se secuencias analizadas; Sit ios: total de sitios analizados, excluyendo gaps; Ss: n\u00famero de sitios segregantes (polim\u00f3rficos); S: n\u00famero de singleton; Ps: : diversidad nucleot\u00eddica por sitio; SD: d esviaci\u00f3n est\u00e1ndar. Previo a la detecci\u00f3n de se\u00f1ales de selecci\u00f3n natural en estos 59 genes, las relaciones filogen\u00e9ticas de miembros de familias multig\u00e9nicas ( identificaci\u00f3n de ort\u00f3logos putativos) fueron establecidas (Anexo 1) . Una vez establecidas l as relaciones de ortolog\u00eda, las se\u00f1ales de selecci\u00f3n fueron detectadas mediante tres enfoques diferentes. Con la prueba MK se detectaron 16 genes bajo selecci\u00f3n balanceante ( \u00edndice de neutralidad (NI) > 1) y uno bajo selecci\u00f3n positiva ( NI < 1). La relaci\u00f3 n /K identific\u00f3 11 genes bajo selecci\u00f3n balanceante (Tabla 3). Estos genes podr\u00edan ser blancos del sistema inmune y, por lo tanto , podr\u00edan ser considerados como potenciales candidatos a vacuna. Sin embargo, el alto polimorfismo dentro de algunos de ellos , reducir\u00eda la eficacia de la vacuna debido a las respuestas inmunes alelo -espec\u00edficas que se presentar\u00edan . 33 Figura 5. Distribuci\u00f3n del polimorfismo dentro de los 59 genes Plasmodium vivax estudiados. Los codones con mutaciones sin\u00f3nimas (naranja) y no sin\u00f3nima s (rojo) se muestran con l\u00edneas verticales encima de cada gen. En azul se representan las regiones que codifican el p\u00e9ptido se\u00f1al , en verde las regiones predichas como transmembrana les o de anclaje a GPI, en cian oscuro se representan los dominios s48/45 y en negro las regiones con INDELs (INserci ones o DEL eciones ). 34 S\u00f3lo 7 genes mostraron se\u00f1ales de selecci\u00f3n balanceante por ambas pruebas (/K y MK). Una baja correlaci\u00f3n entre estas pruebas ha sido previamente demostrada (72). Esto podr\u00eda ser debido al efecto de la selecci\u00f3n negativa d\u00e9bil, que puede producir un exceso de polimorfismo, pero a bajas frecuencias. Sin embargo, el valor del NI > 1 (o Pn/P s > Dn/Ds) encontr ado en este estudio , parece deberse al alto n\u00famero de sustituciones sin\u00f3nimas entre las especies (Ds), resultando en un Pn/Ps > Dn/Ds. El alto n\u00famero de sustituciones sin\u00f3nimas entre las especies, sugiere que la evoluci\u00f3n ha mantenido las secuencias de prote\u00ednas conservadas en ambas, por lo que una restricci\u00f3n funcional/estructural parece ser probable. Esto sugiere que algunos genes podr\u00edan no estar bajo selecci\u00f3n balanceante, sino bajo una selecci\u00f3n negativa. Esta interpretaci\u00f3n fue soportada por el hecho de que se encontr\u00f3 valores bajos de y valores negativos estad\u00edsticamente significativos en la prueba KN-KS (Tabla 3 y Anexo 2 ). Tabla 3. Raz\u00f3n diversidad nucleot\u00eddica/divergencia ( /), \u00edndice de neutralidad de la prueba McDonald -Kreitman (NI) y tasas de sustituci\u00f3n no sin\u00f3nima (d N) y sin\u00f3nima (d S) para algunos genes de P. vivax evaluados. # ID Gen Pcyn Pkno Pcyn Pkno dN (SE) dS (SE) / / NI p-value NI p-value Genes sin estudios previos de gen\u00e9tica ,0044) 8 PVX_003830 pvsera -5 - - - PVX_097695 pvmsp -3, - ,0048) 0,0689 (0 ,0059) 28 PVX_097700 pvmsp -3, - ,0054) 0,1160 (0 ,0074) 29 PVX_097705 pvmsp -3, - - - (0 ,0047) 0,0705 (0 ,0062) 35 30 PVX_097710 pvmsp -3, putative - - - - de gen\u00e9tica de poblaciones 1 PVX_003905 pv230 -: El valor de la prueba no pudo ser estimado ya que no se encontraron secuencias ort\u00f3logas; Null: El \u00edndice de neutralidad (NI) no pudo ser estimado debido a que el polimorfismo neutral (o no neutral) es igual a 0; SE: error est\u00e1ndar; Pcyn: Valor obtenido al comparar las secuencias de P. vivax con P. cynomolgi; Pkno: Valor obtenido al comparar las secuencias de P. viv ax con P. knowlesi. El v alor de p para el NI de pv230, p vmsp -1 y pvama -1 no pu do ser estimado en el servidor web; por lo tanto, se calcularon con el programa DnaSP, que no considera la correcci\u00f3n de Jukes -Cantor. *: p < 0 ,06; : p < 0 ,05; ; p < 0 ,04; : p < 0,01; : p < 0 ,002; : p < 0 ,0001. Se muestran s\u00f3lo genes en los que se detect\u00f3 una se\u00f1al de selecci\u00f3n . Los resultados de la prueba dN y dS mostraron 12 genes con se\u00f1ales de selecci\u00f3n positiva, 9 con se\u00f1ales de selecci\u00f3n negativa (Tabla 3), mientras que para los restantes, la neutralidad no pu do ser descartad a. Esto sugiere que genes como pvsera 5, pvvir 35, los miembros de la familia pvmsp3 , pvrbp 1, PVX_092995 y PVX_101555 podr\u00edan estar bajo presi\u00f3n del sistema inmune, fijando o acumula ndo mutaciones de tipo no -sin\u00f3nimo como mecanismo de evasi\u00f3n. Por lo tanto, una vacuna basada en las prote\u00ednas codificadas por estos genes , podr\u00eda tener una baja e fectividad debido a su alto polimorfismo. Por otra parte, la s prote\u00ednas codificadas por genes bajo selecci\u00f3n ne gativa podr\u00edan ser tenidas en cuenta para el desarrollo de vacunas (68, 74-76). Genes tales como pv41 , PVX_0 92425, pvclag (PVX_121885) o pvmsp 10, podr\u00edan ser buenos candidatos a vacuna, ya que la selecci\u00f3n 36 negativa podr\u00eda ser consecuencia de restricciones funcionales y, por lo tanto , las respuestas inmunes alelo -espec\u00edficas ser\u00edan abolidas . Las presiones select ivas (o la restricci\u00f3n funcional/estructural) no son iguales a lo largo de toda la mol\u00e9cula , por lo tanto, diferentes tipos de selecci\u00f3n podr\u00eda actuar sobre \u00e9sta (90). Para determinar c\u00f3mo se han acumulado las mutaciones sin\u00f3nimas y no sin\u00f3nimas en estos genes , se realiz\u00f3 un a ventana deslizante de las tasas ( dN/dS o K N/KS) permitiendo identificar dominios /regiones bajo selecci\u00f3n positiva ( > 1 ) o negativa ( < 1). El an\u00e1lisis de ventana d esliza nte, mostr\u00f3 que varios genes que carecen de valores significativos de d N o d S, tienen dominios con un valor > 1, mientras otras regiones presentaban valores de < 1 ( Anexo 2 ). Interesantemente, las r egiones con un valor de < 1, coinciden con aquellas regiones donde dominios funcionales han sido descritos, sugiriendo que estos dominios tienen restricciones funcionales, debido a su rol en la invasi\u00f3n del par\u00e1sito a la c\u00e9lula hospedera (Figu ra 6 y Anexo 2 ). Figura 6. Ventana deslizante de la tasa en la regi\u00f3n C -terminal de PvMSP -1 El fragmento de PvMSP -1 de 33 kDa est\u00e1 involucrado en el reconocimiento de la c\u00e9lula hospedera (38). Las regiones espec\u00edficas que interact\u00faan con los reticulocitos (resaltadas e n cuadros p \u00farpura ) presentan una baja divergencia ( < 1), mientras las regiones no funcionales presentan una alta divergencia ( > 1). El p\u00e9ptido 2 muestra una alta divergencia que podr\u00eda ser el resultad o de adaptaciones especie -espec\u00edfica s (105, 106), lo que eleva el valor . Este resultado concuerda con an\u00e1lisis poblaciones previos de este fragmento (107). 37 Teniendo en cuenta lo anterior , se buscaron este tipo de regiones (con < 1) en genes con se\u00f1ales de selecci\u00f3n negativa. Por ejemplo, l os genes pvron 2 y pvron 4 presentaron regiones con valores < 1 hacia los extremos 3' . Consecuentemente, la regi\u00f3n C-terminal de las prote\u00ednas PvRON2 y PvRON 4 podr\u00eda n ser las regiones funcionales . As\u00ed mismo, miembros de la fa milia 6-Cys ( , pv41 y pv38 ) s48/46, mostraron una baja diversidad gen\u00e9tica , donde los dominios s48/46 mostraron un exceso de sustituc iones sin\u00f3nimas entre especies , generando un NI > 1 y valores ( KN/KS) < 1, lo cual es consistente con la acci\u00f3n de la selecci\u00f3n negativa . Por lo tanto, estos do minios parecen estar bajo restricciones funcionales , convirti\u00e9ndolos en potenciales candidatos a vacuna que eviten las respuestas inmunes alelo -espec\u00edficas. Otras prote\u00ednas con este tipo /clag, pvser /Thr, PVX_081810 y PVX_092425, po r lo que estos podr\u00edan tambi\u00e9n ser considerados durante el dise\u00f1o de una vacuna (Publicaci\u00f3n 1) . Conclusiones El uso de tres pruebas diferentes permiti\u00f3 la identifica ci\u00f3n de se\u00f1ales consistentes con selecci\u00f3n natural. Miembros de la s familias multig\u00e9nica s pvsera y pvmsp 3 mostraron se\u00f1ales de selecci\u00f3n positiva, probablemente debido a que las prote\u00ednas codificadas son reconocidas por el sistema inmune, sin embargo, no parece n ser los candidatos m\u00e1s apropiados para el desarrollo de vacunas , debido a su alto polimorfismo. Las dominios dentro de ell as), mostraron patrones esperados en regiones bajo restricciones funcionales , por lo tanto , podr\u00edan ser consideradas como los candidatos m\u00e1s adecuados y as\u00ed, ser priorizad as para estudios posteriores ( an\u00e1lisis poblacion ales y funcionales) para el desarrollo de una vacuna contra P. vivax que evite las respuestas inmunes alelo -espec\u00edficas . El enfo que ac\u00e1 utilizado (Figura 4 ) podr\u00eda entonces ser una herramienta \u00fatil para la selecci\u00f3n de candidatos promisorios a vacuna. Los ant\u00edgenos para tener en cuenta deben presentar : 38 a. una diversidad gen\u00e9tica limitada o, al menos, un dominio con este patr\u00f3n b. una se \u00f1al de selecci\u00f3n negativa (dS > d N o K S > K N), as\u00ed como un < 1. Sin embargo, los genes bajo selecci\u00f3n positiva ( > 1), podr\u00edan tomarse en cuenta si estos presentan dominios con un a diversidad gen\u00e9tica limitada y valores bajos en la tasa . Los resulta dos de este cap\u00edtulo fueron publicado s y est\u00e1n disponibles bajo la siguiente referencia: Publicaci\u00f3n 1: Garz\u00f3n -Ospina D CAPITULO 2 Adaptaciones linaje -espec \u00edficas, un a limitante para la selecci\u00f3n de ant\u00edgenos basados en el enfoque propuesto . 40 Introducc i\u00f3n Estudios p revios han mostrado que la regi\u00f3n C -terminal de miembros de la familia multig\u00e9nica MSP7 de P. vivax (pvmsp 7) son altamente conservados (63, 90), inclusive entre par\u00e1logos (90). Por esta raz\u00f3n , el dominio C -terminal de los ant\u00edgenos codi ficados por los genes pvmsp7 podr\u00edan ser buenos candidatos a vacuna (63, 90). Entre el grupo de genes analizados en el Cap\u00edtulo 1, se encontraba el gen msp7K, miembro altamente conservado en P. vivax (63), quien no mostr\u00f3 patrones que nos permitieran seleccionarlo como potencial candidato, a pesar de ha berlo propuesto previamente (63). Los resultados obtenidos para este gen en el Cap\u00edtulo 1, no mostraron se\u00f1ales de selecci\u00f3n negativa entre especies y por el contrario mostraron que pvmsp7K es altamente diverg ente entre P. vivax y P. cynomolgi . Trabajos p revios , Merozoite Surface Protein 1 ) han sugerido que \u00e9ste presenta se\u00f1ales de selecci\u00f3n positiva linaje -espec\u00edfic as (105, 106), observ\u00e1ndose una alta divergencia en este gen entre P. vivax y especies de Plasmodium que infectan cercopit\u00e9cidos (primates del viejo mundo). Esta divergencia p or selecci\u00f3n positiva coincide con la radiaci\u00f3n de los macacos asi\u00e1ticos hace 3 a 6 millones de a\u00f1os [26, 65] , sugiriendo que esta selecci\u00f3n , podr\u00eda ser el resultado de adaptaciones a nuevos hospederos disponibles hace 3 a 6 millones de a\u00f1os atr\u00e1s . Teniend o en cuenta que en P. falciparum las prote\u00ednas MSP1 y MSP 7 forma n un complejo implicad o en la invasi\u00f3n [9, 10] y dada la presencia de ambas prote\u00ednas en P. vivax , \u00bfpodr\u00eda n entonces los miembros de la familia msp7 de P. vivax , estar bajo las mismas presione s selectivas de msp1? Si los genes pvmsp 7 divergieron por selecci\u00f3n positiva como consecuencia de la adaptaci\u00f3n a los seres humanos durante el cambio de hospedero (15), esto podr\u00eda incrementar la tasa , incrementando la divergencia entre especies, y por ende, msp7K ser\u00eda descartado como potencial candidato a vacuna. Con el fin de evaluar esta hip\u00f3tesis se reconstruyeron las relaciones filogen\u00e9ticas de la familia msp7 en Plasmodium y se evalu\u00f3 la presencia de se\u00f1ales de selecci\u00f3n linaje -espec\u00edfica. 41 Metodolog\u00eda Usando una aproximaci\u00f3n similar a la previamente reportada (92), se identificaron miembros de la familia msp7 en 13 especies de Plasmodium y se establecieron las relaciones de ortolog\u00eda . Las s ecuencias de ADN de miembros de msp7 identificad os fueron usadas para deducir su respectiva secuencia de amino\u00e1cidos , para posteriormente, ser alineadas usando el m\u00e9todo MUSCLE (95). El m\u00e9todo DLRTS (108) se utiliz\u00f3 con el fin de inferir el \u00e1rbol de los genes msp7 teniendo en cuenta la filogenia de Plasmodium spp. Adicionalmente, se infiriero n \u00e1rboles filogen\u00e9ticos utilizando m\u00e9todos de m\u00e1xima verosimilitud (ML, con el programa RAxML (109)) y Bayesiano (BY con el programa MrBayes (110)) con el modelo JTT +G +F (seleccionado como el mejor modelo evolutivo por el m\u00e9todo ProtTest (111)). Esto s an\u00e1lisis se realizaron en la plataforma CIPRES Science Gatewa y (112, 113). Identificaci\u00f3n de selecci\u00f3n epis\u00f3dica linaje -espec \u00edfica El modelo Branch -site REL se utiliz\u00f3 para evaluar la presencia de linajes (ramas) en la filogenia de la familia msp7 , donde un porcentaje de sitios presenten una selecci\u00f3n diversificada epis\u00f3dica (114). El m\u00e9todo MUSCLE se us\u00f3 para alinear independientemente las secuencias de amino\u00e1cidos de cada grupo ort\u00f3lo go (Figuras 8 y 9), para posteriormente inferir el alineamiento por codones de cada grupo ort\u00f3logo con el programa PAL2NAL (97). El mejor modelo evolutivo para cada alineamiento (para ADN y prote\u00ednas) fue determinado usando los programas jModelTest (115) y ProtTest (111), respectivamente. Los alineamientos y filogenias inferidas por ML para cada alineamiento fueron utilizadas como entrada para correr el m\u00e9todo Branch -site REL en el paquete HyPhy (116). Adicionalmente, el servidor web Datamonkey (117) fue utilizado para este mismo an\u00e1lisis. Finalmente, el m\u00e9todo MEME (118) se utiliz\u00f3 para inferir qu\u00e9 sitios estaban bajo selecci\u00f3n positiva epis\u00f3dica en cada grupo de ort\u00f3logos . 42 Figura 7. Metodolog\u00eda del Cap\u00edtulo 2 Figura 8. Filogenia de la familia de g enes msp7 inferida por el modelo evolutivo DLTRS 43 A. Filogenia del g\u00e9nero Plasmodium utilizada para inferir el \u00e1rbol MSP7 por el m\u00e9todo DLTRS. B. \u00c1rbol MSP7 inferido a partir del \u00e1rbol de l g\u00e9nero Plasmodium . Los n\u00fameros representan clados diferentes, mien tras que los n\u00fameros en las ramas son valores de probabilidad posteriores. Nueve clados principales fueron identificados en el \u00e1rbol. Las prote\u00ednas se agrupan de acuerdo con las relaciones filogen\u00e9ticas del par\u00e1sito, los clados 1 (rojo) y 2 (amarillo) son los m\u00e1s ancestrales y el clado 5 (violeta) tambi\u00e9n podr\u00eda ser ancestral . Las secuencias del linaje de par\u00e1sitos que infectan cercopit\u00e9cidos se representan en verde, las prote\u00ednas del linaje de par\u00e1sitos que infectan roedores en azul y el linaje de par\u00e1sito s que infectan hom\u00ednidos en gris. 44 Figura 9. Representaci\u00f3n esquem\u00e1tica de los loci msp7 en 13 genomas de Plasmodium Los genes que flanquean la regi\u00f3n que contiene la familia msp7 en las especies de Plasmodium est\u00e1n representado s por recuadros de color naranja. Los recuadros de colores dentro de las secuencias flanqueantes representan los genes msp7 en cada especie, mientras que los recuadros negros simboliza n los pseudogenes. Los genes se nombraron en orden alfab\u00e9tico de izquier da a derecha. Las l\u00edneas punteadas conectan genes ort\u00f3logos. Todos los genes est\u00e1n representados a escala, pero la distancia entre ellos no es representativa. Los signos de interrogaci\u00f3n indican relaciones de ortolog\u00eda que no fueron claramente establecidas . A diferencia de los par\u00e1sitos que infectan hom\u00ednidos , las especies de linaje de par\u00e1sitos que infectan cercopit\u00e9cidos y roedores parecen tener historias evolutivas similares con respecto a la expansi\u00f3n de msp7. Los recuadros grises son genes espec\u00edficos del linaje y que no pertenecen a la familia msp7 (las representaciones de estos \u00faltimos genes no est\u00e1n a escala). 45 Tabla 4. Caracterizaci\u00f3n in-silico de las prote\u00ednas MSP7 Genes msp7 A B C D E F G H I J K L M P. vivax SP y y y y y y y y y - y y y MSP7_C y y y - y y y y y y y y - P. cynomo lgi SP y y y y - y y y y - y y y MSP7_C y y y - y y y y y y y y - P. inui SP y - y y y - y y MSP7_C y y y y y - y y P. knowlesi SP y y y y y MSP7_C y - y y y P. coatneyi SP y - y y y MSP7_C y - y y y P. chabaudi SP y y y y MSP7_C y y y - P. vinckei v. SP y y y y MSP7_C y y y - P. vinckei p. SP y y y y MSP7_C y y y - P. bergh ei SP y y y y MSP7_C y y y - P. yoelii SP y y y y MSP7_C y y y - P. falciparum SP y y - y y y y MSP7_C y y y y y y y y y P. reichenowi SP y - y y y y y MSP7_C y y y y y y y y y P. gallinac eum SP y MSP7_C y Las prote\u00ednas MSP7 fueron evaluad as con respecto a la presencia de p\u00e9ptido se\u00f1al (SP) y del dominio MSP_7C ( n\u00famero de acceso en Pfam : PF12948 ), caracter\u00edstico de los miembros de esta familia. Con la letra \"y\" se indica la presencia de l p\u00e9ptido se\u00f1al o del dominio. Aquellas prote\u00ednas que no presenta ron estas estructuras se indican con el s\u00edmbolo \" -\". 46 Resultados y discusi\u00f3n Estructura gen\u00e9tica y relaciones filogen\u00e9ticas de la regi\u00f3n msp7 en Plasmodium spp. La reg i\u00f3n cromos\u00f3mica en P. vivax , donde la familia msp7 est\u00e1 ubicada, es delimitada por los genes PVX_082640 y PVX_082715 (92, 93, 119), por lo tanto , ort\u00f3logos a \u00e9stos fueron identificados en las dem\u00e1s especies (Figura 9 ). Dado que las prote\u00ednas MSP7 parecen ser codificadas por un \u00fanico ex\u00f3n (54), las regiones cromos\u00f3micas entre l os genes que delimitan la familia , fueron analizadas con la herramienta ORFFinder y GeneRunner . Este an\u00e1lisis identifico 79 marcos abiertos de lectura (ORFs por sus siglas en ingl\u00e9s , Publicaci\u00f3n 2) con la misma orientaci\u00f3n de trascripci\u00f3n ( Figura 9 ). Estos ORF fueron nombrados en orden alfab\u00e9tico con respect o a su aparici\u00f3n despu\u00e9s del gen PVX_082640 ( o sus ort\u00f3logos en cada especie ). Posteriormente, se determin\u00f3 la presencia del p\u00e9ptido se\u00f1al y del dominio MSP_7C (Tabla 4 ). El n\u00famero de genes msp7 var\u00eda de especie a especie, sugiriendo que eventos de duplicaci\u00f3n (o deleci\u00f3n ) han ocurrido de manera especie -espec\u00edfica. Esto confirma resultados previos (92, 119), donde se ha sugerido que esta familia evoluciona bajo el modelo de nacimi ento y muerte de genes (Figura 9 ). Relaciones filogen\u00e9ticas de los miembros de msp7 en Plasmodium El m\u00e9todo DLTRS (108, 120) fue utilizado para reconciliar el \u00e1rbol de los genes msp7 con la filogenia del g\u00e9nero . En el \u00e1rbol inferido por este m\u00e9todo (Figura 8 ) se observan 9 grupos principales. Los grupos 1, 2, 3a, 3b, 3c, 4 y 5 representan grupos ort\u00f3logos, mientras en los grupos 3d y 6 se agrupan tanto ort\u00f3logos como par\u00e1logos. Este agrupamiento fue similar al observad o en las filogenias inferidas por ML y BY (Anexo 3). El grupo 1 (MSP7A/H) fue el gen m\u00e1s ancestral, seguido por el grupo 2 , el cua l incluye secuencias de par\u00e1sito s que infectan cercopit\u00e9cidos y roedores. En P. gallinaceum , se observ\u00f3 un gen con una longitu d mayor a los otros msp7 , pero a\u00fan no es claro si este gen es ort\u00f3logo al gen m\u00e1s ancestral ( msp7A/H ). Como s \u00f3lo se encontr\u00f3 un gen msp7 en el genoma de P. gallinaceum , la expansi\u00f3n de la familia msp7 debi\u00f3 haber ocurrido despu\u00e9s de la radiaci\u00f3n de par\u00e1sit os de mam\u00edferos hace 40 millones de a\u00f1os (11). 47 Selecci\u00f3n positiva linaje -especifica en msp7 MSP1 es la prote\u00edna que media la interacci\u00f3n inicial entre los merozo\u00edto s y los gl\u00f3bulos rojos (121-124). Estudios previos han mostrado que el gen msp1 presenta se\u00f1ales de selecci\u00f3n positiva. Esta selecci\u00f3n ocurri\u00f3 en alg\u00fan momento y dentro de s \u00f3lo algun os linajes ancestral es (selecci\u00f3n positiva epis\u00f3dica linaje -espec \u00edfica) dentro del grupo de par\u00e1sitos de cercopit\u00e9cidos (105, 125) y esto ser\u00eda el resultado de la adaptaci\u00f3n de poblaciones ancestrales del par\u00e1sito a las nuevas especies de macacos que surgieron hace 3,7 a 5 ,1 millones de a\u00f1os (105) o durante el cambio de hospedero que dio origen a P. vivax (15). Dado que MSP7 forma un complejo con MSP1 (121, 123, 124), MSP7 deber\u00eda estar bajo las mismas presiones selectivas y por lo tanto , se\u00f1ales de selecci\u00f3n linaje -espec \u00edfica podr\u00eda n estar pr esentes en los miembros de esta familia. Varias ramas (linajes) mostraron se\u00f1ales de selecci\u00f3n positiva en miembros de la familia msp7 . Como en MSP1 (105, 125), muchas de estas rama s eran ramas internas (Figura 10 A, E, F and G). La mayor cantidad de codones bajo selecci\u00f3n positiva se localiz\u00f3 en las regiones centrales de msp7 y pocos en los extremos 5' o 3 '. Estudios previos han mostrado que la regi\u00f3n central es la m\u00e1s polim\u00f3rfica y parece estar involucrada en la evasi\u00f3n de la respuesta inmune (90). Los siti os seleccionados positivamente en las regiones centrales de las prote\u00ednas MSP7, podr\u00edan ser la consecuencia de la evasi\u00f3n a la respuesta inmune del h ospedero , lo que permitir\u00eda la adaptaci\u00f3n del par\u00e1sito . Por otro lado, los sitios bajo selecci\u00f3n positiva en la regi\u00f3n C - terminal , podr\u00edan ser el resultado de la coevoluci\u00f3n entre el receptor del hospedero y los ligandos MSP7 del par\u00e1sito o del resultado de la adquisici\u00f3n de nuevas funciones (Publicaci\u00f3n 2). Si la selecci\u00f3n posit iva ha actuado de manera lin aje-espec \u00edfica, se observar\u00e1 una alta divergencia entre las secuencias de especies relacionadas. Mientras un determinado amino\u00e1cido se fij\u00f3 en un linaje (o especie) por selecci\u00f3n positiva en una determinada posici\u00f3n, en los otros linajes (o especies), amin o\u00e1cidos diferentes podr\u00edan present arse en esa misma posici\u00f3n. Por lo tanto, esto generar\u00e1 un incremento en la tasa cuando se comparan las secuencias. As\u00ed, aunque se trate de regiones funcionalmente importantes, la presencia de la selecci\u00f3n positiva linaje -espec \u00edfica en esta regi\u00f3n , har\u00e1 que la tasa sea alta 48 y, por lo tanto, regio nes funcionales con este patr\u00f3n, ser\u00e1n descartadas si se sigue el enfoque presentado en el Cap\u00edtulo 1. Figura 10. Filogenias de msp7s analizadas por el m\u00e9todo Branch -site REL Cada gr upo ort\u00f3logo identificado en la Figura 9 fue analizado por el m\u00e9todo Branch -site REL. El color sobre las ramas indica el tipo de selecci\u00f3n (rojo > 13, selecci\u00f3n positiva; azul 1, selecci\u00f3n negativa) mientras el color gris representa un = 1 (neutral idad). La longitud de cada color representa el porcentaje de sitios en la clase correspondiente encontrada por Branch -site REL . A. Clado 1; 2; H. pviv/pcynmsp7L y pinumsp7H y I. Clado 4. En la parte inferior de cada filogenia hay una representaci\u00f3n a escala del gene msp7 correspondiente . Los cuadros azul oscuro dentro de este esquema representan la regi\u00f3n N -terminal, los marrones claros simbolizan la regi\u00f3n central y los cuadros 49 morados , el dominio MSP_7C. Los n\u00fameros dentro de las casillas representan el n\u00famero de codones bajo selecci\u00f3n positiva inferida por los m\u00e9todo s MEME, SLAC, FEL, REL y FUBAR utilizando el servidor web Datamonkey. Conclusiones La familia msp7 es el resultado de procesos de duplicaci\u00f3n diferencial en Plasmodium spp, lo que gene ra que el n\u00famero de copias var\u00ede de una especie a otra. Estos genes ha n fijado mutaciones por sele cci\u00f3n positiva de manera linaje -espec\u00edfica. Este tipo de selecci\u00f3n genera un incremento en las tasas evolutivas , a pesar de que se trate de regiones funcionalmente importantes, por lo tanto, se\u00f1al es de selecci\u00f3n positiva linaje -espec \u00edficas podr\u00edan representar una limitante cuando se seleccione n genes como candidatos a vacuna siguiendo el enfoque presentado en el Cap\u00edtulo 1. Los resultados de este cap\u00edtulo fueron publicados y est\u00e1n disponibles bajo la siguiente referencia: Publicaci\u00f3n 2: Garz\u00f3n -Ospina D 50 CAPITULO 3 Validaci\u00f3n del enfoque alternativo presentado en el Cap\u00edtulo 1 para la selecci\u00f3n de candidatos a vacuna. 51 Introducci\u00f3n El desarrollo de una vacuna antimal\u00e1rica es una de las estrategias propuestas para el control de la malaria . Sin embargo, en P. vivax , pocos ant\u00edgenos han sido caracterizados como candidatos promisorios a ser incluidos dentro de una vacuna (126, 127). Adicionalmente, l a alta diversidad gen\u00e9tica presente en algunos de los ant\u00edgenos parasitarios (61, 64, 65, 67, 70, 71, 90, 128, 129) ha obstaculizado el desarrollo de una va cuna debido a las respuestas inmunes alelo -espec\u00edficas que esta diversidad podr\u00eda genera r (32, 34, 59). Por tal motivo, la evaluaci\u00f3n de la diversidad gen\u00e9tica de los ant\u00edgenos parasitarios es esencial durante el dise\u00f1o de una vacuna completamente efectiva. No obstante , llevar a cabo estos estudios para todos y cada uno de los genes candidatos, implicar\u00eda tiempo y recursos econ\u00f3micos, convirti\u00e9ndose en una nueva limitante para el desarrollo de una vacuna contra este pat\u00f3geno. En el Cap\u00edtulo 1 de este proyecto , se propuso un flujo de trabajo que permite realizar una selecci\u00f3n de ant\u00edgenos promisorios en un menor tiempo. Sin embargo, con el fin d e validar este flujo de trabajo, se realizaron an\u00e1lisis poblacionales para determinar si lo observado a partir de 5 secuencias de asilados de diversas partes del m undo , coincide con los an\u00e1lisis realizados a partir de un n\u00famero mayor de secuencias . Metodolog\u00eda Entre los genes seleccionados en el C ap\u00edtulo 1 como candidatos promisorios , se destacan tres miembros de la familia del dominio de 6 -cisteinas (6 -Cys), tres prote\u00ednas de roptrias, algunos ant\u00edgenos de membrana y una prote\u00edna hipot\u00e9tica. Algunos de estos fueron seleccionados para ser analizados mediante an\u00e1lisis poblacionales y as\u00ed val idar los datos obtenidos en el C ap\u00edtulo 1 . Adicionalmente, miembros de la fa milia msp7 fueron tambi\u00e9n seleccionados para estos an\u00e1lisis. Verificaci\u00f3n de la integridad del ADN. El ADN parasitario utilizado fue extra\u00eddo a partir de muestras de sangre total provenientes de diferen tes regiones del pa\u00eds (Figura 11 ) obtenidas desde el 2007 hasta el 2016. La presencia e integridad del ADN parasitario (almacenado a -20 oC) fue verifica do por la amplificaci\u00f3n por PCR de la subunidad ribosomal 18S de P. vivax . Los productos de PCR 52 fueron evaluados por electr oforesis en gel de agarosa al 1,5%, con el marcador de peso Hyperladder I. Figura 11. Lugar de procedencia de las muestras de ADN parasitario en Colombia A. Procedencia de las muestras de ADN gen\u00f3mico obtenido entre el 2007 y el 2016. B. Procedencia de las secuencias de las cepas de referencia Determinaci\u00f3n de la presencia de infecciones \u00fanicas por P. vivax y de diferentes genotipos en las muestras utilizadas . La t\u00e9cnica de PCR -RPLFs fue implementada c on el fin de determinar si las muestras positivas para P. vivax correspond \u00edan a infecciones \u00fanicas. Adicionalmente, esto permit i\u00f3 evaluar la presencia de diferentes genotipos en las muestras . Un fragmento del gen msp1 (o msp3 ) fue amplificado por PCR con iniciadores previamente reportados (130, 131). Los ampl\u00edmeros fueron entonces digeridos con las enzimas de restricci\u00f3n Alu y Mnl -I (Alu-I y Hha-I para msp3 ). Los productos de esta digesti\u00f3n fueron evaluados por electroforesis en gel de agarosa al 3%, con el marcador de peso Hyperladder V. Adicionalmente, algunos de los ampl\u00edmeros de msp3 fueron secuenciados para confirmar la presencia de infecciones \u00fanicas. 53 Dise\u00f1o de iniciadores y amplificaci\u00f3n por PCR El dise\u00f1o de los iniciadores para la amplificaci\u00f3n del genes seleccionados, se realiz \u00f3 con el programa Gene Runner (Hastings software, Inc.) y el servidor en -l\u00ednea Oligoanalizer (IDT\u00ae Integrated DNA Technologies , https://www.idtdna.com/calc/analyzer ), utilizando para \u00e9 sto, los datos gen\u00f3micos de la cepa Sal-I de P. vivax . Se dise\u00f1\u00f3 un juego de iniciadores para la amplificaci\u00f3n de cada gen, y de ser necesario, ot ros para la secuenciaci\u00f3n . La optimizaci\u00f3n de las condiciones de PCR para la amplificaci\u00f3n de los genes, se realiz \u00f3 utilizando los iniciadores dise\u00f1ados previamente. Para \u00e9sta, se utiliz \u00f3 la enzima de alta fidelidad KAPA - HiFi HotStart Readymix VCG -I como control positivo. Una vez optimizadas las condiciones de PCR, se amplific \u00f3 el ADN paras itario de al menos 30 muestras procedentes de Colombia (Publicaciones 3 - 6). Purificaci\u00f3n y Secuenciaci\u00f3n de los fragmento s amplificado s. Los productos de PCR fueron purificados con el kit de purificaci\u00f3n UltraClean PCR Clean - up (MOBIO\u00ae), siguiendo las recomendaciones del fabricante. Los fragmentos purificados fueron verificados por medio de electr oforesis en gel de agarosa al 1,5%, con el marcador de peso Hyperladder I. Para el gen pvron4 se realiz \u00f3 la clonaci\u00f3n de este fragmento en el vector pGEM -T (Publicaci\u00f3n 6 ). Los productos de PCR purificados o el ADN plasm\u00eddico fueron secuenciados bidireccionalmente con los iniciadores de amplificaci\u00f3n o los iniciadores universales T7 y SP6 . La secuenciaci\u00f3n se realiz\u00f3 utilizando el kit BigDye Terminator en Macrogen, Se\u00fal, Corea del Sur. Al menos dos productos de PCRs independientes o dos pl\u00e1smidos por muestra , fueron enviados a secuenci aci\u00f3n. An\u00e1lisis de la diversidad gen\u00e9tica y de las fuerzas evolutivas en los loci seleccionados. Se analizar on y ensamblar on los electroferogramas obtenidos por secuenciaci\u00f3n usando el programa CLC DNA workbench (CLC bio, Cambridge, MA, USA). Una vez corr egidas las secuencias, \u00e9stas fueron comparadas y analizadas frente a secuencias de referencia y de especies filogen\u00e9ticamente relacionadas disponibles en bases de datos. 54 Figura 12. Metodolog\u00eda del Cap\u00edtulo 3 55 Con las secuencias de la poblaci\u00f3n Colombiana, se realiz aron alineamiento s de las secuencias derivadas de amino\u00e1cidos con el m\u00e9todo MUSCLE (95) y a partir de \u00e9ste, se infiri \u00f3 el alineamiento de ADN usando el programa Pal2Nal (97). A p artir de este \u00faltimo alineamiento y usando el programa DnaSP v.5 (98), se calcular on el n\u00famero de sitios segregantes y la diversidad nucleot\u00eddica por sitio. Se evaluar on se\u00f1ales de selecci\u00f3n natural utilizando m\u00e9todo s basados en el c\u00e1lculo de sustituciones de tipo sin\u00f3nimo y no -sin\u00f3nimo. Usando el programa MEGA v.5 (103), se calcularon el n\u00famero promedio de s ustituciones sin\u00f3nimas por sitio sin\u00f3nimo (d S) y el n\u00famero promedio de sustituciones no -sin\u00f3nimas por sitio no -sin\u00f3nimo (d N) empleando el m\u00e9todo modificado de Nei -Gojobori (104). Por otra parte, para determinar se\u00f1ales de selecci\u00f3n natural entre especies, se calcul \u00f3 el n\u00famero prom edio de divergencias sin\u00f3nimas por sitio sin\u00f3nimo (K S) y el n\u00famero promedio de divergencias no -sin\u00f3nimas por sitio no - sin\u00f3nimo (K N), empleando el m\u00e9todo modificado de Nei -Gojobori, teniendo en cuenta la correcci\u00f3n de Jukes -Cantor (101). Las diferencias estad\u00edsticas entre estas tasas se determinar on aplicando la prueba Z-test, incorporada en el programa MEGA. Presiones selectivas por sitio (cod\u00f3n) fueron inferidas calculando las tasas de sustituciones sin\u00f3nimas y no -sin\u00f3nimas mediante los m\u00e9todos SLAC, FEL, REL, IFEL (132), MEME (118) y FUBAR (133), implementados en el servidor en l\u00ednea Datamonkey (117), con previa evaluaci\u00f3n de recombinaci\u00f3n por el m\u00e9todo GARD (134). Resultados y discusi\u00f3n Muestras de ADN parasitario provenientes de diferentes regiones del pa\u00eds (Figura 11), fueron utilizadas para la amplificaci\u00f3n de l a amplificaci\u00f3n de estos genes, se realiz\u00f3 una aproximaci\u00f3n para la detecci\u00f3n de infecciones por cepa \u00fanica mediante PCR -RFLP. Adicionalmente, esta t\u00e9cnica permiti\u00f3 identificar la presencia de diferentes genotipos en la s muestras utilizadas (Figura 13 ). 56 Figura 13. Patrones de PCR -RFLPs A. Amplifi caci\u00f3n del fragmento 2 de pvmsp 1; Carril 1: Muestra con infecci\u00f3n m\u00faltiple, carriles del 2 -5: Algunas de las muestras utilizadas en este es tudio, C+: ADN de la cepa VCG -I, C-: control C -2: ADN cepa FVO de P. falciparum, MP: marcador de peso. B. Carriles del 1 -11: Algunas de las m uestras utilizadas en este estudio, panel superior fragmentos de digesti\u00f3n con Alu -I, panel inferior fragmentos de digesti\u00f3n con Mnl -I, MP: marcador de peso. Fragmentos genes (Publicaci\u00f3n 6 y pvceltos (manuscrito en preparaci\u00f3n) fueron amplificados y secuenciados. A partir de las secuencias obtenidas , varios par\u00e1metros de diversidad para cada gen fueron calculados (Tabla 5). Estos par\u00e1metros fueron entonces comparados con los obtenidos al analizar s \u00f3lo secuencias de cepas de referencia (Tabla 5). Poste riormente, estos mismos par\u00e1metros fueron calculados a partir de alineamientos con todas las secuencias disponibles a la fecha para cada gen. Ventanas deslizantes de la diversidad nucleot\u00eddica por sitio (), fueron obtenidas a partir de estos 3 sets de d atos (Figura 14). Adicionalmente, a partir de estos 3 set s de datos, fueron calculadas las diferencias entre K N y K S (Tablas 6), as\u00ed como ventanas deslizantes para la tasa evolutiva (K N/KS, Figura 15 ). Los resultados observados en las Figuras 14 y 15, as \u00ed como las tablas 5 y 6 , muestran una concordancia entre los datos obtenidos a partir de 5 cepas de P. vivax de diferentes regiones del mundo y los an\u00e1lisis realizados a partir de un n\u00famero mayor de secuencias. 57 Tabla 5. Estimador es de diversidad gen\u00e9tica Datos Capitulo 1 Datos Capitulo 3 Datos con secuencias disponibles Gen n Sitios Ss n Sitios Ss n Sitios Ss pv12 7 942 4 0,0014 (0 ,0006) 70 1047 1 (0 ,0001) 156 19 (0 pv38 1065 0,0022 (0 ,0004) 1062 (0 ,0002) 132 19 (0 ,0002) pv41 6 1086 14 0,0064 (0 ,0013) 30 1115 10 0,0028 (0 ,0005) 119 33 (0 ,0003) pvmsp7E 1047 0,0651 44 171 (0 ,0044) pvmsp7F 1164 0,0007 (0 ,0002) 36 1176 2 0,0007 (0 ,0004) 120 1146 8 0,0009 (0 ,0001) pvmsp7L 6 1212 3 0,0008 (0 ,0004) 31 1212 4 0,0006 (0 ,0001) 122 13 (0 0,0024 (0,0010) 62 546 1 0,0008 (0 ,0001) 209 546 7 0,0018 (0 ,0001) Los estimadores de la diversidad gen\u00e9tica se calcularon utilizando las secuencias obtenidas de cepas de referencia (datos Capitulo 1), con secuencias obtenidas en Colombia (datos Cap\u00edtulo 3 ) y a partir de las secuencias de cepas de referencia, de las secuencias colombianas y de todas las secuencia s disponibles a la fecha obtenidas de PlasmoDB o GenBank como un \u00fanico set de datos. n: n\u00famero de secuencias analizada s, sitios: total de sitios analizados (sin incluir gaps ), Ss: n\u00famero de sitios segregados, : diversidad de nucle\u00f3tidos por sitio. Tabla 6. Tasas de divergencia no -sin\u00f3nima ( KN) y sin\u00f3nima ( KS) Datos Capitulo 1 Datos Capitulo 3 Datos con secuencias disponibles Gen n KN-KS n KN-KS n KN-KS pv12 pvmsp7F -0,014 (0 ,010) 36 -0,002 (0 ,002) 120 0,000 (0 ,001) pvmsp7L 6 -0,018 (0,012) 31 -0,003 (0 ,003) 122 -0,001 (0 ,001) pvron4 6 -0,187 (0,002) *: p <0 ,001 **: p < 0 ,03 58 Figura 14. Ventanas deslizantes de para 8 ant\u00edgenos de P. vivax La di versidad nucleot\u00eddica por sitio fue calculada mediante ventanas deslizantes para 8 ant\u00edgenos de P. vivax para comparar l os resultados de los tres set s de datos (datos Capitulo 1 [azul, incluye solo las cepas de referencia], datos Capitulo 2 [rojo, incluye las secuencias obtenidas de la poblaci\u00f3n parasitaria de Colombia] y secuencias (seq) disponibles [verde, incluye las sec uencias de las cepas, las de par\u00e1sitos colombianos y otras secuencias disponibles en bases de datos]) . A. pv12, B. pv38, F. pvmsp7L, G. pvron4 y H. pvceltos. 59 Figura 15. Ventanas deslizante s de la t asa entre especie s Ventanas deslizantes de la tase entre especies (K N/KS) para 8 ant\u00edgenos de P. vivax fueron calculadas para comparar los resultados de los tres sets de datos (datos Capitulo 1 [azul, incluye solo las cepas de referencia], datos Capi tulo 2 [rojo, incluye las secuencias obtenidas de la poblaci\u00f3n parasitaria de Colombia] y secuencias (seq) disponibles [verde, incluye las secuencias de las cepas, las de par\u00e1sitos colombianos y otras secuencias disponibles en bases de datos]) . A. pv12, B. 7L, G. pvron4 y H. pvceltos. 60 Conclusiones A partir de al menos 30 muestras de ADN parasitario obtenido de regiones end\u00e9micas de malaria en Colombia , de estas secuencias, se obtuvieron datos de diferentes estimadores de diversidad gen\u00e9tica, as\u00ed como de la tasa evolutiva . Estos resultados mostraron una concordancia con aquellos obtenidos en el Ca p\u00edtulo 1 de este trabajo. Por lo tanto, el enfoque implementado en el Cap\u00edtulo 1 , se convierte en una aproximaci\u00f3n alternativa para la selecci\u00f3n de candidatos promisorios a vacuna, desde el punto de vista que los candidatos deben ser altamente conservados para evitar las respuestas alelo -espec\u00edficas que disminuyen la eficacia de las vacuna s. Adicionalmente, la evaluaci\u00f3n de la tasa evolutiva podr\u00eda ayudar a la identificaci\u00f3n de regiones funcionalmente restringidas dentro de los ant\u00edgenos parasitarios. Los resultados de este cap\u00edtulo fueron publicados y est\u00e1n disponibles bajo las sig uientes referencias: Publicaci\u00f3n 3: Forero Patarroyo MA. -4. 62 CAPITULO 4 Implementaci\u00f3n del enfoque del Cap\u00edtulo 1 durante la caracterizaci\u00f3n de nuevos ant\u00edgenos de P. vivax . 63 Introducci\u00f3n En 2013 , la malERA (del ingl\u00e9s Malaria Eradication Research Agenda ) reconoci\u00f3 la necesidad de desarrollar de una vacuna contra P. vivax debido a las complicaciones que la infecci\u00f3n por este par\u00e1sito est\u00e1 generando en diferentes zonas end\u00e9micas (23). Con respecto a P. falciparum , la investigaci\u00f3n en P. vivax se encuentra retrasada debido a la compleja biolog\u00eda de este par\u00e1sito (135), y a la fecha pocos candidatos a vacuna han sido evaluados en fases cl\u00ednicas (21). Uno de los principales factores de este retraso es la predilecci\u00f3n de P. vivax por los reticulocitos, los cuales son c\u00e9lulas rojas inmaduras que no suelen superar el 1% de las c\u00e9lulas circulantes en sangre perif\u00e9rica (136, 137). Debido a que P. vivax invade exclusivamente est e tipo celular, los cultivos in vitro de este par\u00e1 sito son de corta duraci\u00f3n y, por lo tanto, no ha sido posible realizar las mismas aproximaciones hechas en P. falciparum (138, 139). En P. vivax se han descrito m\u00e1s de 50 ant\u00edgenos expresados en el estadio sangu\u00edneo (el merozo\u00edto ) (24, 26, 28, 87, 140, 141), pero las regiones de interacci\u00f3n con los reticulocitos s \u00f3lo han sido establecid as para un reducido n\u00famero de ellos (36-38, 142). Adicionalmente, P. vivax presenta casi el doble de la diversidad gen\u00e9tica de P. falciparum (29), y \u00e9sto, es un problema adicional para el desarrollo de una vacuna. Para dise\u00f1ar una vacuna contra P. vivax , siguiendo la misma estrategia utilizada en P. falcipar um (138, 139), se hace entonces necesario , no s\u00f3lo la identificaci\u00f3n de ant\u00edgenos parasitarios, sin o adem\u00e1s, se deben establecer las regiones de interacci\u00f3n pat\u00f3geno - hospedero, as\u00ed como la diversidad de esos ant\u00edgenos (u regiones espec\u00edficas ). Sin embargo, para evaluar estos aspectos , ser\u00eda necesario, primero, contar una fuente permanente de reticulocit os que permitiera realizar ensayos de uni\u00f3n con la prote\u00edna completa y diferentes fragmentos de la mol\u00e9cula , siendo \u00e9sta, precisamente una de las limitantes que no ha permitido avanzar con los ensayos de uni\u00f3n. Segundo, la diversidad de estos ant\u00edgenos se hace en determinadas poblaciones, amplificando y secuenciando al menos 30 muestras parasitari as (21). El enfoque presentado en este trabajo est\u00e1 basado en la premisa que es posible hacer un acercamiento a la diversidad de un ant\u00edgeno a partir de pocos asilados de diferentes 64 regiones del mundo. Los resultados del Cap\u00edtulo 1 de este trabajo , muestran que dominios involucrados en la interacci\u00f3n parasito -gl\u00f3bulo rojo son conservados entre especies y mostraron se\u00f1ales de selecci\u00f3n negativa ( < 1). Por lo tanto, este enfoque, adem\u00e1s de proporcionar informaci\u00f3n de las regiones ideales para el dise\u00f1o de una vacuna (conservadas por selecci\u00f3n negativa), podr\u00eda tambi\u00e9n delimitar qu\u00e9 regiones d e un ant\u00edgeno podr\u00edan ser evaluadas en ensayos funcionales y as\u00ed, en lugar de utilizar toda la mol\u00e9cula (36-38), s\u00f3lo una parte de ella ser\u00eda utilizada, optimiz ando los recursos disponibles. As\u00ed, p ara determinar la utilidad del enfoque presentado en este trabajo durante el desarrollo de una vacuna altamente efectiva contra P. vivax , \u00e9ste fue implementado durante la caracterizaci\u00f3n de nuevos ant\u00edgenos de P. vivax (publicaciones 7 -9). Metodolog\u00eda Con la colaboraci\u00f3n del grupo de Biolog\u00eda molecular de la FIDIC, quienes describen nuevos ant\u00edgenos de P. vivax , se seleccionaron tres ant\u00edgenos : PvGAMA, PvRBSA y PvCelTOS. Paralelamente a la caracterizaci\u00f3n de estos ant\u00ed genos (143), se implement\u00f3 la metodolog\u00eda de la Figura 4, con el fin de t ener una aproximaci\u00f3n a la diversidad gen\u00e9tica y las fuerzas evolutivas de estos loci. Secuencias de ADN que codifican para pvgama , pvrbsa y pvceltos de (Sal-I, Brazil -I, India -VII, Mauritania -I y Corea del Norte (29)) y ort\u00f3logos de al menos dos especies filogen\u00e9ticamente relacionadas ( P. cynomolgi y P. knowlesi ) (144) fueron obtenidas y alineadas (siguiendo los mismos pasos mencio nados en anteriores Cap\u00edtulos) . A partir de las secuencias de P. vivax , la diversidad nucleot\u00eddica por sitio ( ) fue estimada . Usando las secuencias de P. vivax junto con las de especies relacionadas , se estim\u00f3 una ventana deslizante de la tasa (KN/KS). Sitios bajo selecci\u00f3n entre especies fueron inferidos usando los algoritmos SLAC, FEL, REL (132), MEME (118) y FUBAR (133) en el servidor Datamonkey , con previa evaluaci\u00f3n de recombinaci\u00f3n por el m\u00e9todo GARD (134). 65 A partir de los resultados de los an\u00e1lisis anteriores , se seleccionaron al menos dos fragmentos de los ant\u00edgenos pvgama (CR1, CR 2, VR (pvrbsa -A y pvrbsa -B), los cuales fueron evaluados en ensayos de uni\u00f3n , para determinar su participaci\u00f3n en la interacci\u00f3n pat\u00f3geno -hospedero. Estos experimentos fueron realizados por el grupo de Biolog\u00eda Molecular de la FIDIC. Brevemente, los fragmentos seleccionados fueron amplificados por PCR, purificados y ligados a un vector de expresi\u00f3n. El pl\u00e1smido recombinante fue utilizado para transformar c\u00e9lulas E. coli BL21 -DE3. Las c\u00e9lulas recombinantes fueron utilizadas para la expresi\u00f3n cada fragmento de forma soluble , como ha sido descrito previamente (140). Posteriormente, los fragmentos recombinantes fueron purificad os por cromatogra f\u00eda de afinidad en fase s\u00f3lida , utilizando una resina Ni+2-NTA (Qiagen, Valencia, CA, USA ). La uni\u00f3n de estos fragmentos a reticulocitos humanos (obtenidos de sangre de cord\u00f3n umbilical (SCU) de ni\u00f1os reci\u00e9n nacidos ), fue analizada por triplicado a trav\u00e9s de citometr\u00eda de flujo. 2x107 de reticulocitos fueron incubados con 25\u00b5g de cada prote\u00edna recombinante por 16h a 4\u00b0C y 4 RPM en un agitador de tubos . Posteriormente, l as muestras se incubaron con el anti -His-PE (diluci\u00f3n 1:40, MACSmolecular - Miltenyi Biotec, San CA, USA) en oscuridad y sin agitaci\u00f3n. Los reticulocitos fueron marcados con los anticuerpos monoclonales -APC (diluci\u00f3n 1:80, -APC -H7, respectivamente. Posteriorme nte, la uni\u00f3n de las mol\u00e9culas a reticulocitos (CD71+CD45 -) fue cuantificada analizando 100.000 eventos en un cit\u00f3metro FACS Canto II (BD, San Diego, CA, USA) y el programa FACS Diva (145). Las regi ones II y III/IV de DBP fueron usadas como control de uni\u00f3n positivo y negativo, respectivamente . Para PvCelTOS, se realiz\u00f3 un ensayo de competici\u00f3n (inhibici\u00f3n de la uni\u00f3n de la prote\u00edna recomb\u00ednate), el cual fue ll evado a cabo por el grupo de Receptor -Ligando de la FIDIC. Brevemente, en experimentos iniciales , la prote\u00edna PvCelTOS recombinante mostr\u00f3 ser capaz de interactuar con c\u00e9lulas HeLA. Para determinar las regiones dentro de la prote\u00edna responsables de esta in teracci\u00f3n, p\u00e9ptidos de 20 amino\u00e1cidos cubriendo la totalidad de la 66 secuencia, fueron sintetizados. Estos fueron pre -incubados en un radio molar de 1:20 (prote\u00edna :p\u00e9ptido ) con 2x107 c\u00e9lulas de la linea HeLA por una hora a 4 \u00b0C y 4 RPM en un agitador de tubos . Posteriormente, esta mezcla fue incubada con la prote\u00edna PvCelTOS recombinante y el porcentaje de inhibici\u00f3n de la actividad de uni\u00f3n de PvCelTOS se cuantific\u00f3 mediante el an\u00e1lisis de 100.000 eventos usando un cit\u00f3metro FACS Canto II (Biosciences) y el s oftware FACSDiva (BD). Figura 16. Metodolog\u00eda del Cap\u00edtulo 4 67 Resultados y discusi\u00f3n El an\u00e1lisis de la s secuencias de los loci pvgama , pvrbsa y pvceltos a partir de 5 cepas de P. vivax , mostr \u00f3 que estos son genes con una limitada diversidad gen\u00e9tica (Tabla 6). Estos datos fueron concordantes cuando se analiz\u00f3 un mayor n\u00famero de secuencias ( Tabla 6 y Publicaciones 8 y 9). Tabla 7. Estimadores de diversidad Datos Cepas Datos con secuencias disponibles Gen n Sitios Ss n Sitios Ss pvgama 6 2013 5 0,0006 (0,0004) 75 (0 ,0002) pvceltos 588 ,0010) 209 546 7 0,0018 (0 ,0001) n: n\u00famero de secuencia utilizadas. Sitios: n\u00famero total d e sitios analizados. Ss: n\u00famero de sitios segregrantes. : diversidad nucleot\u00eddica por sitio. De acuerdo con los resultados de la ventana deslizante de las tasas (Figuras 17 y 18 ), se seleccionar on al menos 2 regiones por cada gen : las primera s (pvgama CR1, CR2 y pvrbsa - A) en donde se observ \u00f3 una baja diversidad entre especies y se\u00f1ales de selecci\u00f3n negativa ( < 1 y codones bajo selecci\u00f3n negativa ). La s segunda s regiones (pvgama VR1, VR2 y pvrbsa -B) fueron regiones donde se observ\u00f3 un valor de > 1, algunos sitios bajo selecci\u00f3n positiva y fue ron variable s entre especies de Plasmodium . Estos fragmentos fueron expresados de forma recombinante en un sistema procari\u00f3tico y ev aluados por citometr\u00eda de flujo para determinar si estas regiones permiten la inte racci\u00f3n entre el pat\u00f3geno y el hospedero. Tanto para PvGAMA como para PvRBSA , las regiones de estas prote\u00ednas que mostraron ser conservadas entre especies y con se\u00f1ales de selecci\u00f3n negativa (PvGAMA CR1 , CR2 y PvRBSA -A) mostraron una uni\u00f3n a los reticulo citos humanos que fue estad\u00edsticamente significativa con respecto al control negativo (regi\u00f3n DBP -III/IV, que no interact\u00faa con estas c\u00e9lulas) y a las regiones sin se\u00f1ales de selecci\u00f3n negativa (PvGAMA VR2 y PvRBSA -B) (Figura 19 ). Esto sugiere que las regi ones conservadas entre especies y con 68 se\u00f1ales de selecci\u00f3n negativa de PvGAMA y PvRBSA son regiones que permiten la interacci\u00f3n entre el par\u00e1sito y los reticulocitos humanos, por lo que podr\u00eda n ser considerad as durante el dise\u00f1o de una vacuna contra P. viv ax. Por otra parte, para PvCelTOS, debido a su cor ta longitud, se sintetizaron p\u00e9ptidos no sobrepuestos de 20 amino\u00e1cidos, los cuales fueron utilizados para ensayos de inhibici\u00f3n de la uni\u00f3n. Los result ados de estos ensayos (Figura 20), muestran que los p\u00e9ptidos que inhiben la uni\u00f3n de PvCelTOS a la s c\u00e9lulas diana, concuerdan con las regiones donde se observ\u00f3 un < 1 y donde codones bajo selecci\u00f3n negativa fueron localizados ( Figura 21 y Publicaci\u00f3n 8). Un mayor a 1 fue observado en la regi\u00f3n C -terminal de la prote\u00edna, cerca de la regi\u00f3n que est\u00e1 inhibiendo la uni\u00f3n de PvCelTOS a la c\u00e9lula diana . En P. vivax , esta regi\u00f3n es predicha por estar expuesta al sistema inmune del hospedero (Publicaci\u00f3n 8 y (146)) y estudios previos han mostrado que esta regi\u00f3n es antig\u00e9nica en infecciones naturales en P. vivax (146). Por lo tanto, esta prote\u00edna es un potencial candidato a vacuna, debido a que es reconocid a por el sistema inmune del hospedero y a que es la regi\u00f3n funcional de la prote\u00edna. Todos estos resultados muestran que el enfoque propuesto en el Cap\u00edtulo 1 puede ser utilizado para tener una aproximaci\u00f3n de la diversidad gen\u00e9tica de un determinado ant\u00edgeno pero, adem\u00e1s, tambi\u00e9n permite establecer las posibles regiones involucradas en la interacci\u00f3n pat\u00f3geno -hospedero. Otros resultados obtenidos por diferentes grupos soportan el uso de este enfoque. PvGAMA fue descrito en 2016 por un grupo coreano (147). La prote\u00edna fue dividida en 7 fragmentos diferentes y cada fragmento fue evaluado con respecto a su habilidad de uni\u00f3n. Los fragmentos que mostraron uni\u00f3n (147), coinciden con el fragmento identificado en el presente trabajo como conservado entre especies, con un < 1 y varios codones seleccionados negativamente. 69 Figura 17. Ventana deslizante para el locus pvgama Los valores de gama (dN/dS) dentro de P. vivax se muestran en azul, mientras l a tasa de divergencia (K N / KS) entre las especies que infectan primates y P. vivax se muestran en morado . Una representaci\u00f3n del gen gama se presenta debajo de la ventana deslizante que indica el p\u00e9ptido se\u00f1al , la regi\u00f3n repetida y el anclaje a GPI. Los sitios bajo selecci\u00f3n negativa est\u00e1n representados por l\u00edneas verdes y los sitios seleccionados positivamente entre especies se muestran por l\u00edneas rojas. 70 Figura 18. Ventana deslizante para el locus pvrbsa Los valores de rbsa (dN/dS) dentro de P. vivax se muestran en azul, mientras la tasa de divergencia (K N / KS) entre las especies que infectan primates y P. vivax se muestran en morado . Una representaci\u00f3n del gen rbsa se presenta debajo de la ventana deslizante que indica el p\u00e9ptido se\u00f1al y las h\u00e9lices transmembranales. Los sitios bajo selecci\u00f3n negativa est\u00e1n representados por l\u00edneas verdes y los sitios seleccionados positivamente entre especies se muestran por l\u00edneas rojas. 71 Figura 19. Actividad de uni\u00f3n de fragmentos de PvGAMA y PvRBSA An\u00e1lisis de citometr\u00eda de flujo mostrando el porcentaje de uni\u00f3n de los fragmentos recombinantes de las prote\u00ednas PvGAMA (A) y PvRBSA (B) a reticulocitos humanos. Como control de uni\u00f3n (positivo) , se utiliz\u00f3 la r egi\u00f3n II de DBP que previamente se ha reportado se une a los reticulocitos , y como control negativo , la regi\u00f3n III y IV (37). regiones con patr\u00f3n de restricci\u00f3n funcional en PvGAMA. VR1 y VR2 son regiones variables de PvGAMA. H: control de histidinas. Panel B: F indica la prote\u00edna PvRBSA completa, A, la regi\u00f3n identificada bajo restricci\u00f3n funcional y B, la regi\u00f3n variable. Figura 20. Ensayos de inhibici\u00f3n d e la uni\u00f3n con p\u00e9ptidos de PvCelTOS Secuencias de 20 amino\u00e1cidos (p\u00e9ptidos) correspondientes a la prote\u00edna PvCelTOS. Se observa el porcentaje de inhibici\u00f3n de la uni\u00f3n de la prote\u00edna completa que cada p\u00e9ptido present\u00f3 . 72 Figura 21. Ventana deslizante para el locus pvceltos Los valores de (d N/dS) para pvceltos se muestran en magen ta, mientras la divergencia ( KN/KS) entre P. vivax y P. cynomolgi es mostrada en azul. Un diagram a del gen se presenta debajo de la ventana deslizante. La regi\u00f3n que codifica el p\u00e9ptido se\u00f1al se indica en caf\u00e9 y los sitios bajo selecci\u00f3n positiva y negativa se indican en rojo y verde, respectivamente. Las secuencias de los p\u00e9ptidos que mostraron una inhibici\u00f3n de la uni\u00f3n de la prote\u00edna recombinante son mostradas en morado. Estos p\u00e9ptidos coincide n con las regiones donde se observaron sitios bajo selecci\u00f3n negativa. Recientemente, ensayos funcionales para PvRON4 fueron realizados (148), identificando que la regi\u00f3n C -terminal de esta prote\u00edna interact\u00faa con los reticulocitos humanos. Esto s resultados (148) concuerda n con los obtenidos en este trabajo (Anexo 4 y Publicaci\u00f3n 6) que sugiri\u00f3 que la regi\u00f3n C -terminal de PvRON4 est\u00e1 restringida funcional/estructuralmente (regi\u00f3n conservada entre especies, con un < 1 y codones bajo selecci\u00f3n negativa) . Conclusiones De acuerdo a la teor\u00eda neutral de evoluci\u00f3n molecular (39), dentro de una prote\u00edna, l as regiones funcionales suelen evolucionar m\u00e1s lentame nte y, por lo tanto , son conser vadas. Esa conservaci\u00f3n suele ser man tenida por la selecci\u00f3n negativa , debido a que cualquier 73 alteraci\u00f3n en la secuencia de amino\u00e1cidos podr\u00eda afectar la funci\u00f3n de la pro te\u00edna. Por lo tanto, la predicci\u00f3n de regiones bajo restricci\u00f3n funcional podr\u00eda ser utilizada como una alternativa para determinar las regiones involucr adas en la interacci\u00f3n pat\u00f3geno -hospedero. As\u00ed, en vez de analizar m\u00faltiples y peque\u00f1os fragmentos de l a prote\u00edna, este enfoque podr\u00eda utilizarse para ubicar regiones funcionales potenciales en P. vivax y as\u00ed realizar ensayos de uni\u00f3n s \u00f3lo con aquellas regiones con se\u00f1ales de selecci\u00f3n negativa, optimizando los reticulocitos, que son la limitante para reali zar estos estudios . Adicionalmente, al ser estas regiones conservadas, se podr\u00edan usar durante el desarrollo de una vacuna antimal\u00e1rica para as\u00ed evitar las respuestas alelo -espec\u00edficas de disminuyen la eficacia de la s vacunas. Los resultados de este cap\u00edt ulo fueron publicados y est\u00e1n disponibles bajo las siguientes referencias: Publicaci\u00f3n 7: Baquero LA, Moreno -P\u00e9rez DA, Garz\u00f3n Natural Selection . Front Genet. 2018 Jan 25;9:10. doi:10.3389/fgene.2018.00010. Publicaci\u00f3n 9: Camargo PA, Garz\u00f3n -Ospina D Moreno -P\u00e9rez DA , Ricaurte - Contreras LA, Noya O and Patarroyo MA. On the . 74 CONCLUSIONES GENERALES Este trabajo present\u00f3 y valid \u00f3 el potencia l de un enfoque alternativo para la selecci\u00f3n de ant\u00edgenos promisorios para el dise\u00f1o de una vacuna altamente efectiva contra P. vivax . A partir de los datos (secuencias gen\u00f3micas ) de 5 cepas de P. vivax , fue posible hacer una aproximaci\u00f3n de la diversidad gen\u00e9tica de varios ant\u00edgenos parasitarios. Es tos datos son similares a los obtenidos si se analizan un mayor n\u00famero de secuencias. Adiciona lmente, a partir de estos datos, fue posible determinar regiones que presentan un patr\u00f3n consistente con restricciones funcionales (regi\u00f3n conservada entre especi es, con un < 1 y codones bajo selecci\u00f3n negativa). Al analizar aquellas regiones con un patr\u00f3n de restricci\u00f3n funcional mediante ensayos de uni\u00f3n , se pudo establecer que estas regiones juegan un papel durante la interacci\u00f3n pat\u00f3geno -hospedero , lo que sop orta la utilizaci\u00f3n de este enfoque durante la selecci\u00f3n de candidatos. Aunque este enfoque present\u00f3 buenos resultados, tambi\u00e9n tiene limitaciones. La presencia de se\u00f1ales de selecci\u00f3n positiva linaje -espec \u00edfica, puede incrementar la tasa , lo que desca rtar\u00eda el ant\u00edgeno (u una regi\u00f3n particular de \u00e9ste) como candidato promisorio . No obstante, la identificaci\u00f3n de este tipo de se\u00f1ales, junto con la identificaci\u00f3n de codones bajo selecci\u00f3n negativa, podr\u00eda ser utilizada para hacer frente a esta limitaci\u00f3n . Teniendo en cuenta toda la informaci\u00f3n presentada en este trabajo , junto con las herramientas bioinform\u00e1ticas disponibles , se dise\u00f1\u00f3 la Figura 22, que muestra una alternativa a seguir para la selecci\u00f3n de ant\u00edgenos promisorios a vacuna . Este trabajo eva lu\u00f3 la diversidad gen\u00e9tica e infiri\u00f3 se\u00f1ales consistentes con selecci\u00f3n natural de diferentes ant\u00edgenos de P. vivax . De acuerdo con los resultados obtenidos, los ant\u00edgenos (o regiones bajo restricci\u00f3n funcional 3) , pv41 (Publicaci\u00f3n 1 y 4), pvron4 (Publicaci\u00f3n 1 y 6), pvgama (Publicaci\u00f3n 7), pvrbsa (Publicaci\u00f3n 9) y pvceltos (as\u00ed ant\u00edgenos promisorios a evaluar durante el dise\u00f1o de una vacuna contra P. vivax altamente efectiva. Figura 22. Flujo de trabajo a seguir para seleccionar ant\u00edgenos promiso rios a incluir en el dise\u00f1o de vacunas contra agentes infecciosos 76 PERSPECTIVAS GENERALES En este trabajo de describi\u00f3 y valido un enfoque alternativo para la selecci\u00f3n de ant\u00edgenos promisorios a ser considerados durante el dise\u00f1o de una vacuna contra P. vivax que evite las respuestas inmunes alelo -espec\u00edficas. Cerca de 20 ant\u00edgenos fueron sugeridos como promisorios. Sin embargo, debido a los alcances de este trabajo, s \u00f3lo las regiones predichas como funcionalmente importantes de 3 de estos fueron corro boradas experimentalmente . Por lo tanto, futuros estudios funcionales en los restantes 16 ant\u00edgenos, as\u00ed como, de otros ant\u00edgenos no incluidos en este trabajo, podr\u00edan ser llevados a cabo tomando como base los resultados obtenidos y as\u00ed determinar el rol d e \u00e9stos durante el proceso de invasi\u00f3n de P. vivax a los reticulocitos humanos. Por otra parte, estudios de antigenicidad, inmunogenicidad y protec ci\u00f3n, podr\u00edan ser llevados a cabo con los ant\u00edgenos ac\u00e1 descritos como promisorios (o regiones restringida s funcionalmente dentro de ellos ), para as\u00ed evaluar si estos pueden ser considerado s candidatos a vacuna y ser incluidos en ensayos precl\u00ednicos de una vacuna contra P. vivax . Finalmente, e l enfoque presentado en este trabajo podr\u00eda ser aplicado a otros pa t\u00f3genos, durante la b\u00fasqueda de potenciales candidatos a vacuna. 77 REFERENCIAS 1. de Meeus T, McCoy KD, Prugnolle F, Chevillon et al. Population genetics and 2007 2015]. Global, regional, and national age -sex specific all -cause and cause -specific mortality for 240 causes of death, 1990 -2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015 Jan 10;385(9963):117 -71. 4. Escalante Ayala Proceedings of the National Academy of Sc iences of the United States of America. 1994 Nov 22;91(24):11373 -7. 5. Rich SM, Ayala FJ. Progress in the case for phylogenetics. Advances parasitology. 2003;54:255 Decher J, Leendertz FH, Fahr J, Weber N, et al. High diversity of West African bat malaria parasites and a tight link with rodent Plasmodium taxa. Proceedings of the National Academy of Sciences of the United States of America. 2013 Oct 22;110(43):17415 -9. 7. Cowman AF, Crabb BS. Invasion of blood cells by malaria parasites. Cell. 2006 Feb 24;124(4):755 Infectious Diseases (U.S.). The primate malarias. Bethesda, Md.,: U.S. National Institute of Allergy and Infectious Diseases; for sale by the Supt. of Docs., U.S. Govt. Print. Off., Washington; 1971. 10. Pain A, Bohme U, Berry AE, Munga ll K, Finn RD, Jackson AP, et al. The genome of the simian and human malaria parasite Plasmodium 2008 Oct 9;455(7214):799 -803. 11. Pacheco MA, Battistuzzi FU, Junge RE, Cornejo OE, Williams CV, Landau I, et al. Timing the origin of human malarias: the Horii T, Tanabe K. Big bang in the evolution of extant malaria parasites. Mol Biol Evol. 2008 Oct;25(10):2233 Mammalian hosts. Mol Biol Evol. 2015 May;32(5):1354 -64. 14. Liu Li Y, Shaw KS, Learn GH, Plenderleith LJ, Malenke JA, et al. malaria parasite Plasmodium vivax. Nat Commun. 2014;5:3346. 15. Mu J, Joy DA, Duan J, Huang Y, Carlton J, Walker J, et al. Host switch leads to emergence of Plasmodium vivax malaria in humans. Mol Biol Evol. 2005 Aug;22(8):1686 -93. 16. WHO. World Geneva: Malaria surge Appl. Apr;11(4):415 von L, Valecha N, Nosten F, 2014 Oct;14(10):982 -91. 21. Barry Lancet. Feb 22;383(9918):723 -35. 23. Garrido -Cardenas JA, Mesa -Valle C, Manzano -Agugliaro F. Genetic approach a vaccine against malaria. Eur J Clin Microbiol Infect Dis. 2018 Jun 28. 24. Patarroyo D, Moreno -Perez DA. Vaccines against challenge. Expert Rev Vaccines. Oct;11(10):1249 25. Luo The biology of Plasmodium vivax explored through genomics. Ann N Y Acad Sci. 2015 Apr;1 342:53 -61. 26. Arevalo -Pinzon G, Curtidor H, Neafsey DE, Galinsky K, Jiang RH, Young L, Sykes SM, Saif S, e t al. The Sagara I, Doumbo O, Wu Y. Blood stage vaccines for Plasmodium falciparum: current status and the way forward. Hum Vaccin. 2010 Aug;6(8):627 -34. 31. Fluck C, Smith T, Beck HP, Irion A, Betuela I, Alpers MP, et al. 32. et al. Molecular basis of allele -specific efficacy of a blood -stage malaria vaccine: vaccine development implications. J Infect Dis. 2013 1;207(3):511 -9. 34. Takala SL, Plowe CV. Genetic diversity TL, Saul A. Progress and challenges for malaria vaccines. Nature. 2002 Feb 7;415(6872):694 -701. 79 36. Urquiza M, Patarroyo MA, Mari V, Ocampo M, Suarez J, Lopez R, et al. Identification and polymorphism of Plasmodium vivax to reticulocytes. Peptides. 2002 Dec;23(12):2265 -77. 37. Ocampo M, Vera R, Eduardo Rodriguez L, Curtidor H, Urquiza M, Suarez -22. 38. Rodriguez LE, Urquiza M, Ocampo M, Curtidor H, Suarez J, Garcia J, et al. have high reticulocytes. Vaccine. 2002 Jan 31;20(9 -10):1331 -9. 39. Kimura M. The neut ral theory of molecular evolution. Cambridge Cambridgeshire ; New York: Cambridge University Press; 1983. 40. Graur D, Zheng Y, Price N, Azevedo RB, Zufall RA, Elhaik E. On the sets: \"function\" in the human genome Lorenzi E, et of the human malaria parasite Plasmodium vivax. Nature. 2008 Oct 9;455(7214):757 -63. 42. Bozdech Z, Mok S, Hu G, Imwong M, Jaidee A, Russell B, et al. The parasites. Proceedings of the National Academy of Sciences of the United States of America. 2008 Oct 21;105(42):16290 -5. 43. Chen JH, Jung JW, Wang Y, Ha KS, Lu F, Lim CS, et al. Immunoproteomics profiling of research. 2011 Dec 3;9(1 2):6479 -89. 44. Moreno -Perez DA, Degano R, Oct 11. 45. Tachibana S, Sullivan SA, Kawai S, Nakamura S, Kim HR, Goto N, et Nat Genet. 2012 Sep;44(9):1051 -5. 46. Good MF. Towards a blood -stage vaccine for malaria: are all the leads? Nature reviews. :117-25. response in individuals immune to malaria. The Journal of experimental medicine. 2001 Jun 18;193(12):1403 -12. 48. Rojas -Caraballo J, Mongui A, Giraldo MA, Delgado G, Granados D, -Cortes Malaria Vaccines. Cl in Immunol. 2015 Sep 2. 50. Angel DI, Mongui A, Ardila J, Vanegas M, Patarroyo -7. 80 51. Mongui A, Angel DI, Gallego G, Rey es C, Martinez P, Guhl F, et al. Characterization and Mongui A, Angel DI, Moreno -Perez DA, Villarreal -Gonzalez S, Almonaci d H, Vanegas M, et al. Identification -Caraballo J, DI, A, Perez -Leal O, Soto SC, Cortes J, DA, Mongui A, Soler LN, -Ladino M, Identifying RhopH1/Clag family in vivax. 2011 Jul 15;481(1):17 -23. 56. Perez -Leal O, Mongui A, Cortes J, -8. 57. Perez -Leal O, Sierra AY, Barrero CA, Moncada C, Marti nez P, Cortes J, et al. Identifying Perez -Leal O, Sierra AY, Barrero CA, Moncada C, Martinez P , Cortes J, et al. 59. -Villa S, Rosales -Borjas D, Carrero JC, Ortiz -Ortiz Laurens MB, Ouattara A, Kone AK, et al. A field trial to assess a blood -stage malaria vaccine. N Engl J Med. 2011 Sep 15;365(11):1004 -13. 61. Figtree M, P asay CJ, Slade R, Cheng Q, 1 and genes. Molecular and biochemical parasitology. 2000 Apr 62. Evol. 2011 Mar;11(2):528 -31. Gomez A, Suarez CF, Martinez P, Saravia C, Patarroyo MA. 4) :353-66. 81 66. Martinez P, Suarez CF, Gomez A, Cardenas PP, Guerrero JE, Patarroyo MA. level Khuntirat B, Sattabo ngkot J, Yan G, Escalante AA, et al. Molecular intragenic recombination of Jul;131(Pt 1):25 -35. 68. Pacheco MA, Elango AP, Rah man AA, Fisher D, Collins WE, Barnwell JW, et al. Evidence of purifying selection on 8 Evol. 2012 Jul;12(5):978 -86. 69. Putaporntip C, Jongwutiwes S, Ferreira MU, Kanbara H, Ud omsangpetch R, Cui L. Limited global diversity the Jul;109(2):111 -9. Gene. 2010 May 15;456(1 -2):24 -35. 72. Tetteh KK, Stewart LB, Ochola LI, Amambua -Ngwa A, Thomas AW, Marsh K, et al. Prospective identification of malaria parasite under balancing Trends Parasitol. 2010 Jul;26(7):363 -9. 74. Suzuki Y. Natural selection on the influenza virus genome. Mol Biol Evol. 20 06 amino acid sites in dengue E proteins relevant to development of diagnostics and vaccines. Virus Gen es. 2007 Oct;35(2):175 -86. 76. Suzuki Y. Negative selection on neutralization for Gene. 2004 Mar 17;328:127 -33. 77. Rich SM, Licht MC, Hudson RR, Ayala Malaria's Eve: of Plasmodium falciparum. Proceedings of the National Academy of Sciences of the United States of America. 1998 Apr 14;95(8):4425 -30. 78. Hughes AL, Verra F. An cient polymorphism and the hypothesis GM, Mixson -Hayden T, Sridaran S, Alam MT, de Oliveira AM, et al. Historical shifts in Brazil Villegas L, Udhayakumar V, Escalante AA. Common origin and fixation of Plasmodium dhfr and dhps mutations associated with sulfadoxine -pyrimethamine low area in South America. Antimicrob Agents Chemother. 2007 Jun;51(6):2085 -91. 82 81. Rodrigues PT, Valdivia HO, de Oliveira TC, Alves JMP, Duarte A, Cerutti -Junior C, et al. Human migration and the spr ead of malaria parasites to the New World. Sci Rep. 2018 Jan 31;8(1):1993. 82. Restrepo -Montoya D, Becerra D, Carvajal -Patino JG, Mongui A, Malar LB, Riitho V, Marsh K, DJ. Allele frequency - based and polymorphism -versus -divergence indices selection in new of polymorphic genes in Plasmodium falciparum. Mol Biol 2010 Oct;27(10):2344 -51. 86. Mongui DI, Guzman C, Vanegas -Perez DA, Areiza -Rojas R, Florez -Buitrago X, Silva The Patarroyo ME, -Leal O, Lopez Y, Cortes J, Rojas -Caraballo J, Gomez A, et al. Identification and Arisue N, Kawai S, Hir ai M, Palacpac NM, Jia M, Kaneko A, et al. Clues to evolution of the SERA multigene family in 18 model of JM, Barnwell JW, Acids Res. 2004;32(5):1792 -7. 83 96. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. PAL2NAL: Res. 2006 Jul 1;34(Web -12. 98. Librado P, Rozas J. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics. 2009 Jun 1;25(11):1451 -2. 99. Nielsen R. Molecular signatures of natural selection. Annu Rev Genet. 2005;39:197 - 218. 100. McDonald JH, Kreitman M. Adaptive protein evolution at the Adh locus Drosophila. Nature. 1991 Jun 20;351(6328):652 -4. 101. Jukes THaCRC. Evolution of protein molecules. Protein Metabolism. New York: Academic Press; 1969. 102. Egea S, Barbadilla A. Standard and generalized McDonald -Kreitman test: a website to detect selection different classes of DNA sites. Nucleic A cids Res. Jul 1;36(Web Server issue):W157 -62. 103. Tamura K, Stecher G, Filipski A, Kumar S. Molecular Genetics Analysis version 6.0. Mol Biol Evol. 2013 Dec;30(12):2725 -9. 104. Zhang J, Rosenberg HF, Nei M. Positive Da rwinian selection after gene duplication in primate ribonuclease genes. Proceedings of the National Academy of Sciences of the United States of America. 1998 Mar 31;95(7):3708 -13. 105. Sawai H, Otani H, Arisue N, Palacpac N, de Oliveira Martins L, Pathiran a S, et al. Lineage -specific M, Arisue N, Horii T, et al. Recent independent -20. 109. Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post -analysis of large phylogenies. Bioinformatics. 2014 May 1;30(9):1312 -3. 110. Ronquist F, Teslenko M, van der Ma rk P, Ayres DL, Darling Syst Biol. 2012 May;61(3):539 -42. 111. Abascal F, Zardoya R, Posada D. ProtTest: selection of best -fit models of protein evolution. Bioinformatics. 2005 May 1;21(9):2104 -5. 112. Miller MA, Pfeiffer, W., and Schwartz, T. Creating the CIPRES Science Gateway for inference of large phylogenetic trees. Proceedings of the Gateway Computing Environments Workshop (GCE), 14 N ov 2010, New Orleans, LA pp 1 - 8. 2010. 113. Miller MA, Schwartz T, Pickett BE, He S, Klem EB, Scheuermann RH, et al. A RESTful API for Access to Phylogenetic Tools via the CIPRES Science Gateway. Evol Bioinform Online. -8. 84 Fourment Taboada Posada jModelTest 2: models and parallel Methods. 2012 malaria parasite: the MSP1 complex and the MSP7 family. Int J Parasitol. 2010 Aug 15;40(10):1155 -61. 120. J, Sennblad B, Arvestad L, Lage rgren J. DLRS: gene tree evolution in light of a species tree. Bioinformatics. 2012 Nov 15;28(22):2994 -5. al. Interactions between merozoite surface proteins 1, 6, and 7 Plasmodium falciparum. J Biol Chem. 2006 Oct 20;281(42):31517 -27. 122. Garcia Y, Puentes A, Curtidor H, Cifuentes G, Reyes C, Barreto J, et JA, Ling IT, Grainger M, Trucco C, Howell S, Fernandez -Reyes D, et al. The 22 kDa com ponent of the protein complex on the surface of Plasmodium Molecular and biochemical parasitology. 2001 Sep 28;117(1):83 -9. 124. Mello K, Daly TM, Morrisey J, Vaidya AB, Long CA, Bergman LW. A multigene family that interacts with the 2002 -25. 125. Muehlenbein MP, Pacheco MA, Taylor JE, Prall SP, Ambu L, Nathan S, e t al. Accelerated of nonhuman primate malarias Oct;56(4):327 -43. 127. Jones TR, Hoffman SL. Malaria vaccine development. Clin Microbiol Rev. 1994 Jul;7(3):303 -10. 128. Escalante AA, Lal AA, Ayala FJ. Genetic polymorphism and natural 1998 May;149(1):189 -202. 129. Chenet SM, Tapia LL, Escalante AA, Durand S, Lucas C, Bacon DJ. Genetic diversity and population r J. 2012;11:68. 85 130. Imwong M, Pukrittayakamee S, Gruner AC, Renia L, Letourneur F, Looareesuwan S, et al. Practical Trop Med Hyg. 1999 Oct;61(4):518 -25. 132. Kosakovsky Pond SL, Frost SD. Not so different after all: comparison of methods f or detecting Sheward Malleret B, Li A, Zhang R, Tan KS, Suwanarusk R, Claser C, et al. -86. 139. Rodriguez LE, Curtidor H, Urquiza M, Cifuentes G, Reyes C, Patarroyo ME. Intimate molecular interactions of P. falciparum merozoite proteins in invasion of blood cells implications for vaccine design. Chem Rev. 2008 Sep;108(9):3656 -705. 140. Moreno -Perez vivax VCG sch izonts Aug 30;7(1):9616. 143. Moreno -P\u00e9rez DA. Determinaci\u00f3n del proteoma de la cepa VCG1 de Plasmodium vivax y caracterizaci\u00f3n de mol\u00e9culas candidatas para su inclusi\u00f3n en el desarrollo de una vacuna. Bogot\u00e1: Universid ad del Rosario y Universidad de Salamanca . 2017. 144. Escalante AA, Cornejo OE, Freeland DE, Poe AC, Durrego E, Collins WE, et al. A monkey's tale: the origin of Plasmodium vivax as a human malaria parasite. Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):1980 -5. 145. Baquero LA, Moreno -Perez DA, Garzon -Ospina 2017 May 19;10(1):25 1. 146. Rodrigues -da-Silva RN, Soares Lopez -Camacho C, Martins da Silva JH, Perce Front Immunol. 2017;8:77. 147. Cheng Y, Lu F, Wang B, Li J, Han JH, Ito D, M, Arevalo -Pinzon G, Rubio L, Chaloin O, Muller S, Curtidor et al. Jul;20(7):e12835. 87 ANEXOS Anexo 1. \u00c1rbol filogen\u00e9tico de la familia msp3 Los genes ort\u00f3logos deben agruparse en una relaci\u00f3n uno a uno. Se muestra s \u00f3lo el \u00e1rbol de la familia msp3, los \u00e1rboles restantes pueden ser consultados en el Su plemento 2 d e la publicaci\u00f3n 1 (https://www.sciencedirect.com/science/article/pii/S156713481500163X ). 88 Anexo 2. Ventanas deslizantes de la tasa (d N/dS o K N/KS) La raz\u00f3n dN/dS dentro P. vivax es mostrad a en azul, mientras la raz\u00f3n de la divergencia K N/KS entre P. vivax y P. cynomolgi , y entre P. vivax and P. knowlesi , es mostrada en rojo y verde, respectivamente. S \u00f3lo se muestran las venta nas de los genes pv 41 y msp10, las ventanas deslizantes restantes pueden ser consultadas en el s uplemento 3 de la publicaci\u00f3n 1 (https://www.sciencedirect.com/science/article/pii/S156713481500 163X ). En msp10, la regi\u00f3n 3' que mostr < 1 codi fica para los dominios EGF -like, involucrados en interacciones prote\u00edna -prote\u00edna. 89 Anexo 3. Filogenia de la familia msp7 inferida por el m\u00e9todo de m\u00e1xima verosimilitud Los n \u00fameros (bas ados en los n\u00fameros de la Figura 7 ) representan los diferentes clados, mientras que los n\u00fameros en las ramas son los valores de l bootstrap y de la probabilidad posterior. Trece clados fueron identificados en el \u00e1rbol; sin embargo, los clados 1 y 6 no fueron claramente respaldados por los valores del bootstrap o los valores de probabilidad posteriores. Las prote\u00ednas se agrupan de acuerdo con las relaciones filogen\u00e9ticas del par\u00e1sito, siendo los clado s 1 (rojo) y 2 (amarillo) los m\u00e1s ancestrales; el clado 5 tambi\u00e9n podr\u00eda ser un cl\u00faster ancestral . Las secuencias de los clados del linaje de par\u00e1sitos que infectan cercopit\u00e9cidos se representan en verde, las prote\u00ednas del linaje de par\u00e1sitos que infectan roedor es en azul y el linaje de par\u00e1sitos que in fectan hom\u00ednido s en gris. El grupo de prote\u00ednas en marr\u00f3n es un a duplicaci\u00f3n observada s \u00f3lo en l a especie P. inui. Tanto los \u00e1rboles ML como BY mostraron topolog\u00edas similares, por lo que s\u00f3lo se muestra el \u00e1rbol ML. 90 Anexo 4. Venta na deslizante del gen pvron4 Los valores de ron4 (d N/dS) dentro de P. vivax se muestran en verde , mientras la tasa de divergencia (K N / KS) entre las especies que infectan primates y P. vivax se muestran en azul (para las especies evolutivamente m\u00e1s cercanas a P. vivax) y rojas (m\u00e1s distantes). Una representaci\u00f3n del gen ron4 se presenta debajo de la ventana deslizante que indica el p\u00e9ptido se\u00f1al (azul), la regi\u00f3n repetida (negra) y el dominio putativo de esterasa /lipasa (p\u00farpura). Lo s SNP s identific ados en vivax se mue stran como l\u00edneas discontinuas. La numeraci\u00f3n est\u00e1 basa da en el alineamiento del archivo adicional 2 de la Publicaci\u00f3n 6 . Los sitios bajo selecci\u00f3n negativa est\u00e1n representados por l\u00edneas verdes claras (dentro de P. vivax) y verde os curo (entre las especies ), mientras que los sitios seleccionados positivamente entre especies se muestran por l\u00edneas rojas. Detalles de esta figura pueden ser consultado s en la Publicaci\u00f3n 6 ( https://malariajournal.biomedcentral.com/articles/10.1186/s12936 -016-1563 -4). 91 PUBLICACIONES Publicaci\u00f3n -P\u00e9rez DA, Garz\u00f3n -Ospina D Natural Selection . Front Genet. 2018 Jan 25;9:10. doi:10.3389/fgene.2018.00010. Publicaci\u00f3n 9: Camargo PA, Garz\u00f3n -Ospina D Moreno -P\u00e9rez DA , Ricaurte - Contreras LA, Noya O and Patarroyo MA. On the Immunology Department, Fundaci\u00f3n Instituto de Inmunolog\u00eda de Colombia (FIDIC), Carrera 50 No. 26-20, Bogot\u00e1 DC, Colombia bBasic Sciences Department, School of Medicine and Health Sciences, Universidad del Rosario, Carrera 24 No. 63C-69, Bogot\u00e1 DC, Colombia article info Article vivax lated and selection signatures were detected by using different approaches. Our results may et al., Patarroyo et al., 2012 ). Likewise, anti- P. vivax vaccine development is behindhand and few vaccine candidates have been proposed to date. potential new candidates involved the search for sequences identity with Patarroyo et al., 2012 could be used for P. vivax asexual-blood vaccine since they however, such studies all these genes wouldinvolve much time and resources. However, Cornejo et al. (2014) , using a limited sample ed genes having signatures consistent with selection. This kind of analysis could be a starting point for detecting potential new vac- cine candidates ( for P. falciparum (Ochola et al., 2010; Tetteh et al., 2009 ). The present study has used three different approaches for detecting selection signals within 59 a effective methods 2.1. Target sequences and alignments Sequences were obtained for 59 protein-encoding genes from the Salvador I isolate (Sal-I); these genes had been previously char-acterised by approach 2013; Moreno-Perez et al., Patarroyo et al., 2012 )o as not been subjected to previous Department, Fundaci\u00f3n Instituto de Inmunolog\u00eda de Colombia (FIDIC), Carrera 50 No. 26-20, Bogot\u00e1 DC, were used as query reported for other stains (VCG-I, al., 2011; Garzon-Ospina et al., 2010, 2014; Rice et al., 2014 ).P. vivax ,P. cynomolgi knowlesi best evolutionary model was selected for eachalignment by Bayesian Information Criterion, for genes using sequences from sequences. Genetic diversity and natural selection analysis software ( Librado and Rozas, 2009 ) was used for estimat- ing several measures regarding DNA sequence variation. Cornejo et al. (2014) had previously identied patterns thegenome-wide McDonald-Kreitman test and Tajima D estimator; however, natural selection not several genes involved in merozoite We assessed and server Egea et al., 2008 ). The p/Kratio was evaluated identifying al., al., ). MEGA software was used to assess selection signals within ,P. sequences as data set) of substitu- tions annotation as reference. The most suitable antigens vaccine development regarding our approach should have limited diversity or this pattern. Such genes/domains should have a natural negative signal x< 1). However, genes underpositive selection genes absent or incomplete in some isolates; i.e. the PVX_003825 gene was not found in a North Korean isolate whereas PVX_092425 was incomplete at the 5 were missing the in the Mauritania-I isolate and not to be present in the India-VII isolate in which the PVX_096990 gene 1 shows the nucleotide polymorphism distribution within the aforementioned 59 in a clade in a one-to-one relationship and had to have a similar genomic position. Rice et al., 2014 ). Hence, 34 of these 59 genes were found in both P. cynomolgi and P. knowlesi species, whereas another 15 genes were only present in P. cynomolgi ; 10 genes appeared to be exclu- sive to P. vivax . 3.2. Natural selection signatures in P. vivax genes Three different approaches were used for screening natural selection signals. The neutral index (NI) from the MK test showed that 16 genes had excess polymorphism regarding divergence (NI > 1) and only one had NI < 1, while the p/Kratio showed 11 genes which might be under balancing selection 1 ). A statistically signicant dN>dSwas found genes had dN<dSvalues ( Table 2 and Supplementary gave negative selection between species for 35 genes whereas another 10 displayed positive selection (Supplementary data 1 ). Some genes had a different natural selec- tion signal from that previously reported 5 the Some genes eval- uated here were assessed in the aforementioned report. Since the Nei-Gojobori method is a conservative test, species. Garz\u00f3n-Ospina et Evolution 33 182-188 183antigen characterisation. Natural selection signatures found in antigens could be a starting point for identifying potential new vaccine candidates ( Weedall and Conway, 2010 ). assume that pat- tern as being under selection ( Cornejo et al., 2014 ).Cornejo et al. (2014) found P. vivax genes under positive selection by using mod- ied versions of the aforementioned tests; however, most genes found are not involved in host-merozoite interactions and could not therefore be used in vaccine development.Table 1 Measurement of DNA sequence variation for the 59 P. vivax genes. # ID Name n Sites Ss SP s Genes 0.0096 (0.0001) 3 PVX_002510 Nucleosomal binding protein PVX_003800 pvsera PVX_086930 pvrhopH1/clag 5 3978 38 30 8 0.0043 (0.0010) 16 PVX_090075 pv34 6 1092 1 1 0 0.0003 (0.0003) 17 PVX_090210 pvarp 7 682 exported 25 PVX_097670 pvmsp-3 c, putative 0.1408 (0.0154) 26 PVX_097675 pvmsp-3 c, putative 27 PVX_097695 a, 0.0163 PVX_097960 pv38 6 PVX_109280 pvfam-a 7 (0.0003) 39 Tryptophan-rich antigen 0.0018 (0.0004) 40 PVX_113775 pv12 7 942 4 2 1 0.0014 (0.0006) 41 PVX_117230 pvser/thr 5 4 1 2 2532 0.0006 (0.0001) protein 3 , 3 PVX_085930 pvrap-1 , putative 0 0.0003 PVX_092275 pvama-1 6 5 , 0.0000 6 PVX_097625 pvmsp-8 6 1320 6 3 3 0.0021 (0.0006) 7 PVX_097720 pvmsp-3 a 6 2016 154 72 82 0.0349 (0.0158) 8 PVX_097680 pvmsp-3 b 6 2007 0.0747 (0.0094) PVX_099980 pvmsp-1 D. Garz\u00f3n-Ospina et al. / Infection, Genetics and Evolution 33 (2015) 182-188The 59 genes evaluated here did not display selection signa- tures in the protein-encoding and selection, suggesting they sys- tem However, high protein polymorphism immune responses. both p/K and MK between them has shown Tetteh et al., 2009 ), suggesting the had low power balancing selection ( et al., 2009; Weedall and Conway, 2010 ). Such low power could be due to the effect of weak negative selection thereby leading to excess poly-morphism, but just at low frequencies ( Fay et al., 2002 ). However, our statistical that the and thus increasing NI. This implied that the major factor in causing NI > 1 could was not balancing selection within species but long-term purifying selection the fact that also found low xvalues and negative values The high amino a functional/structural constraint would then have been likely. Therefore, some genes could not have been subject to balancing selection but rather negative selection. Both kinds of selection might be genes had selection signals, 9 were under negative selection and neutrality could notbe ruled out for the remaining polymorphism. negatively selected genes found could be taken into account for vaccine development ( Mazumder et al., 2007; Pacheco et al., 2012; negative selection might be a and themunsuitable as candidates. been to differ- ent selective pressure acting on the above genes. Some regions could be under negative selection but others accumulated throughout full encoded protein sequence, sev-eral genes under selection might not have been found as the Nei- Gojobori method is a conservative test (as are the and MK tests). Regardless of such difculties, domains substitutionswere accumulated different rates and therefore Polymorphism distribution studied here. having non-synonymous (red) mutations synonymous ( dS) rates for (0.0059) 28 PVX_097700 pvmsp-3 (0.0074) 29 PVX_097705 pvmsp-3 a, (0.0062) 30 PVX_097710 pvmsp-3 found; null: neutral index (NI) could not be estimated due to neutral (or non-ne utral) ,pvmsp-1 could not be estimated the web server; therefore they were calculated the Jukes-Cantor divergence Infection, and Evolution 33 (2015) 182-188of selection could positive: x> under vaccine development should be such domains ( Richie and Saul, had a high dN/dSratio (>2 from nucleotides 120 to 139, 370 to 434, 810 to 849, 1115 to 1174 and 1290 to 1329), therebyagreeing with a previous report ( Gunasekera et al., 2007 ). Low K N/KSratios were found throughout the entire data ( Vulliez-Le Normand et al., 2012 ) or host (Kato et al., 2005 ).pv230 had neither signicant dNordSrates, in spite of negative ( Doi et al., 2011 ).dN/dSvalues above 1 were found in this having x< 1 might have been under negative selection due to the pres- ence of the s48/45 domains which are involved in et 3 '-end which low divergence (KN/KS< has been previously shown that polymorphism is mainly found at the et al., 2011 ) and between ( Pacheco et al., 2012 ) species, probably because this region is the has similar have its encoded et al., 2002 ). This gene had d divergence between Supplementary 4 ). functional constraint. Consequently, these regions could of vaccine candidates. Wethus searched for similar patterns the 30-ends in and had a region having dN/dSvalues around 0.4 or near to 1 ( Supplementary data 3 ). Regarding the influenza virus, a dN/dSlarger that 0.3 is associated with escape mutants ( Suzuki, 2006 ); consequently, these particular domains could have been the outcome of immune pressure whereas theremaining gene et al., d Nevertheless, species, providing signicant low divergence between P. vivax thus, structures been maintained in the long-term and, consequently, NI > 1 could have resulted from negative selec- tion. Hence, similar to pv230 (Doi 6-cystein pro- tein family members might be also be for a vaccine. These genes had limited diversity, displayed selection signa- not be between species(Garzon-Ospina ) and these domains 5. dis- played selection signals in the used here, we did identify some signatures consistent with multigene families were targets for animmune response; however, they would not be the most appropri- ate ones for vaccine development due to their expected in regionshaving they could thank Jason Garry for translating and revising the manuscript. This work was nanced by ''ColombianScience, Department (COLCIENCIAS)'' Garz\u00f3n-Ospina 33 (2015) 182-188 187Appendix A. Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.meegid.2015.05. 001. References Arevalo-Pinzon, G., Curtidor, H., Abril, Palacpac, N.M., Kaneko, A., Tanabe, K., Horii, T., 2011. Clues to evolution of the SERA multigene family in 18 Plasmodium species. for elimination. Malar. J. 11, 14. Barry, A.E., Arnott, A., History of the discovery of the malaria parasites and their vectors. Parasit. Vectors 3, 5 . Chen, J.H., Jung, J.W., Wang, Y., Ha, K.S., Lu, F., Lim, C.S., Takeo, S., Tsuboi, T., Han, 2010. Tanabe, K., Tachibana, S., Hamai, M., Mita, Y.M., T., Torii, M., Tsuboi, 2011. Worldwide transmission-blocking throughput. Nucleic Acids Res. 32, 1792-1797 . Egea, R., A., 2008. Standard and generalized McDonald- Kreitman test: Wu, C.I., 2002. Testing the neutral theory of molecular evolution with genomic data from Drosophila. Nature C.G., Vanegas, family in Plasmodium New York . Kato, K., Mayer, D.C., Singh, S., Reid, M., Miller, L.H., 2005. Domain III of Plasmodium falciparum P., Rozas, J., 2009. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics (Oxford, England) 25, amino acid sites in dengue E proteins relevant to development diagnostics and vaccines.Virus .McDonald, J.H., Kreitman, M., Adaptive protein evolution 652-654 . S., Gujja, S., Goldberg, Allele frequency-based and polymorphism-versus-divergence indices of balancing selection in a ltered set polymorphic Pasini, E.M., Aslett, M.A., I., Chillingworth, T., Clark, T.G., Galinski, M.R., Hall, N., Harper, D., Harris, D., Hauser, H., Ivens, A., Janssen, C.S.,Keane, T., Larke, N., Lapp, S., Marti, M., Moule, S., Meyer, I.M., Ormond, D., Peters, N., Sanders, M., Sanders, S., Sargeant, T.J., Simmonds, M., Smith, F., Squares, R., Thurston, S., Tivey, A.R., Walker, malaria vaccines. Nature 415, 694-701 . Rodriguez, L.E., Urquiza, M., Ocampo, M., Curtidor, H., Suarez, J., Garcia, J., Vera, R., Puentes, A., Lopez, R., Pinto, M., Rivera, Z., Patarroyo, M.E., Vaccine 20, 1331-1339 . 127-133 . Suzuki, Y., 2006. Natural selection on the influenza virus genome. Mol. Biol. Evol. 23, 1902-1911 . Tachibana, S., Sullivan, Kawai, Nakamura, S., Kim, H.R., Goto, N., Arisue, N., Palacpac, N.M., Honma, H., Yagi, M., Tougan, T., Katakai, Y., Kaneko, O., Mita, T., Kita, Nat. Genet. 44, 1051-1055 . Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M., Kumar, S., 2011. MEGA5: molecular 2009. Prospective identication of M.J., Lebrun, M., 1998. Positive Darwinian selection after gene duplication in primate ribonuclease genes. Natl. Acad Sci. U.S.A. 3708-3713 .188 D. Garz\u00f3n-Ospina et al. / Infection, Genetics and Evolution 33 (2015) 182-188RESEARCH ARTICLE Open Access functional in parasite invasion; t h eg e n ee n c o d i n gi tb e l o n g st oam u l t i g e n ef a m i l y .I t has been proposed that MSP7 paralogues they could have different roles. Results: The msp7 a birth-and-death evolutionary model, gene conversion has taken place between genes allowing them to maintain their functional redundancy. On other source of novelty re- garding new [1, 2]. The genomes from the three kingdomsof been modulated by model [3]; paralogous genes keep the the former due to gene conversion whilst paralogous could lose described to located in chromosome 13 in and rodent-parasites but in chromosome 12 in monkey- Immunology Department, Fundaci\u00f3n Instituto de de Colombia (FIDIC), Carrera 50#26-20, Bogot\u00e1, DC, Colombia 3School of Medicine and Health Sciences, Universidad del Rosario, Carrera 24#63C-69, Bogot\u00e1, DC, Colombia Full list of author information is available at the end of the article \u00a9 The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link tothe Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available cells [21]. C-terminal regions in P. yoelii from different MSP7s copies have been main-tained in the genome for a long time and others appear to be more recent [15]. This family has had a complex evolutionary history regarding P. vivax . The C-terminal region is 11 amino acid sequences by using Gene Runner software; these se- were screened distinguish the bootstrap, chain Carlo was used for BY analysis [36] also performed; this method i n f e r sag e n et r e eb ye v o l v i n gd o w no nag i v e ns p e c i e stree (with divergence times) by means of duplication, 2 and were from al. from species [15].The sequence number in this research was increasedand evolution rate after duplication (or speciation) events calculating the coefficient divergence ( D) determining (e.g. [5]) whether it was relative to the other (reference branch). The Datamonkey web server was used for this Fig. 1 Schematic representation of the msp7 are genes are in alphabetical order from left to right. The dashed lines connect orthologous genes. All genes are represented to scale, but the distance between them is not representative. Question marks refer to have similar evolutionary histories regarding msp7 expansion. The grey boxes are lineage-specific genes only found in hominid-parasite species, as they do not belong to themsp7 family (the latter gene representations are scale)Garz\u00f3n-Ospina et al. BMC Biology (2016) 16:256 Numbers whilst on posterior probability Nine clades were identified phylogenetic relationships, clades 1 ( red), 2 (yellow )a n d5( purple )b e i n g the most ancestral ones. The clades clustering genes from monkey-parasite lineage are depicted in rodent-parasite lineage in b lue hominid-parasite lineage grey. The P. inui specie-specific duplicate was not considered in this analysis. Due to the family 's complex evolutionary history (which includes gene conversion, intragenic recombination, positive and/or selection) therefore the duplication/lost rates were not obtained even though a tree reconciliation similar to other topologies inferred and ML)Garz\u00f3n-Ospina et al. species, 1 subspecies and 1 [15, 13 genomeshaving the same transcription orientation were found (Fig. 1). These ORFs had 0.6 to 1.3 kilobases (kb) but P. gallinaceum msp7 had a 3.1 spp. P. vivax and P. cynomolgi had the l a r g e s tc o p yn u m b e r( 1 2O R F s )w h i l s tt h el o w e s tc o p y number was found in P. gallinaceum (just one gene). P. cynomolgi ,P. falciparum and P. reichenowi .T h e s e ORFs (and small fragments) were named in alphabeticalorder regarding PVX_082640 and its homologous genes(Fig. 1 and Additional file 1). Data regarding P. inui ,msp7B (pinumsp7B ) was Phobius algorithm was for determining the presence of signal peptides within ORFs and Pfam for the MSP_7Cdomain; some genes did not have a signal peptide or the characteristic MSP_7C domain in the C-terminal family fragments P. gene). A phylogenetic tree was then inferred by using ML and BY methods with the clustering sequences from 12 Plasmodium species considered in this study, clade 2 another 10 of them andclade 5 clustering the last gene in the chromosomal region from rodent-parasites, P. vivax and P. cynomolgi implemented vivax SP y y y y y y y y y - y y y MSP7_C y y y - y y y y y y y y - P. cynomolgi SP y y y y - y y y y - y y yMSP7_C y y y - y y y y y y y y - P. inui SP y - y y y - y yMSP7_C y y y y y - y y P. knowlesi SP y y y y yMSP7_C y - y y y P. coatneyi SP y - y y yMSP7_C y - y y y P. chabaudi SP y y y yMSP7_C y y y - P. vinckei v. SP y y y yMSP7_C y y y - P. vinckei p. SP y y y yMSP7_C y y y - P. berghei SP y y y yMSP7_C y y y - P. yoelii SP y y y yMSP7_C y y y - P. falciparum SP y y - y y y yMSP7_C y y y y y y y y y P. reichenowi SP y - y y y y yMSP7_C y y y y y y y y y P. gallinaceum SP yMSP7_C y Eighty-three sequences between flanking genes were for a Biology Page 5 of 13was 0.25 but the MCMC chain did not converge after more than 10 million generations, therefore, gene msp7 to species tree was obtained. The tree inferred had 9 major clades (Fig. 2), thereby agreeingwith the ML and BY clades (Fig. 2 and Additional file 3). In all phylogenies (Fig. 2 and Additional file 3) the se- quences without the MSP_7C domain (PvivMSP7D,PcynMSP7D, onlysupported by posterior probabilities but not by bootstrap- ping (Fig. 2 and Additional file 3). Furthermore, these se- quences, like others 4). Since PgalMSP7A is larger than other MSP7s, we did not take it into account for the aforementioned analysis;then, only the MSP_7C domain The branch pattern from this topology (Additional file 5) was similar to the phylogeny obtained by using all sequences probability and bootstrapping were did not cluster with any otherMSP7 in DLTRS tree; it appeared Additional have been expected, PvivMSP7B wasclustered It haspreviously been reported that gene conversion takes place between 7I [23]. We conversion tracks between pvivmsp7C and 7I, whilst there were 3 conversion tracks between and 7Eand another two between pvivmsp7E and 7G. Figure 3 shows the conversion tracks found by GENECONV. The same approach was followed conversion since no found REL identified by the GENECONV % value refers to the similarity value for sequence region recombination)Garz\u00f3n-Ospina et in several external branches (Fig. 4 Additional file 6). Regarding rodent-parasites, thelineages leading to 4a) and (Fig. 4i) were under selection. Just one internal branch vivax ,P. cynomolgi and P. inui well as P. inui and P. knowlesi /P. 4 Phylogenies analysed for episodic selection. Each orthologous cluster was analysed by the Branch-site shade of the percentage of sites in the corresponding class found Branches undergoing episodic diversifying selection by corrected testing u sing the Holm-Bonferroni method at p< 0.05. a.c l a d At phyloge ny there is a scale representation of msp7s .T h e blue boxes represent the encoded N -terminal region, the light brown ones symbolise the central region and the purple boxes the MSP_7C domain. Numbers within boxes represent the number of codons under positive selection episodic positive was ancestral branches (Fig. 4 and Additional for functional between orthologues (e.g. proteins from D) 10 and 20% of the sites had a significant change in their evolutionary rate (Additional file 7). Likewise, we found either amongst logues (Table 2 and Additional 8). Discussion It has been suggested that DNA duplication ( the msp7 LRT Dis the (log) score for the likelihood ratio test against the null hypothesis ( D=0 )[ 5]. It is the output of DIVERGE and it follows a chi-square distribution with degree freedom; method is for paralogous pairwise comparisons (see Additional selected sites and non-significant D. Comparisons 11, an branches, having an intensification of this kind of selection, while the proportion of negative selected sites st ayed et 13always the [69]. are 44], some have functionally diverged (they recognise d i f f e r e n th o s tr e c e p t o r s )[ 7 0 -73]. The msp7 family has been previously [15, 16, 24], displaying different study has analysed 4 new species and com- pleted analysis for P. reichenowi the birth-and-death model of evolu- tion for this family (Fig. 1). Then again, 2 and Additional file 3), MSP7A/H(clade 1) was the most ancestral gene, followed by clade2 which is shared by monkey- and rodent-parasites. Clade 5 was also an old it shared amongst monkey- and rodent-parasites; however, not all monkey-parasites had this copy and it thus became lost in P. knowlesi ,P. coatneyi and P. . Moreover, these in theMSP_7C vivax P. they latter sister taxa common as the whole msp7 repertory. The monkey-parasite lineage. At least two orthologous genes were found within these two lineages whilst only one gene was shared between these and the hominid-parasite lineage (Fig. 1). The most ancientPlasmodium lineage is the bird/reptile-parasite. We analysed P. gallinaceum and found just one large msp7 gene. According to the MSP7 C-terminal phylogenetictree (Additional file 5), it is still unclear whether this l a r g eg e n ei so r t h o l o g o u s to the most ancestral gene (msp7A /H). As we did not find any more msp7 genes in the P. gallinaceum gene expansionshould have taken place after mammal-parasite 40 million year ago [42]. We found 83 sequences between bordering genes in the 13 genomes (Fig. 1 and Additional file 1); however, 11 protein sequences did not have the MSP_7C domain at the C-terminal end, though some of them did clusterwith had high similarity MSP7s (Additional domain lost the domain throughout Plasmodium evolutionary history. On the other hand, (3d clade) similar MSP_7C phylogenetic tree (Addi-tional to PvivMSP7E PcynMSP7I. A previous not near each (Fig. 1) and there was no completegene homogenisation. Therefore, it is not clear whetherthis mechanism is place at present species [74]. MSP7is diversifying selection ( > MSP1 [67, 68], few internal branches were under episodic selection (Fig. 4a, e, f and g); this pattern could be the out- come of adaptation to new hosts during Plasmodium sympatric speciation, as has been suggested for other 68]. On the other hand, several external lineages (branches) were under selection. This of changes in evolutionary rates throughoutmsp7 Evolutionary Biology (2016) 16:256 of 13selection since they may have promoted adaptation to a new host or acquiring new molecular activities. Previous work did not selection was located in central msp7 regions and few at 5 or 3 -ends. Population genetics studies have shown the central region to be the most poly-morphic and it seems to hostadaptation to C-terminal the result of (Additional file 8). Despite functional been suggested MSP7 proteins 2) in a previous in silico study [15]. This could have been because orthologousproteins might use different regions to interact with a host or with their own parasite proteins. The P. falcipa- rum (hominid-parasite lineage) region was analysed here, taking into account that this region has the domain (MSP_7C) defining members of this family, it is the onlyMSP7 region in the protein complex and most regions to in the clades (Table 2 7), suggesting that some have diverged functionally.Such within between monkey-parasite MSP7A and rodent-parasite MSP7A). This could genes ex- perience a brief period of relaxed selection early in theirhistory [69]. This relaxation could have led to to molecular not show relaxation intensification. This could have been due to episodic posi-tive selection. This kind of selection acts very quickly andinvolves a switch from negative selection to positive selec- tion and back to negative selection [62]. Episodic selection was found in all msp7 paralogous clusters by two different approaches (Fig. 4, Additional and 7); consequently, episodic could not have been detected by RELAX. On the other hand, some paralogous proteins had no statistical Dvalues; they also displayed thereforeevolve in line with a birth-and-death evolutionary model, somemembers have evolved in a concerted way. Gene conver-sion has taken place between some paralogous paralo- keeping same tracks could be ancient and thus the homogenisation has been lost. In addition, PlasmoDB accession numbers for msp7 genes from eight species are (TXT 88 kb) P. file phylogeny inferred Numbers represent different clades (based on Fig. 2 numbers from main text) whilst numbers on branches are bootstrap and posterior phylogeneticrelationships, clades 1 (red) and 2 (yellow) being the most ancestral ones; clade 5 could also be an old cluster. The clades clustering genes from monkey-parasite lineage are depicted from rodent-parasitelineage in and hominid-parasite lineage in grey. protein cluster inbrown is a inui specie-specific duplicate. Both ML and BY trees showed similar topologies, but only the ML tree is shown. Some internal brancheswere inconsistent between BY and ML trees. Since msp7 complex evolutionary history (having conversion, were consistent in both topologies as well as in Fig 2 's tree. In BY analysis, the settings for prior and likelihood were: = G + F). million generations were required for sequences lacking an MSP_7C (PDF 24 file trees most ancestral MSP7 protein (clade 1, see Fig. 2 in the main text) though this group was not supported by values. Clades shown in red and yellow were the most ancestral ones. The clades clustering genes from monkey-parasite lineage ML and BY trees showed similartopologies but only the ML tree is outside the clades represent the number of clades in Fig. 2 from main text. (TIF 3038 kb)Additional file performed HyPhy both amino acid DNA Datamonkey. letters in the first panel correspond to the letters in Fig. 4 from the main text. (PDF 292 kb) Additional file 7: Putative the C-terminal region (MSP_7C domain) under positive selection found by the MEME method were tagged with a red plus could involve relaxation of functional constraint could beinvolved the acquisition of a role but could also be the outcome of adaptation to comparison (e.g. Clade 1 Primate-parasitesvs Clade 2 and the relative proportion of sites are plotted for test (blue) and reference (red) branches. The grey vertical dashed line at = 1 represents neutral evolution. The numbers in parenthesis indicate the comparison number in Table 2 from the main text. Comparisons 2, 4 and 15 show thatthe percentage selected sites having an selection on the test branches whilst the percentage We would like thank Jason Garry for translating and reviewing themanuscript. Funding This work was financed by the Departamento Administrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n (COLCIENCIAS) through grant RC # 0309-2013. Availability of data and materials The datasets supporting this article 's results are and wrote the manuscript. JF-R participated in designing the study, the molecular evolutionary analysis and writing the manuscript. MAP coordinated the study and helped to write the manuscript. All the authors have read andapproved the final version of the manuscript.Garz\u00f3n-Ospina et al. BMC Evolutionary Biology (2016) 16:256 Page 11 of 13Competing that Colombia (FIDIC), Carrera 50#26-20, Bogot\u00e1, DC, Colombia. 2PhD Programme in Biomedical and Biological Sciences, Universidad del Rosario, Carrera 24#63C-69, Bogot\u00e1, DC, Colombia.3School of Medicine and Health Sciences, Universidad del Rosario, Carrera 24#63C-69, Bogot\u00e1, DC, Colombia. Received: 15 September 2016 Accepted: 17 November 2016 References 1. Ohno S. Evolution by gene duplication. London, New York: Allen & Unwin; Springer-Verlag; 1970. 2. Zhang J. Evolution gene duplication: an update. Trends Ecol Evol. 2003; 18(6):292 -8. 3. birth-and-death evolution of multigene families. Annu Rev Genet. 2005;39:121 -52. 4. Kimura M. The neutral theory of molecular evolution. Cambridge Cambridgeshire, New York: Cambridge University Press; 1983. 5. Gu X. Statistical methods Trucco C, Howell S, D, Gunaratne R, Holder AA. The 22 kDa complex thesurface of Plasmodium falciparum merozoi t e si sd e r i v e df r o mal a r g e rp r e c u r s o r , merozoite surface protein Rogozin IB, Wolf YI, Koonin EV. Selection in the evolution of gene duplications. Genome 2002;3(2):RESEARCH0008. 9. Duval L, Fourment Sadeuh SA, Goodman SM, Andriaholinirina NV, Randrianarivelojosia M, Paul RE, Robert V, et al. Africanapes as reservoirs of Plasmodium falciparum and of the Laverania Proc Natl Acad Sci U A. 2010; 107(23):10561 -6. 10. Hall N. Genomic insights into the other malaria. Nat Genet. 2012;44(9):962 -3. 11. Tachibana S, Sullivan SA, Kawai S, Nakamura S, Kim HR, Goto N, Arisue N, Palacpac NM, Honma Genet. 2012;44(9):1051 -5. 12. Singh V, Gupta P, Pande V. Revisiting the multigene families: Plasmodium var and vir genes. J Borne Dis. 2014;51(2):75 -81. 13. Sundararaman SA, Plenderleith LJ, Liu W, Loy DE, Learn GH, Li Y, Shaw KS, Ayouba A, Peeters M, S, et al. Genomes of cryptic chimpanzeePlasmodium species reveal evolutionary Commun. 2016;7:11078. 14. A, Thiruvengadam G, family Mol the malaria parasite: the complex and the MSP7 family. Int J Parasitol. 2010;40(10):1155 -61. 17. Mello K, Daly TM, Long CA, Burns JM, Bergman LW. Members of the J, Vaidya AB, Long CA, Bergman LW. A multigene family that interacts with Z, Mok S, Hu G, Imwong M, Jaidee A, Russell B, Ginsburg H, Nosten F, Day NP, White NJ, et Natl Acad Sci U S A. 2008;105(42):16290 -5. 20. Zhu L, Mok S, Imwong M, Jaidee A, Russell B, Nosten F, Day NP, White NJ, Sci Rep. 2016;6:20498. 21. Garcia Y, Puentes A, Curtidor H, Cifuentes G, Reyes C, Barreto J, Moreno A, Blood. 2005;105(1):394 -6. 23. Garzon-Ospina D, Lopez C, Forero-Rodriguez J, Patarroyo Coggill P, Eberhardt RY, Eddy SR, Mistry J, Mitchell AL, Potter SC, Punta M, Qureshi M, Sangrador-Vegas A, et al. The -7. A tool for editing and annotating multiple sequence alignments. 1997. 34. Abascal F, Zardoya R, Posada D. ProtTest: selection of best-fit models of protein evolution. Bioinformatics. 2005;21(9):2104 -5. 35. Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post- analysis of large phylogenies. Bioinformatics. Ronquist F. Parallel Bioinformatics. -15. 37. Mark P, Ayres DL, Darling A, Hohna S, Larget model space. SystBiol. 2012;61(3):539 -42. 38. Miller MA, Pfeiffer W, Schwartz T. Creating the CIPRES Science Gateway for inference of the GatewayComputing Environments (GCE). New LA; 2010. p. 1 -8. http://www.phylo.org/sub_sections/portal/sc2010_paper.pdf. 3 9 . M i l l e rM A ,S c h w a r t zT ,P i c k e t tB E ,H eS ,K l e mE B ,S c h e u e r m a n nR H , Passarotti M, Kaufman S, O 'Leary MA. A RESTful API for Access to Phylogenetic Tools via the CIPRES A, Daubin Arvestad Sennblad B, Arvestad L, Lagergren J. DLRS: gene tree evolution in light of a species tree. Bioinformatics. 2012;28(22):2994 -5. 42. Pacheco MA, Battistuzzi FU, Junge RE, Cornejo OE, Williams CV, Landau I, Rabetafika L, Snounou G, Jones-Engel L, Escalante AA. Timing EF, Amedeo P, theneglected Plasmodium vivax. Nature. 2008;455(7214):757 -63. 44. Neafsey DE, Galinsky K, Jiang RH, Young L, Sykes SM, Saif S, Gujja S, Goldberg JM, Young S, 45. E, Rozas J, Navarro A, Barbadilla A. The estimation of the number and the length tracts from population DNAsequence data. Genetics. 1997;146(1):89 -99. 46. detecting gene conversion. Mol Biol Evol. 1989; 6(5):526 -38. 47. Librado P, Rozas J. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics. 2009;25(11):1451 -2. 48. Martin DP, Lemey M, Moulton V, Posada D, Lefeuvre P. RDP3: a flexible and fast computer program for recombination. 2010;26(19):2462 -3. GL, Doallo R, Posada D. jModelTest 2: models, and parallel computing. Nat 52. Gu Zou Y, Su Z, Huang W, Zhou Z, Arendsee Z, Zeng Y. An update of DIVERGE software divergence analysis of protein family. MolBiol Evol. 2013;30(7):1713 -9. 56. Yan J, Cai Z. Molecular evolution and functional divergence of the cytochrome fish). PLoS One.2010;5(12):e14276. 57. Zhao Z, Liu H, Luo Y, Zhou S, An L, Wang C, Jin Q, Zhou M, Xu JR. Molecular evolution and functional divergence of tubulin superfamily in thefungal tree of life. Rep. 2014;4:6746. 58. Wang Y, Gu X. Functional divergence in the caspase gene functional constraints: statistical analysis and prediction. Genetics.2001;158(3):1311 -20. H, Gu J, Lamont SJ, X. Evolutionary analysis for functional toll-like and J Mol Evol Biol. 2007;7:81. 61. Song W, Qin Y, Zhu Y, Yin G, Wu N, Li Y, Hu Y. Delineation of plant caleosin residues 2015;32(3):820 -32. 63. Mongui A, O, Cortes J, Patarroyo Prediction of complete gene structures Kaneko A, Tanabe K, Horii T. Clues to evolution of the SERA multigene family in 18 Plasmodium species. PLoS One. 2011;6(3):e17775. JM, Barnwell JW, de Oliveira Martins L, Pathirana S, Handunnetti S, Kawai S, Kishino H, Horii JE, Prall SP, Ambu L, Nathan S, Alsisto S, Ramirez D, Escalante AA. fate and consequences of duplicate genes. 2000;290(5494):1151 -5. 70. Orlandi PA, Klotz FW, populations.Nat Med. 2003;9(1):87 -92. 2005;309(5739):1384 -7. 74. Mu J, Joy DA, Duan J, Huang Y, Carlton J, Walker J, Barnwell J, Beerli P, Charleston MA, Pybus OG, et al. switch in humans. Mol 75. Urquiza M, Rodriguez LE, Suarez JE, Guzman F, Ocampo M, Curtidor H, Segura C, falciparum MSP-1 cells. Parasite Immunol. 1996;18(10):515 -26. 76. Rodriguez LE, Urquiza M, Ocampo M, Curtidor H, Suarez J, Garcia J, Vera R, Puentes A, Lopez R, Pinto M, et al. Plasmodium vivax MSP-1 peptides and all major indexing services \u0081 Maximum visibility for your research Submit your manuscript at www.biomedcentral.com/submitSubmit your next manuscript to BioMed Central and we will help you at every step:Garz\u00f3n-Ospina et al. BMC Evolutionary Biology (2016) 16:256 Page Patarroyo1,3* vivax is one the five species causing malaria in human beings, affecting around 391 million people annually. The development of an anti-malarial vaccine has been proposed as an alternative for controlling this disease. However, its development has been polymorphism low genetic diversity. The neutral model for pv12 could not polymorphism in pv38 by encoded proteins seemed to have functional/structural constraints due to the presence of s48/45 domains, which were seen to be highly conserved. Conclusions: good protozoan parasites from thePlasmodium genus infected Anopheles female mosquito. Around 3.3 billon people are at risk of malaria annually,mainly in tropical and subtropical areas of the world,children aged less than five years and pregnant vulnerable [3]. Plasmodium falciparum is responsible for the disease 's most lethal form, being pre- dominantly found on the African continent whilst P. vivax is widely distributed around the though it been complications [4]. It has been found that 2,488 million people are at risk of becoming infected by P. vivax on the continents of Asia and America, 132 to 391 million cases occurring annually [5]. In spite of in different countries, malaria continues to be a public health problem due to the parasite 's resistance to anti-malarial Inmunolog\u00eda de Colombia (FIDIC), Carrera 50 No. 26-20, Bogot\u00e1, DC, Colombia 3School of Medicine and Health Sciences, Universidad del Rosario, Bogot\u00e1, DC, Colombia Full list of author information is available at the end of the article \u00a9 2014 Forero-Rodr\u00edguez et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License use,distribution, and Dedication stated.Forero-Rodr\u00edguez et al. for been characterized of some of them [10-18] has immune system [23]. It been to had [25]. Developing multi-antigen vaccine against the para- site 's blood stage has been focused on blocking host- i - tial interaction with RBC [29-33] and some have been considered as being candidates for being included in a vaccine [34,35]. One group of proteins belonging domains in are expressedduring different parasite stages [28,36] and some of them (e.g., Pf48/45, Pf230) have been considered as vac- vivax teins have a signal peptide, a GPI anchor sequence and have been two s48/45 C-terminal end [38] to be antigenic [38-40], suggesting that they are probably during P. vivax genes structural with to the Pv38 was extractedfrom total blood collected from different Colombian areas (Antioquia, Atl\u00e1ntico, Bogot\u00e1, Caquet\u00e1, Cordoba, Choc\u00f3, Guain\u00eda, Guaviare, Magdalena, Meta, Nari\u00f1o, and Tolima)from 2007 to 2010. P. patients who pro- vided blood samples were of committee. in 100 samplesstored at -20\u00b0C (2007-2010) at FIDIC (from different areas of 18S 0.25 mM dNTPs, 0.5 mM of each primer, 0.1 U Mango Taq DNA polymerase ( Bioline) and 10-40 ng gDNA oneinitial at 95\u00b0C (20 sec), annealing at 65\u00b0C (30 sec) and anextension step at 72\u00b0C cycle at The pvmsp-1 gene fragment (blocks 6, 8) was ampli- fied (Invitrogen). PCR of and of primers was designed 5 -GCACTACATTATAAAGForero-Rodr\u00edguez et al. Malaria Journal 2014, 13:58 Page 2 of 12 http://www.malariajournal.com/content/13/1/58AAAAGGACC-3 and for pv38 Buffer II 2, 0.2 mM of each , 0.5 M polymerase (Applied Biosystems)and 10-40 ng gDNA in a 50 L final volume. The PCR thermal profile was as follows: one cycle at 95\u00b0C (7 min), 40 cycles at 95\u00b0C (20 sec), 56\u00b0C (30 sec), 72\u00b0C (1 min) and a final extension cycle at 72\u00b0C (10 min). PCR products were purified using a commercial UltraClean PCR Clean-up kit (MO BIO). The purified PCR products were se- quenced in Main software (CLC bio, Cambridge, MA, USA). The pv12 and pv38 genes were analysed and numbers : GU476521.1; and for pv38 : JF427570.1). Runner was trans- the for deducing number obtained year. Two test families were used for evaluating the neutral molecular evolution model for the Colombian population:(1) frequency spectrum test, and (2) haplotype involved calculating Tajima 's D Fu and Li 's D* and F* [50] and Fay and Wu 's taken sequences. Fu and * statistic takes the difference between the number of singleton sites and the total of mutations, whilst F* takes the difference between the number of Fay 's H statistic is based on the difference of the ferences statistic tests performed. The effect of natural selection was evaluated regarding intra and interspecies; the average number of non-synonymous substitutions per non-synonymous site N) and the average number of synonymous substitutions persynonymous site (d S) exact test d Nand d S< 10) Z-test in (v.5) Differences between d Nand d Sper site were calcu- l a t e db yu s i n gS L A C ,F E L ,R E L[ 5 5 ] ,I F E L[ 5 6 ] ,M E M E [57], and [58] of divergence Malaria Journal 2014, Page 3 of 12 http://www.malariajournal.com/content/13/1/58sequences). This test involved using a web sequences obtained from the databases plus the Colombian ones and just those obtained for the Colombian population. nS[62] of P. vivax collected from different areas of Colombia and stored from 2007 to 2010. Seventy-seven samples revealed an amplicon of P. vivax gDNA. A region of the pvmsp-1 gene was then amplified and digested with re- striction enzymes, showing that seven of the 77 samplesproving positive for P. vivax had multiple infections. Only thus the pv12 gene (South-west n and sequenced; (N125K), 379 (T127A), 539 (L180W) and 662 (N221S). Only one SNP (nucleotide 375) was found in the Colombian population. A repeatregion the North Korean sequence(Figure and deletions in the Colombian sequences (Figure 1A, haplotypes 2 and 3). Six haplotypes were found in pv12 (Figure 1A and Table 1) around the world, four of which are present inColombia at 8.7, 5.8, 10.1, and 75.4% frequency for haplotypes 2, 3, 5 and 6, respectively. Haplotypes 2, 5and 6 were present in the different Colombian locations (Additional file 1), haplotype 6 being the most predomin- ant per year (2007 n = 9; 2008 n = 17; 2009 n = 15; 2010n absent or had low frequency (Figure 2Aand Additional file 1). Interestingly, haplotype 3 was present in Colombia during 2009 but absent in the other years studied (Figure 2A). The percentage samplesfrom the South-east of them presenting haplotype 3) was greater than for other years, suggesting that haplotype 3 was restricted to a particular geograph-ical area (Additional file 1) and/or that this had very low frequency in different Colombian subpopulations. Haplo- type 2 was absent from 2007 to 2008 but present between2009 and 2010 (Figure 2A); differently to haplotype 3, this haplotype was present everywhere, except in the South- west location (Additional file 1). This appeared to previous tests for evaluating that mutationsinpv12 are neutral were performed. No significant values were found for the Tajima, Fu and Li, Fay and Wu or Fu tests (Table 2); likewise, the Colombian population 'sn K-test and H-test. Since neutrality could not be ruled out, the mutations or haplotypes found in pv12 could have been randomly fixed; this might explain theForero-Rodr\u00edguez et al. Malaria Page 4 of 12 http://www.malariajournal.com/content/13/1/58possible geographical isolation of haplotype 3, since differ- have become fixed in different neutral hypothesis. Alternatively, the geographical isolation haplotype 3 sulted from the structured P. vivax population in America, where haplotypes may have diversified in situ . Natural selection in pv12 The gene was split into regions: 1-546 (amino per non-synonymous site rates (d N)w e r ec a l - culated using the gene 's total length to evaluate whether natural selection had any effect on pv12 evolution. that suggested where purifying selection action been found, cating (once did not appear to deviatefrom neutrality. However, not most recent tor infecting primates (e.g. and P. knowlesi inferring < 1 values throughout the gene (Figure 3), which could have been a consequence of negative selection. Moreover, significant values were N/DS (Table deleterious when the MK test was done with haplotypes found in Colombia (and in spite of exposed to the im- mune system [39,40], it had a high level of pattern could have been six haplotypes found in the pv12 gene. Haplotypes 2, 3, 5 and 6 were found in the Colombian population. B.Alignment of the 17 haplotypes found in pv38 14 of them found in the Colombian population (haplotypes 1, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, and 17). The dots indicate and local genetic diversity n Gene Sites Ss S Ps H w (sd) (sd) Worldwide isolates 76 pv12 927 (0.0005) (0.0001) sd: standard deviation.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:58 Page 5 of 12 http://www.malariajournal.com/content/13/1/58by negative selection, due to a possible functional/struc- samples could be amplified for the pv38 gene, Midwest: 4; sequences obtained from isolates were compared to and analysed different regions of the world [43,44]. Colombian sequences that have a different haplotype to that of previously reported ones can be found in GenBank(accession numbers KF667330-KF667340). SNPs were observed in the to Pf38 [73]. Positions 525 and 969 produced synonymous substitutions in protein sequence was generated when the substitution in position 525 was accompanied with another one in position 524). The parasite populationin Colombia has eight of these nine SNPs, all being informative-parsimonious sites. Similar to that reportedfor its orthologue in P. falciparum [73], most substitutions were in identified from of the world) (Figure 1B), 14 of which were found in Colombia 's para- site population at different frequencies: 11% haplotype 1, 4% haplotype 5, 2% haplotype 6, 20% haplotype 7, 15% haplotype 8, 7% haplotype 9, 2% haplotype 10, 4% haplo-type 11, 13% haplotype 12, 4% haplotype 13, 2% haplotype 14, 4% haplotype 15, 7% haplotype 16, and 4% haplotype 17. Most haplotypes were found in intermediate frequen-cies per year (2007 n = 6; 2008 n = 6; 2009 n = 8; 2010 n = 26) and none exceeded 50% (Figure 2B). The absence of some haplotypes in determined years, or in some loca-tions, could not just have been due to the low frequency which they might have had but also to the difference in the number of samples for each year (n = 6 in 2007, n =6 in 2008, n = 8 in 2009 and n = 26 in 2010) or because American P. vivax 0.0026 \u00b1 0.0002 worldwide \u00b1 0.0002 in population (Table 1),this being 1.3 times lower than orthologue in P. falciparum in the Colombian population. A. Frequency per year for the four pv12 haplotypes found in the Colombian population: n = 9 in 2007, n = 17 in 2008, n = 15 in 2009 and n = 29 in 2010. B.Frequency per year for the 14 pv38 haplotypes found in the Colombian population. n = 6 in 2007, n = 6 in 2008, n = 8 in 2009 and n = 26 in 2010. Table 2 pv12 and pv38 neutrality, linkage disequilibrium for the Colombian population N Gene Tajima Fu and Li Fay and Wu 'sHFu 's FsK-test H-test (sd) Z ns ZZ determined.sd: standard deviation.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:58 Page 6 of 12 http://www.malariajournal.com/content/13/1/58gene had low diversity, at least in the two main species affecting human beings. Deviation from the neutral model of molecular evolution inpv38 Tajima 'sD ,F ua n dL i 's D* and F*, Fay and Wu 'sHa n d neutral evolution model. However, the pres-ence haplotypes and falciparum p38 gene which showed evidence of selection 5 'region [73]. Natural in modified d Nand d Srates for showing some type of selection in the pv38 gene. Similar to that used regarding pv12 , thepv38 gene was non-synonymous site rate (d N) for pv12 and pv38 genes n Gene Region A Region B Full length gene dS(se) d N(se) d S(se) together Colombian ones (worldwide with Colombian 547-1,095. pv38 nucleotides 1-459 and 460-1,065. se: standard P. Cynomolgi n Gene s48/45 domain in region A s48/45 domain in region B Full-length gene KS(se) K N(se) S(se) in region A s48/45 domain in region B Full-length gene K S(se) K N(se) K (worldwide together with Colombian with is Sal-I reference sequence. *: p < 0.000, : p < 0.002.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:58 Page 7 of 12 http://www.malariajournal.com/content/13/1/58the s48/45 domain). There were more d Nsubstitutions in region A than d Ssubstitutions, whilst there were more d S substitutions in region B than d Nones, even though no significant values were observed (Table 4 Additional file 2). Selection tests by codon revealed positive selection in codon 70 and negative selection in codons 175 and 323,suggesting that the gene was influenced by selection. When the long-term effect of natural selection was ex- plored by comparing (K result could have been the re- sult of either a negative selection or a balanced and H-test results (Table at intermediate frequencies(Figure 2B) suggested it is most (red) above each gene. Table 5 McDonald-Kreitman test for evaluating the of natural selection P. vivax/P. cynomolgi obtained from databases (worldwide isolates) together with Colombian and just with those obtained in the Colombian et Journal 2014, 13:58 Page 8 of 12 http://www.malariajournal.com/content/13/1/58was influenced by balanced selection, similar to that re- ported for P. falciparum Such specific. for interspecific divergence was calculated in each re- gion (Additional file 3), this being where most of the substi-tutions found became accumulat ed, whilst neutrality could not be ruled out for region B (p = 0.1). Functional/structuralconstraint due to the presence of an s48/45 domain wasalso probable for pv38 ,g i v e nt h i sr e g i o n 's low diversity, two negatively selected sites method(in Datamonkey web server) gave a recombination break- point in position 524. Prior studies have suggested that new haplotypes could produce new combinations between the gene 's 5(region A) and 3 region (region B) as the breakpoint found in this gene was located upstream of the region en-coding the s48/45 domain (region B). As only one poly- morphic site was found in pv12 , the aforementioned tests were not carried for this pv12 and pv38 should be considered for an antimalarial vaccine The lack of a totally effective vaccine against human malar-ial parasites is at least to high the host 's being exposed to the host 'si m m u n es y s - antigens such as highlighting high conservation at both intra- and inter-species level due to the influence of negative selection exerted on s48/ 45 domains the 6-Cys family are found the surface of malaria parasites in every stage [28,36-39,69] and some of them (e g, P48/45, localizedwithin antigenic characteristics [38-40] and the low genetic diversity found in this study, the proteins encoded by these genes or their functionally/structurallyconstrained (conserved) regions could be born in mind when designing a multistage, multi-antigen subunit-based anti-malarial distribution found in pv12 (A) and pv38 (B) from 2007 to 2010. Additional file 2: Synonymous substitution per synonymous site N) found by codon-based Z-test or Fisher 's exact tests. se: Standard domain in et al. Malaria Journal 2014, 13:58 Page 9 of 12 http://www.malariajournal.com/content/13/1/58pv38 s48/45 domain in region B: nucleotides 481-852 -: There no s48/ 45 domain pv38 region. Numbering is based on the Sal-I reference sequence. Additional file 3: McDonald-Kreitman test for evaluating the action of natural selection in pv12 and pv38 gene regions A and B. The McDonald-Kreitman was done using sequences obtained from databases (worldwide isolates) together with Colombian and just with those obtained in the Colombian 547-1,095. pv38 devised the study, the experiments, made the population analysis and themanuscript. and helped writethe manuscript. All the authors have the final manuscript. Acknowledgements We especially Dr Sylvain Mousset who provided the ALLELIX software for our analysis. We would also like to thank Jason Garry for translating the manuscript and Professor Manuel E. Patarroyo for hiscomments and suggestions. This work was financed by the \"Departamento Administrativo de Ciencia, Tecnolog\u00eda Inmunolog\u00eda de Colombia (FIDIC), Carrera 50 No. 26-20, Bogot\u00e1, DC, Colombia.2Microbiology postgraduate programme, Universidad Nacional de Colombia, Bogot\u00e1, DC, Colombia.3School of Medicine and Health Sciences, Universidad del Rosario, Bogot\u00e1, DC, Colombia. Received: 14 September 2013 Accepted: 13 February 2014 Published: 2014 1. Rich SM, Ayala FJ: Progress in malaria research: the case for 54:255 -280. 2. White Dis 2008, 46:172 -173. 3. WHO: 2012. Geneva: World Health Organization; 2012. http://www.who.int/malaria/publications/world_malaria_report_2012/ wmr2012_no_profiles.pdf. 4. Price RN, 5. Elyazar F, X, Roth CW, Collins FH, Hemingway J: of insect glutathione S-transferases resistance to Microbiol Rev 1994, 7:303 -310.10. Gomez A, Suarez CF, Lopez C, Forero-Rodriguez J, Sattabongkot J, G, Escalante AA, recombination AA, Ayala FJ: Genetic polymorphism natural 1998, 149:189 -202. 18. Chenet SM, AA, Durand Lucas C, Bacon DJ: Genetic diversity T, Beck HP, Irion A, Betuela I, Alpers MP, Anders blood-stage vaccine implications. Infect Dis challenges malaria vaccines. Nature 2002, 415:694 -701. 25. Kimura M: The neutral theory of molecular evolution. Cambridge Cambridgeshire. New York: Cambridge University Press; 1983. 26. O 'Donnell RA, individualsimmune to malaria. Med e m 2005, 280:40169 -40176. 29. Arevalo-Pinzon G, Curtidor 31:1987 -1994. 30. Garcia J, Curtidor H, Pinzon 31. Garcia Y, Puentes A, Curtidor H, Cifuentes G, Reyes C, Barreto J, Moreno 50:5665 -5675.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:58 Page 10 of 12 http://www.malariajournal.com/content/13/1/5832. Urquiza M, Rodriguez LE, Suarez JE, Guzman F, Ocampo M, Curtidor H, Segura Immunol 1996, 18:515 -526. 33. Rodriguez LE, Curtidor H, Urquiza M, Cifuentes G, Reyes C, Patarroyo invasion of blood cells implications for vaccine design. Chem Rev 2008, 108:3656 -3705. 34. Barrero CA, Delgado G, Sierra AY, Silva Y, Parra-Lopez C, Patarroyo MA: with vivax Vaccine 2005, 23:4048 Khan Chen JH, Jung JW, Wang Y, Ha KS, Lu F, Lim CS, Takeo S, Tsuboi Pukrittayakamee S, Gruner AC, Renia L, Letourneur F, Neafsey DE, Galinsky K, Jiang RH, Young L, Sykes SM, Saif S, Gujja S, Goldberg JM, Young Meyer EV, Nene V, I, Ralph SA, Ren Q, Sargeant TJ, et al: Comparative genomics of Acids Rozas J: DnaSP v5: a software for comprehensive analysis of DNA 2009, the distribution of haplotypes under an infinite-site model. M o lB i o lE v o l 1998, 15:1788 -1790. 49. Tajima F: Statistical method 1989, 123:585 Li of of mutations. YX: tests of neutrality of mutations against population growth, hitchhiking and background selection. Genetics 1997, 147: 915 53. Zhang J, Rosenberg HF, Nei M: Positive Darwinian after gene duplication in primate ribonuclease genes. Proc Natl Acad Sci U S A 1998, 95:3708 -3713.54. Tamura K, Peterson D, Peterson N, comparison of methods detecting Drosophila. Nature 1991, 351:652 -654. 61. Egea A: generalized McDonald- Aguade variation properties of the number of recombination events in the history of a sample of DNA sequences.Genetics 1985, 111:147 -164. 65. Kosakovsky evolutionary biology.Bioinformatics 2010, 26:2455 -2457. 67. Taylor JE, Pacheco MA, Bacon DJ, Beg MA, Machado RL, Fairhurst RM, Herrera S, Kim JY, Menard D, P\u00f3voa MM, Villegas L, Mulyanto, Snounou G, Cui L, 68. Tetteh KK, Stewart J Biol Chem 2013, 288:12805 -12817. Pacheco MA, Ryan EM, Poe AC, Basco L, Udhayakumar V, Collins WE, Escalante AA: Evidence for negative selection on the gene encoding protein 1 10:655 -661. 71. Pacheco MA, Elango AP, Rahman AA, Fisher D, Collins WE, Barnwell JW, AA: 12:978 Arredondo Cai Takayama Y, MacDonald Anderson DE, Aravind L, s48/45 2011, Baines JF: The weak Tami A, Sutherland CJ: High sequence diversity and evidence of balancing selection in the Pvmsp3alpha 86-93.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:58 Page 11 of 12 http://www.malariajournal.com/content/13/1/5876. Kang JM, Ju HL, Kang YM, Lee DH, Moon Park JW, Kim TS, Na BK: Genetic polymorphism and natural selection 126:269 -279. 78. Ju HL, Kang JM, Moon SU, Kim JY, Lee HW, Lin K, Lee JS, Kim -267. 81. Martinez CF, Gomez A, Cardenas PP, Guerrero JE, Patarroyo K, Tachibana S, Hamai M, Tachibana M, Mita T, Yagi M, Zeyrek FY, Ferreira MU, Ohmae H, Kaneko A, Randrianarivelojosia M, J, Cao 84. Giraldo Rojas-Caraballo J, Mongui A, Giraldo MA, Delgado G, Granados D, Millan- Cortes D, Martinez P, Rodriguez R, 30:1807 -1812. 88. Feller T, Thom P, Koch N, Spiegel H, Addai-Mensah O, Fischer R, Reimann A, Pradel G, Fendel R, 2013, 13:58. Submit your next advantage of: Convenient online submission Thorough peer gure charges Immediate publication on acceptance Inclusion in PubMed, CAS, Scopus Scholar Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submitForero-Rodr\u00edguez et al. Malaria Journal 2014, 13:58 Page 12 of 12 http://www.malariajournal.com/content/13/1/58RESEARCH Open Access Low Garz\u00f3n-Ospina1,3and Manuel A Patarroyo1,3* Abstract Background: The development of malaria vaccine has been hindered by identified in Plasmodium vivax not described. Methods: aimed at evaluating the P. vivax p41 (pv41 )g e n e 'sp o l y m o r p h i s m .D N A sequences from Colombian clinical isolates from pv41 the genetic and these domains. Africa. In spite of efforts to date forcontrolling malaria, it continues to be a serious public health problem; 18.9 million cases of P. vivax occurred in 2012, children under five years old and pregnant women being the most vulnerable populations [1]. An anti-malarial vaccine represents one of control measures regarding this disease; developinga multi-antigen vaccine against the parasite 's blood stage is focused on blocking all of them high sity [5-12], this mapatarr.fidic@gmail.com 1Fundaci\u00f3n Instituto de Inmunolog\u00eda de Colombia (FIDIC), Carrera 50 No. 26-20, Bogot\u00e1, DC, Colombia 3School of Medicine and Health Sciences, Universidad del Rosario, Bogot\u00e1, DC, Colombia Full list of author information is available at the end of the article \u00a9 2014 Forero-Rodr\u00edguez et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License use,distribution, and Dedication stated.Forero-Rodr\u00edguez et al. P41 containing GPI-anchored do-mains and its presence on merozoite membrane is due the formation of an Pf12 [25,26]. been shown to be antigenic is exposed to the host immune system,probably during invasion of the been located on merozoite no might form complex been shown to behighly gene region being the most diverse, fixing mutations by positive selection, probably as a mechanism for evading the immune system. Like other members of the 6-Cys family, this gene seemed to have functional con-straints due to the presence of reference strain haplotype distribution found Bshows 1 -2 and 6 -13: Colombian isolates.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:388 Page 2 of 10 http://www.malariajournal.com/content/13/1/388Atl\u00e1ntico, Antioquia, C\u00f3rdoba). All P. vivax -infected pa- tients who provided blood samples were notified objective already been approved by the Fundaci\u00f3n described previously [30]. Briefly, this gene 's blocks 6, 7 and 8 were amplified with direct 5 -AAAATCGAGAGCATGATCGC Buffer II 2, 0.2 mM of each dNTP , 0.5 M of each primer Biosystems) and 40 ng genomic DNA at 50 L final volume. The PCR thermal profile was as follows: onecycle at 95\u00b0C (7 min), cycles at 95\u00b0C (20 sec), 60\u00b0C (30 sec), 72\u00b0C (1 min) and a final extension cycle at 72\u00b0C(10 min). The amplification products were purified theelectropherograms obtained [33]. Gene Runner software was for plus the Colombian sequences using based the frequency spectrum haplotype distribution. Tajima 's D test [38], Fu and Li 's D* and F* tests [39], and Fay and Wu 's H test [40] were calculated for the first group of tests. Fu 's Fs test [41] and K-test and H-test [37] were calculated as part of the group of tests based on haplotype distribution. The significance of into account all tests. The effect of natural selection was evaluated by calculat- ing the difference between the average number of non-synonymous substitutions per non-synonymous site (d N) and the average number of synonymous substitutions per Fisher 's exact tests and the Z test incorporated in MEGA v.5 [43]. of natural selection on p41 interspecific (K N) and synonymous (K S)d i v e r g e usedForero-Rodr\u00edguez et al. Malaria 2014, Page 3 of 10 http://www.malariajournal.com/content/13/1/388for determining sites under interspecies sequences data 6 -8 suggested presence of different genotypes in the during the sequencing, we can absence of multiple infections. The 30 genotyped a base pair the .The sequences from these 30 isolates (Additional file 1) werecompared to and analysed together reported KM212268-KM212275). from of the world, 12 of them being parsimony-informative sites and five singleton sites; 13 haplotypes sites were found frequency); the remaining haplotypes frequency 3%). nucleotide differences per pairs of from ferent parts of the world (worldwide ana-lysed and 3.1 for the Colombian from was 0.0023 for showed that the the pv41 locus whilst the lowest value was found in Colombia 's South-west area (Additional file 2). The gene regionhaving the highest was effect of natural selection on pv41 Tajima 's D, Fu and Li 's D* and F*, Fay and Wu 'sH ,F u 's Fs and the K- and H-test tests out. The differences synonymous (d evaluated of natural Ps H wk Worldwide diversity 36 1,068 17 5 12 13 0.0038 \u00b1 0.0009 3.9 0.0037 \u00b1 0.0006 Local diversity 30 1,115 10 1 9 10 0.0023 \u00b1 Colombian Aligning the haplotypes found in the pv41 gene. The numbers in the upper part indicate the nucleotide position where a substitution was observed; the dots indicate nucleotide identity.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:388 Page 4 of 10 http://www.malariajournal.com/content/13/1/388however, no significant values were found (Table 3). (Figure 3) for the (dN/dS) rate gave a close to 1 at the pv41 , indicating a number of non-synonymous substitutions in this region at a higher rate than in the rest of the se-quence. pv41 were under selection; seven codons were found to be under positive selection and one codon under negative selection (Figure McDonald-Kreitman test some areas between thesedomains, thereby indicating that K Stended to be greater than K N. Significant negative values (p < 0.001) difference between non-synonymousand synonymous (K N-K S)( a b l e5 ) .T h e codon-based selection tests found and The Z nS, ZZ and RM calculated for determin- ing theDatamonkey web cell. Previous studies that popula- tion. However, this pattern could have fewsamples having been collected from some locations. The use of neutral markers could but similar to that found in pv38 [29];Table 2 Tests based on the neutral model of molecular evolution, linkage disequilibrium and recombination for the pv41 gene in the Colombian population nTajima and Wu HFu FsK- testH-test Zns ZZ (d N) and synonymous found.Forero-Rodr\u00edguez et al. Malaria 2014, 13:388 Page 5 of 10 http://www.malariajournal.com/content/13/1/388however, fewer haplotypes were pv41 compared topv38 reported Since the protein has with proteins anchored the merozoite Pv12and Pv41 may also interact in P. vivax .T h i sc o u l d explain the high degree of conservation found in Pv12 would be more exposed to a host 's immune system, greater diversity thus being found in Pv41 ( . 7\u00b1 values ( =d N/dSand N/KS) between (Pkno) in below showing the position of the segregant sites and which of them were influenced by natural selection. Intraspecies selected sites can be seen in the upper part of each gene and inter-species selected sites are indicated in the lower part. The sites were identified by the Datamonkey server. The schemes for pv12 and have from al. [29]. Table 4 McDonald-Kreitman test for evaluating the action of natural selection on the p41gene P. vivax/P. cynomolgi P. obtained the databases together with the Colombian ones (worldwide isolates), and jus t those obtained in the Colombian population isolates). P. P. knowlesi . NI: neutral index.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:388 Page 6 of 10 http://www.malariajournal.com/content/13/1/388most exposed to Pv41 would be the C-terminal in which high fixation substitutions was ob-served (Figure 3). No significant values the tests based on polymorphism frequency spectrum meaning values were found when the effect of natural selection was evaluated by means of the differ- ence between non-synonymous and synonymous substi-tutions (d N-dS) in either the whole or s48/ domain (Table 3). However, the pv41 sliding window gave a peak close to 1 at the 3 -end of the gene (Figure 3); several non-synonymous mutations would seem to in this region. The codon-based selection tests showed that seven out of the ten codons having mutationsproducing a change in the protein were this site. Such positively (encoding the protein 'sC - t e r m i n a lr e g i o n ) and could have been fixed to enable evading the immune system since this region would be more exposed due to the possible antiparallel formation of a Pv12/Pv41com-plex. Substitutions in codons 258, 312 located in the s48/45 domain could become deleterious due to them being able to alter the domain 's structure; however, [17]) would be a P41 adaptation values, indicating positions were found in the 3 -end of the gene. The mutations found there led to changes in protein sequenceH359S, Y361F produced radical amino acid change, which was fixed by positive selection whilst the other two changes were con-servative without selection signals. Since amino acid H359S was fixed by positive selection, this led to Y361F and D363N becoming fixed due to the short physical dis-tance between them. Genetic diversity in pv41 have been responsible for the genetic polymorphism found in this gene. The regression combination sites were found and the GARD from the Datamonkey web server) N) and divergence together with the Colombian ones (worldwide isolates) and just 7 of 10 http://www.malariajournal.com/content/13/1/388selection signals which might p41. The latter was calculated for the gene 's and for each s48/45 domain. Sig- nificant values gene (Table 5), polymorphism being greater than divergence; could have from weaknegative selection or population whilst the rest at structure reportedin [58], haplotype could have frequencies or new haplotypes could have diver- sified within American (or Colombian) subpopulations,meaning that if just population is analysed, then bal- ancing positive selection population methods (Tajima, Fu as a major allele a determined time and then become by another frequent several populations involving On other hand, window in the s48/45 domains of (Table A large selected that previously structure in the different members of the 6-Cys family by eliminating alldeleterious mutations due to the protein conservation (at both intraspeciesand fixation of a large amount of synonymous substitutions, these three proteins may have evolved under strong functional constraints,possibly due to the presence of s48/45 seem to have thus these regions may not vary.Pv41 s48/45 domains have been seen to have changes in their protein sequence, which due to the presence of variants in these regions. This is also another aspect that must be taken into ac- count developing It variants 's efficacy. Additional Additional file 1: DNA sequences from 30 isolates devised the study, the experiments, made the population analysis and genetics wrote themanuscript. MAP coordinated the study, and helped to write the manuscript.All the authors have read and approved the final manuscript. Acknowledgements We would like to thank Dr Sylvain Mousset for providing the Allelix software for our analysis, Professor Mar\u00eda Isabel Chac\u00f3n for her comments andsuggestions and Jason Garry for translating this manuscript. This work wasfinanced by the \"Departamento Administrativo e 2014, 13:388 Page 8 of 10 http://www.malariajournal.com/content/13/1/388Author details 1Fundaci\u00f3n Instituto de Inmunolog\u00eda de Colombia No. 26-20, Bogot\u00e1, DC, Colombia.2Microbiology Postgraduate Programme, Universidad Nacional de Colombia, Bogot\u00e1, DC, Colombia.3School of Medicine and Health Sciences, Universidad del Rosario, Bogot\u00e1, DC, Colombia. Received: 5 August 2014 Accepted: 27 September 2014 Published: 30 September 2014 References 1. WHO: World Report 2013. Geneva: and genes. Mol Biochem Parasitol 2000, 108:53-66. One 2012, 7:e45962. 7. Gomez A, Suarez CF, Martinez P, Saravia Lee DH, Moon SU, Park JW, Kim TS, Na BK: Genetic polymorphism and natural selection K, B, Sattabongkot J, Yan G, Escalante AA, Cui L: intragenic recombination 10. Ord S, Tami A, Sutherland CJ: High sequence diversity and evidence of balancing selection in the Pvmsp3alpha 13. Richie TL, Saul A: Progress and challenges for maintained control elimination. Malar J 2012, 11:14. 17. Garcia J, Curtidor H, Pinzon CG, Vanegas lC h e m 2005, 280:40169 -40176. 20. Barrero CA, Delgado G, Sierra AY, Silva Y, Parra-Lopez C, Patarroyo MA: with vivax Vaccine 2005, 23:4048 2009, 87:377 -390. DI, C, SJ, Hodder AN, Thompson J, Bustamante LY, . C h e n gY ,L uF ,T s u b o iT ,H a nE T : Characterization of a novel merozoite surface protein of Plasmodium vivax ,P v 4 1 Acta Trop 2013, 126: 222 -228. 28. Chen JH, Jung JW, Wang Y, Ha KS, Lu F, Lim CS, Takeo S, Tsuboi 13:58. Imwong M, Pukrittayakamee S, Gruner AC, Renia L, Letourneur F, S, Neafsey DE, Galinsky K, Jiang RH, Young L, Sykes SM, Saif S, Gujja S, Goldberg JM, Young Z, Mok S, Hu G, Imwong M, Jaidee A, Russell B, Ginsburg H, Acad Sci U S A 2008, 105:16290 -16295. 33. Pacheco MA, Battistuzzi FU, Junge RE, Cornejo OE, Williams CV, Landau I, Rabetafika L, Snounou G, Jones-Engel L, Escalante AA: Acids Rozas J: DnaSP v5: a software for comprehensive analysis of DNA 2009, the distribution of haplotypes under an infinite-site model. M o lB i o lE v o l 1998, 15:1788 -1790. 38. Tajima F: Statistical method 1989, 123:585 Li of of mutations. -1413.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:388 Page 9 of 10 http://www.malariajournal.com/content/13/1/38841. Fu YX: Statistical tests of neutrality of mutations against population growth, hitchhiking and background selection. Genetics 1997, 147:915 Zhang J, Rosenberg HF, Nei Positive after gene duplication in primate ribonuclease genes. Proc Natl Acad Sci U S A 1998, 95:3708 -3713. 43. Tamura K, Peterson D, Peterson N, M, comparison of methods detecting Drosophila. Nature 1991, 351:652 -654. 49. Egea S, Barbadilla A: Standard and generalized McDonald-Kreitman test: a Aguade variation properties of the number of recombination events in the history of a sample of DNA sequences.Genetics 1985, 111:147 -164. 54. Kosakovsky 2010, 26:2455 -2457. M, Tanabe K, Tachibana S, Hamai M, Tachibana M, Mita T, Yagi M, Zeyrek FY, Ferreira MU, Ohmae H, Kaneko A, Randrianarivelojosia M, J, Cao selection. Malar J 2011, 10:126. 58. Taylor JE, Pacheco MA, Bacon DJ, Beg MA, Machado RL, Fairhurst RM, Herrera S, Kim JY, Menard D, Povoa MM, Villegas L, Mulyanto, Snounou G, Cui L, 124:755 -766. 60. Arredondo SA, Cai Anderson DE, Aravind L, s48/45 U 109:6692 -6697. this article 2014 13:388.Submit your next manuscript to and take full advantage of: Convenient online submission Thorough peer gure charges Immediate publication on acceptance Inclusion in PubMed, CAS, Scopus Scholar Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submitForero-Rodr\u00edguez et al. Malaria Journal 2014, 13:388 Page 10 of 10 http://www.malariajournal.com/content/13/1/388RESEARCH Open compared to pvmsp-7F have limited genetic diversity; pvmsp-7E polymorphism was seen to have been maintained by different types of positive selection. Even though these copies seemed to repertoire. This led to exploring the long-term effect of natural selection by comparing encode proteins 'functional region whilst The positive genes during host switch may have succeeded selection, Background Malaria remains a major public health problem world- wide. Plasmodium falciparum is the shares a common with malaria, P. falciparum has diverged from parasites infecting great apes [3]. such be directed by the MSP-1 protein [6-8] present in all species from forms protein a gene forming part of Inmunolog\u00eda de Colombia (FIDIC), Carrera 50 No. 26-20, Bogot\u00e1, DC, Colombia 2Basic Sciences Department, School of Medicine and Health Sciences, Universidad del Rosario, Carrera 24 No. 63C-69, Bogot\u00e1, DC, Colombia \u00a9 2014 Garz\u00f3n-Ospina et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License use,distribution, and Dedication Plas- modium berghei (pbmsp-7B )h a ss h o w nt h a te v e n though its absence is not lethal, it does reduce ability These results, have suggested that the members of this family could have functional redun-dancy [12,15,16] and protein involved On the other hand, antigenicity studies have shown that some of these genes poly- m o r p h i c[ 2 1 ] .H o w e v e r ,o t h e rm e m b e r s ,s u c ha s pvmsp-7A andpvmsp-7K , There are thirteen msp-7 g e n e si nt h i ss p e c i e s ' chromosome 12; these have been named in alphabeticalorder according to their location regarding the PVX_082640 gene [12]. Eleven of these genes are transcribed, but only seven of them are transcribed during the last hours of theintra-erythrocyte stage [25]. The genetic diversity of four of these seven genes has already been evaluated [21,22]; this study was therefore undergone rapid evolution whilst pvmsp-7F andpvmsp-7L were seen to conserved. The tended to be conserved se- lection, suggesting that they encode the functional region for these proteins. Similar to what happened with the msp-1 gene [26,27], msp-7 genes seem to have diverged due to positive selection, which could have resulted from informed about the purpose of thestudy and all gave their written consent. All procedurescarried out in this study were approved by the ethics committee of the Fundaci\u00f3n Instituto de de genotyping by microscope examination were collected from some of Colombia 's departments (Choc\u00f3 and Nari\u00f1o in the south-west,Guain\u00eda, Guaviare and Meta in the south-east, Tolima inthe Midwest, and Atl\u00e1ntico, Antioquia and C\u00f3rdoba in the north-west) between 2007 and 2010 (nine isolates in 2007, seven isolates in 2008, 8 isolates in 2009 andtwelve isolates in DNA containing 0.3 Mo fe a c h primer in a final 25 L volume. Thermal conditions were set as follows: one cycle of 5 min at 95\u00b0C, 30 cycles of20 sec at 98\u00b0C, 15 sec at 63\u00b0C, 30 sec at 72\u00b0C, followed by a 5 min final extension at 72\u00b0C. products were puri- fied with a BigDye Terminator kit (Macrogen, Seoul, South Korea) in both directions. Three PCR products obtained from independent PCR ones in the in P. vivax ) was analysedGarz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495 Page 2 of 13 http://www.malariajournal.com/content/13/1/495using ORF Finder [29] and Gen e Runner software for iden- tifying open in Bayesi an phylogenetic analysis and the analysis was run for one million generations. ML top- posterior diversity and evolutionary analysis in pvmsp-7 genes CLC Main workbench bio, used to assemble forward reverse well as for the Colombianpopulation alone. Departure from the neutral model was assessed in the Colombian population by frequency spectrum-based tests (Tajima 's D, Fu and Li 's D* and F* statistics Fay and Wu 's H) and tests based on the distri- bution of haplotypes (Fu 's Fs (d N)a n ds y n o n y m o u s( d S) rate substitution. Differences between d Nand d 's (suitable Nand d S< 10 positive or factor ior probability for FUBAR. Recombination was consid-ered was for identifying branches exploring GARD marker. All samples were P. was genotypes amplimers detected for some of the msp-7 genes ( pvmsp-7E n = 31, pvmsp-7F n=3 6 The msp-7 family structure in Plasmodium cynomolgi and phylogenetic analysis meant thatGarz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495 Page 3 of 13 http://www.malariajournal.com/content/13/1/495new sequences from this multigene family are now avail- cynomolgi flanked by the PCYB_122860 and PCYB_122720 eleven 0.9 1.4 ORFs with bp fragment between the pvmsp-7I andpvmsp-7K genes was topolo- though not are therefore, the P. cyno- molgi andP. vivax .E v e nt h o u g h pcmsp-7B andpcmsp-7E did not form a group with pvmsp-7B and ,r e - spectively, their location regarding there little probability that duplica- tion divergence of these two species dependently led to the same order of Evidence of become in the phyl- ogeny from a the P. estimated for this gene (Table 1) was comparable to that found in protein sequence and thereby evading the host 's immune system. Around 60% of the polymorphism found in pvmsp-7E was lo- cated at the gene 's central region whilst the gene 's ends were relatively high conserved (Additional files 3 and 4). the family in P. knowlesi .The genes flanking msp-7 chromosome region in these three species are represented by purple boxes. The blue boxes represent P. vivax msp-7 genes, the red ones represent P. cynomolgi msp-7 genes and the yellow ones represent P. knowlesi msp-7 genes. The genes are given in alphabetical order from left to right. The dashed lines connect orthologous genes. All genes are represented to scale, but in P. cynomolgi and P. knowlesi the distance between them is not representative.Garz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495 Page 4 of 13 http://www.malariajournal.com/content/13/1/495This pattern has been previously observed in other pvmsp- 7 genes [21]. Regarding DNA, 23 haplotypes have been found world- wide in pvmsp-7E (Table 1 and Additional file 4); fourteen different haplotypes have been found in this gene 's3-end, whilst eleven haplotypes have been found in the central region and five in the 5 -end (Additional file 3). Nineteen of these 23 haplotypes were found in the Colombianpopulation (Table 1 and haplotypes 6, 8, 12, 14 -17, 19 -23: 5%) over the course of a 3-year period (2007 -2010) without any longitudinal or spatial trends. Thirteen haplotypes were found inColombia at Of the thirty-six sequencesanalysed for this gene, the North Korean sequence had a premature stop codon, suggesting that pvmsp-7E is strain; however, the annotation in theBroad pvmsp-7E gene (ac- cession: suggests that selection tests Several tests based on the neutral model of molecular evolu-tion used gene deviated from neutral expectations (Table 2 and Additional file 6). Tests based on the polymorphism frequency spectrum had significant values 2 msp-7 (A) and between P. falciparum MSP-7F (PfalH) sequence was used for Ss H w(SD) (SD) Worldwide genetic diversity 0.0573 (0.0040) 1,212 (0.0001) Local genetic diversity theColombian sequences.Garz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495 Page 5 of 13 http://www.malariajournal.com/content/13/1/495had values greater than zero whilst Fay and Wu 'sHe s t i m a - tor had statistically significant negative values (Table 2), indi- cating and the haplotype A sliding F* H statistics gave values greater than zero (D, D* and F*) in the gene 'sc e n - tral region and lower than zero in the 3 -end, this being the region where the most negative value for H was lo- cated (Additional file 7). The gene was divided into three fragments: 5 -end (nucleotide 1 to 390), central (nucleo- tide 391 to 747) and 3 -end (nucleotide 1158); the aforementioned neutrality estimators were calculated foreach of them (Additional file 6). Fu and Li 'sD *a n dF u 'sF s tests gave zero at -end ,F n dL i 's D*, F* and Fu 'sF st e s ts c o r e sw e r e greater than zero in the central region. The haplotype number and haplotype diversity were lower than expectedunder neutrality in the 5 -end and central region. Only Fay and Wu 's H tests gave statistically significant values at the 3 -end (Additional file 6). Natural selection seemed to act in different ways within the pvmsp-7E gene. A sliding window for > 1) in the cen- tral region and a peak at the 3 -end (Figure 3). The d S rate at the 5 and 3 -ends was significantly greater than dN, whilst d Nwas significantly greater than d Sin this gene 's central region (Table 3). Eight positively selected sites were identified in the negatively and 3 -end (14 sites) (Additional files 4 and 8). These results suggested that the central region was under natural positive selection. According to Tajima and Fu and Li had significant values higher than zero) existence of different alleles in the tion. This type of selection which the mutations were accumulated at a greater rate by positive selection (Additional files 4 and 8). Interestingly, as Fay and Wu 's H tests gave significant negative values and as K-test and H-test under neutrality (Table 2), a selective sweep 1). When recombination present in become reduced close There was evidence of recombin- ation throughout the pvmsp-7E gene (Table 1 and and since the deepest H \"valley \"was located at the 3 -end (Additional file 7), the selective sweep may not have affected the gene completely but just this region. The5-end and central regions showed no evidence of select- ive sweep (Additional file 6) and was high in the central region and low at the 5 extreme (Additional file 3). The 3-end had significant values in H and Z nStests (Additional file 6), suggesting that the selection site shouldhave been located in this region. The value in 3 -end was considerably reduced regarding that for the central re- gion (Additional file 3). However, the number of SNPs selective affected the pvmsp-7E gene, the selection site was located in the gene 's 3-end and this seemed to be an incomplete selective sweep due to the presence of recombination since not allvariability had been lost. However, if the selective sweep has not been recent, new mutations could have become fixed following greater than zero (Table 2 and Additional file 6) which may have resulted from a reduc-tion in haplotypes due have been due to a reduction of pvmsp- 7Ehaplotypes by the selective sweep, causing the ber haplotypes to be than that expected.Table 2 Neutrality, linkage disequilibrium and recombination tests pvmsp-7 genes for the Colombian population n Gene Tajima Fu and Li Fay and Wu 'sHFu 's FsK-test H-test (SD) Z nS ZZ <0.02.Garz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495 Page 6 of 13 http://www.malariajournal.com/content/13/1/495Figure 3 P. vivax and cynomolgi is shown purple. A diagram above of pvmsp-7 site (d S) and non-synonymous substitutions per non-synonymous site (d N) n Gene 5 -end Central 3 -end Full-length gene Worldwide isolatesdS(SE) p = 0.06, : p <0.001.Garz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495 Page 7 of 13 http://www.malariajournal.com/content/13/1/495pvmsp-7F la si n pvmsp-7A andpvmsp-7K [22]. Aligning databases (referencesequences, Additional files 9 and 10) revealed that these genes only had four and six segregant sites, respectively. The values and the number of haplotypes for these genes were low (Table 1). The most frequently occurring pvmsp-7F haplotype 1 (19%), haplotype and haplotype 4 (3%), whilst haplotype by haplotype 3 (16%), haplotype 2 (14%) and haplotypes 4, 5 and 6 (3%). pvmsp-7F and pvmsp-7L neutrality and selection tests Neutrality for in the Colombian population ruled out as no statistically sig-nificant values were found for the tests based on the neutral model of molecular evolution (Table 2 andAdditional file 6). Likewise, no natural selection signals were found to be acting on these genes when d Nand d S rates were calculated (Table 3). However, effect of selection on each codon was evaluated, it was seen that codon to the (Table 2 and Additional file 6). No evi- dence of LD was found in pvmsp-7F orpvmsp-7L and Additional file 6), indicating that poly- morphism within these genes was not associated. regression between in pvmsp-7E ,s u g g e s t i n gi n t r a g e n e recombination. Twelve minimal recombination (RM)events were found for pvmsp-7E one was found in pvmsp-7F andpvmsp-7L recombination inpvmsp-7E (ZZ = p < 0.05 and GARD 2 breakpoints, p < 0.0004) but not in pvmsp-7F orpvmsp-7L .F i g u selection Natural selection 's long-term effect on evolutionary history compared branch-site model (Branch-site REL) was performed for the non-synonymous divergence non-synonymous rate gave divergent areas in the central region and 3 -end of these three genes (Figure 3). A statistically significant K N>K Swas found in the central region < 0.001) in pvmsp-7E (Table 4). No significant values represented by a colour bar; segment having a different below the bar represents the recombination event so identified.Garz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495 Page 8 of 13 http://www.malariajournal.com/content/13/1/495Figure 5 Positive lineage-specific selection in msp-7E (A) and msp-7L genes. diversifying and non-synonymous diver- gence per non-synonymous site (K N) n Gene 5 end Central 3 end Full-length gene Worldwide isolatesKS(SE) K N(SE) K S(SE) : p : p <0.001.Garz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495 Page 9 of 13 http://www.malariajournal.com/content/13/1/495positive selection between pvmsp-7 and pcmsp-7 se- quences (Additional files 4, 9, 10 and 11). These results suggested that these genes have become diversified by positive selection; a similar pattern pvmsp-1 gene by positive selection in msp-1 same se- lective may thus have evolved in a [66,67], it has locus, provided that the gene flow between these populations is low. Since malarialparasites could become for adapting the ancestral P. vivax population to a new host during the switch to and thus the ef- adaptation. Negative selection within and between species supports the idea that the 3 -end encodes in invasion be under negative selection in msp-7E ,t w e n t y - four in msp-7F and thirty-six in msp-7L (Additional files 4, 9, 10 11). A large percentage of selected in pvmsp-7A ,7C,7H,7I, 7K[21,22], 7E,7Fand-7L;f u r t h e r m o r e ,t h i sr e g i o nh a s been conserved for a long period of time (2.6 to 5.2 millionyears ago [3]), at least in The negative selection signals identified at the 3 '-end of these three genes (Additional files 8 and 11) suggested that the biological structure encoded by this region has been stable slowly evolving since divergence between P. vivax and P. cynomolgi due to its functional importance. These results support the idea that this region encodes this family 'sf u n c - tional domain premature stop caused by the deletion of one or two nucleotides from the sequence(Additional file 10). The protein encoded by this gene thushad no domain the region (the sequences were compared. Thirteen in were under negative selection in msp-7L (Additional files 10 and 11). The GeneScan and acceptor sequences inpcmsp-7L but not in pcmsp-7F .T h e r ew a sat h y m i n ei n pcmsp-7L nucleotide 609, whilst there was a cytosine in the homologous position in its orthologue in P. vivax (nucleo- tide 615 in the Sal-I sequence). Such change may have pro- duced a (GT) site in pcmsp-7L whilst acceptor was lo cated in an intron msp-7 genes must have evolved differently from those in P. falciparum which have low polymorphism [23,24]. The PvMSP-7s C-terminalregion (the gene 's3-end) tended to conserved within and between genes [21]. This region 'sc o n s e r v a t i o nt e n d e d to be maintained by negative selection in msp-7E ,msp-7F andmsp-7L , suggesting that this is the functional region for this group of proteins. On seen to have undergone rapid evolution at the protein 's central region; immune respon ses would thus been directed t o w a r d st h i sp o r t i o no ft h ep r o t e i n .N e wa l l e l e sh a v ec o n s e - quently arisen in the population and been maintained mechanism for evading an immune response. In addition to this type of evasion, the P. vivax msp-7 family (similar to that suggested for the pvmsp-3Garz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495 Page 10 of 13 http://www.malariajournal.com/content/13/1/495family [72]) would follow a revealed lineage-specific positive signals which are similar to those reported for pvmsp-1 .M u t a - tions occurring in msp-7s genes during host switch may in the ancestral P. GenBank accession number: NC_020405. ORF Finder and Gene Runner software were used to identify open reading frames per site the DNA polymorphism measurements at the -end, central region based files 4, 9 and 10. Additional file 4: pvmsp-7E gene alignment. The alignment shows the 23 (intra-species) and turquoise (inter-species) and those under negative selection are shown in yellow (intra-species) and fuchsia(inter-species). Additional file 5: at PvMSP-7E level Colombia. The alignment shows the 13 haplotypes at protein level found 6: and recombination tests at the 5 -end, central region and 3 -end for pvmsp-7 9 and 10. p *: p <0.05. Additional file sliding window for the pvmsp-7E gene. Tajima 's D (blue), Fu and Li 's D* (red), F* (green) and Fay and Wu 's H (purple). The gene was divided into 3 regions: the 5 -end (nucleotide 1 to 390), central (nucleotide 391 to 747) and 3 -end region (nucleotide 748 to 1,158). The bars at the indicate 4, 9 and 10.Additional file 9 pvmsp-7F gene alignment. The alignment shows the haplotypes turquoise (inter-species) and those under negative selection are in (inter-species). Additional file 10: pvmsp-7L gene alignment in turquoise and those population genetics analysis and wrote the manuscript. MAPcoordinated the study, and helped to write the manuscript. All the authors have read and approved the final manuscript. Acknowledgements We would like to thank Jason Garry for tra nslating the manuscript. This work was financed by the \"Departamento Administrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n Treat Agrawal Singh N: Malaria in a tertiary health care facility of Central India with Pacheco MA, Battistuzzi FU, Junge RE, Cornejo OE, Williams CV, Landau I, Rabetafika L, Snounou G, Jones-Engel L, Escalante AA: P, Q, RM, BS, Feldblyum Fernandez-Becerra Meyer EV, Nene V, I, O, Ralph SA, Ren Q, Sargeant TJ, et al:Comparative genomics of the Plasmodium vivax .Nature 2008, 455:757 -763.Garz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495 Page 11 of 13 http://www.malariajournal.com/content/13/1/4955. Iyer J, Gruner AC, Renia L, Snounou G, Preiser PR: Invasion of host cells by malaria parasites: a of two protein families. Today 2000, 16:411 -415. 7. Rodriguez LE, Urquiza M, Ocampo M, Curtidor H, Suarez J, Garcia J, Vera R, Puentes A, Lopez R, Pinto M, Rivera Z, Patarroyo 2002, 20:1331 -1339. 8. Urquiza M, Rodriguez LE, Suarez JE, Guzman F, Ocampo M, Curtidor H, Segura AA: The 22 kDa of evolution. Mol Phylogenet Evol 2010, 55:399 -408. 13. Garcia Y, Puentes A, Curtidor H, Cifuentes G, Reyes C, Barreto J, Moreno vivo. Blood 2005, 105:394 -396. 16. Mello K, Daly TM, Morrisey J, Vaidya AB, Long CA, Bergman LW: A multigene family that with Chen JH, Jung JW, Wang Y, Ha KS, Lu F, Lim CS, Takeo S, Tsuboi J 2010, 9:77. 20. Mello K, Daly TM, Long CA, Burns JM, Bergman LW: Members of the 443:12-21. 24. KK, Stewart LI, Amambua-Ngwa selection. PLoS One 2009, 4:e5568.25. Bozdech Z, Mok S, Hu G, Imwong M, Jaidee A, Russell B, Ginsburg H, 2008, 26. Sawai H, Otani H, Arisue N, Oliveira Pathirana M, Arisue N, Horii T, Culleton R, Hayakawa T, S, Pukrittayakamee S, Gruner L, Letourneur F, ORF Finder (Open Reading Frame Finder). [http://www.ncbi.nlm.nih.gov/ projects/gorf/] 30. Edgar RC: MUSCLE: multiple Acids Res Posada D: ProtTest: best-fit 21:2104 -2105. 32. Neafsey DE, Galinsky K, Jiang RH, Young L, Sykes SM, Saif S, Gujja S, Goldberg JM, Young J: DnaSP v5: a software for comprehensive analysis of DNA 2009, infinite-site model. Mol Biol Evol 1998, Positive after gene duplication in primate ribonuclease genes. Proc Natl Acad Sci U S A 1998, 95:3708 -3713. 38. Nei M, Kumar S: Molecular evolution and phylogenetics. Oxford New York: Oxford University Press; 2000. 39. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, comparison of methods for detecting amino acid sites under selection. M o lB i o lE v o l 2005, 22:1208 -1222. 43. Murrell B, Aguade variation et al. Malaria Journal 2014, 13:495 Page 12 of 13 http://www.malariajournal.com/content/13/1/49549. Hudson RR, Kaplan NL: Statistical properties of the number of recombination events in the history of a sample of DNA sequences. Genetics 1985, Posada D, Lefeuvre P: RDP3: a flexible and fast computer program for analyzing recombination.Bioinformatics 2010, 26:2462 -2463. 51. Tachibana S, Sullivan SA, Kawai S, Nakamura S, Kim HR, Goto N, Arisue N, Palacpac NM, Honma H, Yagi M, Tougan T, Katakai Y, Kaneko O, Mita T, KitaK, Yasutomi Genet 2012, 44:1051 -1055. 52. Mongui A, Sattabongkot J, Yan G, Escalante AA, Cui L: intragenic recombination 2005, 131:25-35. 55. CF, Martinez Kanbara H, Udomsangpetch R, 59. Martinez P, Suarez CF, Gomez A, Cardenas PP, Guerrero JE, Patarroyo 60. Pacheco MA, Elango AP, Rahman AA, Fisher D, Collins WE, Barnwell JW, AA: 2014, 13:388. 63. Chenet SM, Bacon DJ, Collins WE, Barnwell JW, Escalante AA: The evolution MA, Ryan EM, Poe AC, Basco L, Udhayakumar V, Collins WE, Escalante AA: Evidence for negative selection on the gene encoding protein 1 Arez AP, Pinto J,Michon P, Escalante AA, Nosten F, Burke M, Lee R, Blaze M, Otto TD, Barnwell JW, Pain A, Williams J, White NJ, Day G, Lockhart PJ, Joy DA, Duan J, Huang Y, Carlton J, Walker J, Barnwell J, Beerli P, Charleston MA, Pybus OG, in human genomic DNA. J Mol Biol 1997, 268:78-94. 72. Rice to advantage of: Convenient online submission Thorough peer gure charges Immediate publication on acceptance Inclusion in PubMed, CAS, Scopus Scholar Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submitGarz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495 Page 13 of 13 http://www.malariajournal.com/content/13/1/495Buitrago et al. Malar J (2016) 15:501 DOI 10.1186/s12936-016-1563-4 RESEARCH polymorphism Abstract Background: Designing a vaccine against Plasmodium on antigens involved variable amount of region leads to extensive size polymorphism. This region seems to be exposed to the immune system. The central region has a putative esterase/lipase domain which, like the protein's C terminal fragment, is highly con served at intra and inter species level. Both regions are under purifying The repeat regions in the N terminal region could be associated with immune evasion mechanisms while the central region and the Cterminal be under functional promising candidates This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/ ), which permits unrestricted use, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative waiver http://creativecommons.org/ publicdomain/zero/1.0/ ) otherwise stated.Background Malaria is the parasitic disease having the impact on public health [ 1]. It is caused by different species from parasites cause 140-300 million clini - cal cases annually during the last few years [ 6, 7] has made this species a growing public health problem, affecting more than a third of the world's population, having high prevalence in Asia and South and Central America [ 3, 7, 8]. Designing an anti-malarial vaccine against P. vivax (as for P. falciparum ) has been focused on blocking Open AccessMalaria Journa l *Correspondence: mapatarr.fidic@gmail.com 1 Fundaci\u00f3n Instituto de Inmunolog\u00eda de Colombia (FIDIC), Carrera 50 No. 2620, Bogot\u00e1 D.C., Colombia Full list of author information is available at the end of the articlePage 2 of 12 Buitrago et al. Malar J parasite-host be tection having low efficacy after vaccination. On the con - trary, those having limited diversity are attractive targets the tight a host cell [14-18]. The RON described the C-termi - and falciparum 2657 bp in this species, expressed during the last hours the from the rhoptry neck. This signal peptide sequence, a low complexity domain formed by two types of tandem repeats, a spiral an obstacle for a completely effective vac - cine against P. vivax, 2007 to 2015 10, 2008: 12, 2010: 18, and 2015: 33 samples). These came from Colombia's Pacific coast region (Choc\u00f3 and Nar - i\u00f1o departments), Urab\u00e1/lower Cauca/southern C\u00f3rdoba (C\u00f3rdoba and Antioquia departments) and the quia-Amazonia region (Amazonas cases of P. vivax infection were recorded between 2007 and 2015, more than 14 % of them regarding Colombia's Pacific coastal region, Urab\u00e1/lower Cauca/southern C\u00f3r - doba 62 % while 7.5 % of P. vivax cases were recorded in the Orinoquia-Amazonia region. Malaria then invited to donate 5 mL of venous blood. Some Amazonia samples were and in the study. DNA was extracted and stored at 20 \u00b0C before being processed and were genotyped by PCR-RFLP from the Amplifying, dir (20 bp) and pvron4 rev 5 GCAAGCTAATTTCACAA GTCTTC (23 as follows: a 5 min denaturing step at 95 \u00b0C, 10 cycles consisting of 20 s at 98 \u00b0C, 15 s at 68 \u00b0C (temperature was reduced by one degree per cycle) and 1 min at 72 \u00b0C, followed by 35 cycles of 20 s at 98 \u00b0C, 15 s at 60 \u00b0C, 1 min at 72 \u00b0C and a final 5-min extension at 72 \u00b0C. PCR products were purified selected by the alpha complementation method and their growth Page 3 of 12 Buitrago et al. Malar J (2016) 15:501 ability in the presence of ampicillin. These were con - firmed by PCR using MangoTaq DNA polymerase the 3 (17 bp), and intrev: tions 5 min denaturing step at 95 \u00b0C, 35 cycles of 20 s at 98 \u00b0C, 15 s at 60 \u00b0C, 1 min at 72 \u00b0C and a final 5-min extension at 72 \u00b0C. The plasmid from the two recombi - nant colonies per sample was extracted Minute (MOBIO) and sent to be BigDye Terminator kit (MAC - ROGEN, Seoul, South Korea), with universal prim - prim - ers (pvron4dseq: 5 CACTAGAAAAGCTAAACATA AACC 3 (24 bp), and pvron4rseq: 5 CCTCAAC 3 (18 bp) designed on the genomic sequencing. pvron4 CLC DNA workbench v.3 software (CLC bio, Cambridge, MA, USA). The 73 consensus sequences obtained in this study (Addi - tional file [33], Li [34], Fu [36] tests were used for evaluating devi - ations from the neutral model of molecular bearing coalescence simulations in mind for having gaps average number of synonymous substitutions per synonymous site (d S) and the average number of non-synonymous substitutions per non-synonymous site (dN) amount of synonymous diver - gences per synonymous site the average amount of non-synonymous divergences per non-synonymous site is fewer than ten) or MEGA software Additionally, the McDonald-Kreitman of selection throughout Individual sites having gaps were not was used - ages under episodic diversifying in for the this then used for inferring the best evolutionary model using MEGA software. Phy - logeny was then inferred by using the maximum likeli - hood method with the JFF + G + F model. This is used as reference for analysing lineage-specific positive selection with the REL-branch-site method in the HyPhy package Page 4 of 12 Buitrago et al. Malar J (2016) 15:501 [48], effective of codons This is a measurement of pressure at level, leading loss test compares of each codon versus a null distribution (uniform use of synonymous codons). ENC values close amino (F ST), software NET - median by the amount GEHGEHAEHGE) population (24 from Orino - quia-Amazonia, 21 from the Pacific coast and 28 from Urab\u00e1/lower-Cauca/southern C\u00f3rdoba) were analysed. pvron4 was initially annotated from the strain [22], analysed from Colombian amino acids (repeated one three times) and longer sequence CGGAGAGCACGGTGAACACGCTGAACATGGGGA GCA encoding the GEHGEHAEHGE peptide (repeated one to seven times). Few SNPs were found. Regarding the 2542 sites ana - lysed concerning the Colombian sequences and refer - ence ones, the number of SNPs varied from five to eight (Table 1). genetic diversity estimators gave low val - ues ( w = 4.7 \u00d7 104 and = 4.1 \u00d7 in the the refer - ence ones 1). total amount in pop - ulation (21 when Colombian and reference analysed together) and high Colombian sequences in mind, 32 haplotypes were identified (Additional file 2). Evaluating the effect on the pvron4 locus were found for pvron4 when using the Tajima, Fu and Li, Fay and Wu and Fu estimators (Table 2). Likewise, the MK test deviations regarding (Table however, the was under purifying selection. The sliding windows led to < 1 values being observed throughout the gene (Fig. and in posi - tion 2955; N (Table 3) gave negative values suggesting that purifying selection has Page 5 of 12 Buitrago et al. Malar J (2016) 15:501 played an important role in the other hand, four negatively selected sites (28, 112, 149, 643; Fig. 1) were found throughout the gene in P. vivax when calculat - ing selection per codon based probability and the Bayesian method (MEME), while no sites were found to be under positive selection (Fig. 1). These methods revealed 162 sites under negative selection and 21 under positive selection between species (Fig. 1). Phylogeny was inferred Plasmodium was as reference framework for the This method to finding six branches (lineages) having evidence of episodic selection (Fig. 2). Three were ancestral branches (internal) while the other regarding use of was evaluated as a means of selection at translational level. The ENC Fig. 1 Representation of pvron4 encoding sequence and shown in the species evolutionar ily closest to P . vivax) and red (most distant). A representation of the ron4 gene is given below the sliding window indicating signal (blue), the repeat region (black) and the putative esterase/lipase domain (purple). The P . vivax SNP positions shown as discontinue lines, their number ing is based on Additional file 2 alignment. The sites under purifying selection within species are represented by light green lines and dark green between species while positively selected sites between S H Hd w Sites No InDels H Hd Colombian and reference isolates 15 15 0.78 104Page of 12 Buitrago et al. J (2016) 15:501 for pvron4 value 0.162, sug - gesting that there effective use of codons, thereby = 0.06, p = 0.04). The Nari\u00f1o sub-population (from the Pacific region) could be responsible for genetic differences regarding each of the other subpopulations (Additional files 3, 4). Calculating the F ST index between populations (regions) gave values close to 0. the 32 haplotypes available for the locus (Fig. 3 and Additional file 3). The network showed that the parasite's populations shared haplotypes, regardless pathways and ancestral sequences (median vectors) (Fig. 3 and file 3). occurring hap (12.5 specific regional alleles.Table 2 Neutrality, linkage disequilibrium and recombination not performed, since not all sequences belonged to the same population p < 0.05N Gene Tajima Fu and Li Fay and Wu's between dN dS, KN KS and the neutral index from MK test Non-synonymous substitution rate coatneyi, P .fra P fragile* p 0.597 0.857 1.133 0.919Page strain revealed the presence of a putative domain 1.10e-03. This located after and was highly and potentially antigenic region between positions 41-171 and 178 up to 256 for haplotype 6 and up to position 340 for haplotype 17 (Additional file 5). This agreed with hydrophobicity and accessibility predictions so be a potential immune target. By contrast, the central region (following the region) and seemed to apical method. shows the values, the of (Pr = +]) each colour on branches indicates strength of selection (red shows + > 15, blue 1 and grey = 1). The size of each colour represents the percentage of sites been episodic diversifying by for multiple testing using the HolmBonferroni Malar J (2016) 15:501 protein located in [15, must have several characteristics [10, 65]; one of diversity to avoid allele-specific immune responses, which could reduce vaccine efficacy. The analysis of P. falciparum laboratory strains from different geographically origins vivax. spite of the number report align - ment. pvron4 had a low genetic diversity, being more conserved to date for P. vivax. As it has been suggested for pvrap1 and pvra p2 [67] the low be the consequence of functional/structural constraint (see below) due to the invasion. Even a high polymorphism Previous pro showed that the pvron4 repeat region consisted of two of repeats having % identity; the first encoded three GES amino acids (one to three copies) and the second one GEHGEHAE - HGE amino acids (one to seven copies). gave mechanism 21 types were identified in PvRON4 when the InDels were Fig. 3 Medianjoining regions. shows the identified isolates from the three regions of Colombia. Haplotypes 22 and 28 were included within haplotype 15 using the contraction star lines connecting different mutational and ancestral sequences explaining the relationship and evolutionary originPage 9 of 12 et al. Malar J (2016) 15:501 analysed. PvRON4 N-terminal region seems to solvent availability and hydrophobicity peptide and repeat region) seems to be a potential anti - genic target due to this being where largest PvRON4 N-terminal region could thus be region exposed to a host's immune system and repeats could hypothesis. As the repeat region was highly conserved regarding sequence, it could play an impor - structural or functional 73]. While the N-terminal region might to be exposed to the immune system, the central and C-terminal regions seem to be under functional constraint. is under then it should show high polymor - phism unless is selection translational level could also be responsible for conservation in the pvron4 codon use not use (ENC = 53-55). In fact this value was similar to that reported for the com - plete genome suggesting that high conservation was not due to selection at translational level and could have been a result of strong purifying selection. The d S rate dN this locus has evolved under purifying selection. However, it is not easy to evaluate how as towards the C-terminal. The K S was that functional regions tend to [79], suggest of conserved the associated other RONs the presence of a puta - tive esterase/lipase domain in the protein's central region could be in RON4 entry a yet-unknown mechanism. The presence of an esterase/lipase domain in the PvRON4 central region could provide a clue regarding the action mechanism. This is one associated with evasion of the immune response, the central region (containing the esterase/lipase domain) could be associated with the rupture of ester in turn, enable AMA1-mediated interaction between the parasite and host thus be hypothesized that such putative esterase/lipase domain could highly between spe - selection be selection were identified, regions where > 1 was observed. stud - ies shown genetic diversity) which [76, 81, 82]. The topology for ron4 was similar that relationships not been seen infecting monkeys. These species have a complex evolutionary history, which includes bio - geographic aspects, adaptation to new macaque hosts and even a change from monkeys to humans [81, 84]. The episodic selection observed here might been a consequence of this group of parasites' rapid diversifica - tion (in the N-terminal region and a small portion of the C-terminal region) thereby enabling RON4 to adapt an as previ - ously suggested [76, 81, 82, 84].Page 10 of 12 Buitrago et al. Malar J (2016) 15:501 A relatively high number of haplotypes has been found in the pvron4 locus in Colombia, resulting from a be genetically similar. However, it was observed that a 6 % of estimated variation between these regions was due to differences between the subpopulations constituting them. The F ST that some subpopulations might not be genetically similar; this could be associated with the pres - ence of unique haplotypes. This agreed with suggest - ing that the parasite population in America is structured and has limited gene flow. However, since some subpopu - lations analysed here had limited sample size, the num - ber of sequences for such results to be confirmed. Conclusions Designing genetic diversity regarding SNPs but had a large to tandem in evading the immune response. On the other hand, the central are highly conserved, they are under functionally or structurally constraint. The central region has a putative esterase/lipase domain, leading to the hypothesis that this domain enables RON4 entry to host cells while the complex. candidate for when evolutionary O devised and designed the study participated in the experiments as well as in the population genetics and molecular evolutionary analysis and writing the manuscript. MAP coordinated the study and helped to write the manuscript. All the authors read and approved the final manuscript. Author details 1 Fundaci\u00f3n Instituto de Inmunolog\u00eda de Colombia (FIDIC), Carrera 50 No. 2620, Bogot\u00e1 D.C., Colombia. 2 Microbiology Postgraduate Program, Univer sidad Nacional de Colombia, Bogot\u00e1 D.C., Colombia. 3 School of Medicine and Health Sciences, Universidad del Rosario, Bogot\u00e1 D.C., Colombia. Acknowledgements We would like to thank Jason Garry for translating and reviewing the manuscript. We would also Badillo by her technical assistance and Johanna Forero Rodr\u00edguez and Carlos Fernando Su\u00e1rez for their valuable comments and suggestions. MAP would like to especially thank Liliana Andrea C\u00f3rdoba for all her love and support during the last couple of years. Competing interests The authors declare that they have no competing interests.Additional files Additional file 1. The sequences of the Colombian isolates obtained in this study, sequences from the 2. 32 haplotypes file 3. Colombian departments, together with the reference sequence. Haplotypes 22 and 28 were included within haplotype 15 when using the star contraction algo 0 low below diagonal indicate ST those above the the regions having the greatest probability of being recognised and on protein surface.Page 11 of 12 Buitrago et al. Malar J (2016) 15:501 Availability of data and material The sequences obtained here and which showed different haplotypes to alreadyreported stored database, accession numbers KX513800 KX513824. These sequences, together with the others analysed in this study are available in Additional file 1. Ethics approval and purpose. procedures were approved by the Fundaci\u00f3n Instituto de Inmunolog\u00eda de Colombia and the Universidad del Rosario's ethics committees. Funding This work was financed by the Departamento Administrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n (COLCIENCIAS) through grant October 2016 References 1. Naghavi M, Wang H, Lozano R, Davis A, Liang X, Zhou M. GBD 2013 mortality and causes of death collaborators. Global, regional, and national agesex specific all cause and cause specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117-71. 2. Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW. The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis. 2004;4:327-36. 3. WHO. World malaria report 2015. Geneva: World Health Organization; 2015. http://www.who.int/malaria/publications/worldmalariareport 2015/wmr2015 without profiles.pdf?ua=1. Achieving the incidence of malaria 2000-2015 http://www.unicef.org/publications/files/Achieving_the_Malaria_MDG_Target.pdf . 5. Price associated with severe and fatal malaria: a prospective study in Papua Indonesia. PLoS Med. 2008;5:e128. 7. Winter DJ, Pacheco MA, Vallejo AF, Schwartz RS, Arevalo Herrera M, Her rera S, et limits and population at risk of Plasmodium vivax transmission Chitnis CE, in vaccines: DA. against Plasmo dium a research 13. SL, Plowe Lebrun M, Michelin A, El Hajj H, Poncet J, Bradley PJ, Vial H, Dubremetz JF. Gong H, Ishiwa A, Recuenco FC, et al. T, Tham WH, de Jong NW, al. Revealing Thongkukiatkul Host parasite interactions that A, Bargieri D, Lagal V, et al. Independent roles apical J. glideosome and Gesti\u00f3n para la vigilancia entomol\u00f3gica y control de la transmisi\u00f3n de malaria. Gu\u00eda de Vigilancia Entomol\u00f3gica y Control de Malaria. http://www.ins.gov.co/temas deinteres/Documentacin%20Malaria/03%20 Vigilancia%20entomo%20malaria%20.pdf . 27. Camargo Ayala PA, Cubides JR, Nino CH, Camargo M, Rodriguez Celis CA, Quinones T, et al. High Plasmodium malariae prevalence an area ONE. pGEM \u00aeT easy Acids P , Rozas J. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics. 2009;25:1451-2. 33. Tajima F. Statistical method hypothesis DNA polymorphism. Genetics. 1989;123:585-95. 34. Fu Statistical neutrality of mutations. Genetics. 1993;133:693-709. 35. Fu YX. Statistical tests of neutrality of mutations against population growth, hitchhiking and background selection. Genetics. 1997;147:915-25. 36. Hitchhiking under selection. Genetics. Zhang J, HF, Nei M. Positive Darwinian selection after gene duplication in primate ribonuclease genes. Natl Acad Sci USA. 1998;95:3708-13. 38. Tamura Stecher D, Filipski A, Kumar S. at the Adh Nature. 1991;351:652-4. 41. Standard & generalized McDonald-Kreitman Test. http://mkt.uab.es/mkt/MKT.asp .Page 12 of 12 Buitrago et al. Malar J (2016) 15:501 42. Egea R, Casillas S, Barbadilla A. Standard and generalized McDonald-Kre itman test: a website comparison of methods DG, F. \"Silent\" sites in Drosophila on tRNA availability. J Mol neutrality associations. Aguade M. DNA variation of the number of recombination events in the history of a sample of DNA sequences. Genetics. 1985;111:147-64. 55. Kosakovsky Schneider S. Arlequin (version 3.0): an integrated software package for population a virusspecific synthetic peptide. J Virol. MH, Pugniere M, Douguet D, by apicomplexan parasites: AF, blood cells by malaria parasites. Cell. 2006;124:755-66. 65. Richie TL, Saul A. Progress and challenges for malaria vaccines. Nature. 2002;415:694-701. 66. Pacheco MA, Ryan EM, Poe AC, Basco L, Udhayakumar V, Collins WE, et al. Evidence for negative selection on the gene encoding rhoptryassociated protein 1 (RAP 1) in Plasmodium spp. Infect Genet Evol. 2010;10:655-61. 67. Garzon Ospina Murillo Limited genetic Biol. 2005;37:700-6. 70. Ferreira MU, da Silva Nunes M, Wunderlich G. Antigenic diversity and and patho genesis in Acta. CS, The repeat circumsporozoite protein is critical and Emiliani C, Dottorini T, Bistoni F, Crisanti A, et al. Roles of the amino terminal region and repeat region of the parasite infectivity. PLoS ONE. 2012;7:e32524. Kimura M. The neutral theory of molecular evolution. Cambridge: Cambridge University Press; 1983. 75. Cornejo OE, Fisher D, AA. Genome wide patterns 78. Pacheco MA, Elango AP , Rahman AA, Fisher D, Collins WE, Barnwell JW, et al. Evidence of purifying selection on 8 Genet Evol. Price Zufall RA, E. On the \"function\" in the Glen J, Shimp RL, Lambert L, et al. Identification Infect Immun. JE, Prall SP , Ambu L, Nathan S, et al. malarias Otani N, Palacpac N, de Oliveira Martins L, Pathirana S, et al. Lineage specific parasite the Plasmodium falciparum antigens. Malar J. 2013;12:328. 84. Mu J, Joy DA, Duan J, Huang Y, Carlton J, Walker J, et al. Host switch leads to emergence of Plasmodium vivax malaria in humans. Mol Biol Evol. 2005;22:1686-93. 85. Taylor JE, Pacheco MA, Bacon DJ, Beg MA, Machado RL, Fairhurst RM, et al. The evolutionary A. Moreno-P\u00e9rez1,2, Diego Garz\u00f3n-Ospina1,2, Johanna participate reticulocyte molecular rol e regarding preferential according to natural binding ability was confirmed. These findings support the notion important role in is a priority on the international [1]. As a strategy for eradicating this species, several research groups have focused their efforts on developing a vaccine, as vaccination of proteins expressed by [5], transcripts [6] and Inmunolog\u00eda de Colombia (FIDIC), Carrera 50 No. 26-20, Bogot\u00e1 DC, Colombia 3Basic Sciences Department, School of Medicine and Health Sciences, Universidad del Rosario, Carrera 24 No. 63C-69, Bogot\u00e1 DC, Colombia Full list of author information is available at the end of the article \u00a9 The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link tothe Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in its binding region which is located in the amino terminal sequence, is involved a reduction during invasion well as a delay in the time to deathin an in vivo to the 's ing reticulocytes which are between isolates, which would be counterproductive for the development of a broadlyprotective vaccine. A new strategy has recently been proposed identified genes a for selectingconserved antigens that are to functional restrictions.However, been Given the the synonymous mutations rate (d S,t h o s ee n c o d i n gt h e same amino acid) in the search for natural selection signals.Deleterious mutations are usually removed from popula-tions by negative natural selection (d N<dSor<1 ) maintaining high sequence conservation between the other mutations having an adaptive advantage (or a beneficial role) are fixed in a population by positive natural selection(dN > dS or statistical test to determine whether is significantly different to 1 (neutral evolution). TheBranch-site or neutral evolution). The Datamonkey web server was used to perform fragments using PCR involved a denaturing step of 95 \u00b0C for 5 min, followed by 35 cycles of 98 \u00b0C for 20 s, Tm \u00b0C (Table 1) for 15 s and 72 \u00b0C for 30 s or 1 min and 30 sdepending on product size. A Wizard coli recommendations. 1 Primer designed for pvgama gene amplification Target Primer sequence (5 '-3')aMT position purple .Avalue equal 1 means neutral evolution, < 1 negative selection whilst > 1 means positive selection. A diagram of the in Vectors (2017) 10:251 Page 3 of 11overnight at \u00b0C Luria then seeded in 1 l of LB with ampicillin (100 g/ml) and left to grow at 37 shaking ~300\u00d7 until reaching 0.5 OD 600. The culture was incubated on ice for 30 min and then IPTG 1 mM was used to induce expression by incubation for 16 h at room temperature (RT) with shaking at ~200\u00d7 rpm. The culture was then spun at 2400\u00d7 gfor 20 min and nised in buffer (DEB) (6 M urea, 10 mM Tris, 100 mM NaH 2PO4and 20 mM imidazole) containing the SIGMAFAST protease inhibitor St. by incubating with 0.1 mg/ml lysozyme overnight rpm rotator (Fisher Scientific, Waltham, supernatant therespective positive and homogenised in native extraction buffer (NEB) (50 mM Tris, 300 mM imidazole, 0.1 Tween-20, pH 8.0). The mixture was incubated for 1 h at 4 \u00b0C at 10\u00d7 rpm and the supernatant was collected by spinning with buffer used for extracting and then incubated with the E. lysate at 4 \u00b0C. The protein- resin mixture was placed on a column and then weakly bound proteins were eluted by washing with 20 containing 0.1% Triton X-114 followed by 50 mlof proteins extracted in denaturing conditions were dialysed on the column by passing 20 ml DEB with urea in descendingconcentrations (6 M, 3 M, 1.5 M, 0.75 M and PBS). Bound proteins were then eluted with PBS containing imidazole at increasing concentrations (50 mM to500 mM) in 3 ml fractions; those having a single band (confirmed on 12% SDS-PAGE Coomassie staining The peptide was homogenised in PBS and then stored at -20 \u00b0C until use. Blood sample collection and processing Individuals with a clinical history of P. vivax (37 subjects) orP. falciparum (30 subjects) malaria, aged 18 to 50 year- old and living in malaria-endemic areas of Colombia(Choc\u00f3, Nari\u00f1o, C\u00f3rdoba, Vichada and Guaviare) wereselected for this study. Sera from healthy individuals (16 adult subjects) who had never been affected by the disease and who were living in non-endemic areas were used asnegative controls. The blood samples in BD Vacutainer tubes without anticoagulant by personnel from the Fundaci\u00f3n Instituto de Inmunolog\u00eda de Colombia(FIDIC) from October 2006 to March 2011 (for P. vivax ) and June to October 1993 (for P. falciparum )a n ds t o r e d at 4 \u00b0C until transport. Samples were then transported toBogot\u00e1 for processing. Total blood was spun at 5000\u00d7 g for 5 min and the serum was then recovered and stored at-80 overnight at 4 \u00b0C and then incubated at 37 \u00b0C for 1 h. The dishes were blocked with 200 l5 % skimmed milk - PBS-0.05% Tween for 1 h at 37 reactivity skimmed milk - PBS-0.05% Tween for 1 h at 37 - PBS-0.05% Tween for 1 h at 37 \u00b0C and then a peroxidase substrate solution (KPL Laboratories, Gaithersburg, MD, nm et research were collected by personnel from the Hemo-centro Distrital (Bogot\u00e1) and by Cell (Biosafe, 's recommendations. The samples were stored 4 \u00b0C Duffy at100\u00d7 at 4 \u00b0C at 4\u00d7 rpm.T w e n t y - f i v e g of DBP region II and III/IV were used as positive and controls, re-spectively. The 6 histidine of human sera (1:10 dilution) for 1 h at 4 \u00b0C before putting them in contact with cells. The sam- ples were (1:40 dilution) (MACSmolecular-MiltenyiBiotec, San Diego, CA, USA) for 30 min in the dark after washing with 1% BSA-PBS solution (v/v). White cells usinga FACSCanto II cytometer (BD, San Diego, CA, USA) and Flowjo V10 software. PE signal intensity in n dh i g h( C D 7 1hi) cells. Statistical analysis Mean values and standard deviations (SD) were calcu- lated from was assessed bycomparing means using a Student 'st-test and of for comparing the means of each experimental group to those for control. Tukey 's multiple comparison test was used for multiple comparison of experimental group means to those for control. GradhPad Software (San Diego, CA) was used for all statistical Results 5 different strains from different geographical regions(North Korea, Brazil, Mauritania and India). These were aligned with the VCG-I strain the G/C][G/A]AC[G/C/A] repeat which was not present in P. cynomolgi ,P. inui ,P. fragile ,P. knowlesi codons were observed amongst Branch-site the lineage formed polymorphism analysis results, it the carboxyl region was more anti-genic than the amino one by the presence of the r from 37 patients suffering of P. vivax malaria and sera from people who had never suffered the disease. r PvGAMA-Nt reactedBaquero et Page 5 of 11positively with sera in screening (0.26 of cut-off point). These data agreed with study of the profile of the humoral immune response for P. vivax in which r PvGAMA was recognised by 54.5% of the sera used in the array [41]. The statistical test for the withrPvGAMA-Nt gave a significant difference between m= 0.12 for the control group). was a signifi- cant difference between the means 7 infected patients and m=0 . 1 4 f o r t h e c o n t r o l group) when r PvGAMA-Ct was detected by human sera (Fig. 2a). There recognition by 2b). The predicted natural analysis and with anti-His PE antibody).All recombinant proteins had a curve shift when the PE signal was compared to control (cells not incu- bated with recombinant proteins) in the histogram(Fig. 3). Interestingly, was verysimilar to the positive control ( the (Fig. Regarding regions, VR1 was able to ; C R 2 malaria The plot shows 6 of 11(Fig. 4b). These findings that GAMA in P. vivax a in preferential , P=0 . ; C R t(4)=0 . conserved c) and variable ( band d) GAMA fragments compared to control (cells not incubated with the protein). Each figure is representative from and regarding CD71-APCH7 signal for CD71 + CD45- cells) ( b). analyses as \u00b1 et rhoptries and nemes binding role amino and 695consisting of residues [A/L]AN[A/G][N/D] was pre- dicted. This RR was common in different P. vivax strains but not in phylogenetically-related species (Additional file immune pressure. Evidence of episodic positive selection was in parasite -51], found in GAMA could be the outcome of to different hostsduring be an adaptation of the species to humans since the RR in malaria are associatedwith c tt h a tr PvGAMA-Ct (where the RR is lo- cated) can trigger a species-specific immune response (Fig. Therefore, t h ei m m u n er e s p o n s em u s tb ed i r e c t e da g a i n s tc o n -served strategy,low genetic diversity was found in the to that observed in msp4 [55, 56], m s p greater than K N, suggesting negative selection. Many codons were found tobe experiencing negative selection which probably plays important Given the polymorphism analysis, it was decided to determine PvGAMA conserved and variable region interaction silico included to totally excludethe lymphocytes from the analysis once the Wright stain- 0.4% of such cells file 4: Figure S4). It was that reticulocyte per- centage by incubating the samples for 4 and 16 h at 4 \u00b0C (4 h: m\u00b1 SD time to enable complete protein-cell interaction. It recently forPvGAMA where this fragment [F2 (aa 345 to 589) or F7 (408 regions in that study] showed higherrosetting 's 10:251 Page 8 of 11SD = 69.3 \u00b1 can be the explanation of why PvGAMA fragment binding to 100% of the CD71+ reticulocytes was not found (Fig. 4a). It has been can besuggested that P. vivax target cell selection is not only governed by the RBPs but other ligands for selecting molecules when developing a vaccine. Although there w a sa ni m m u n er e s p o n s ea g a i n s t PvGAMA (Fig. 2), this was not sufficient to inhibit the conserved regions binding to non-conserved ones trigger evolve more slowly and that natural to thus be focused on them. Conclusions To our knowledge, this study described PvGAMA reticulocyte comprises by a repetitive region. On the other hand, it was shown that consists of sequences were switchfrom negative to positive natural selection and back to negative and mightenable adaptation to a new host. Phylogeny was inferred in MEGA v6 by the maximum likelihood method using GTR tests Holm-Bonferroni Additional show purified recombinant proteins and lanes 3, 5, 7 blot detection. The proteins 'molecular markers are indicated in Lane 1 on all figures. (TIF 5327 kb) Additional file 4: representative histogram from three would like to thank Ana Mar\u00eda Perdomo and Bernardo Camacho forsupplying the umbilical cord blood, Diana D\u00edaz for technical support incytometry and Jason Garry for translating this manuscript. Funding This research was financed had no role in study design, collection and analysis or data interpretation.Baquero et al. Parasites & Vectors (2017) 10:251 Page 9 of 11Availability of data and materials All data generated or analysed during this study are included within this article and its additional files. The pvgama sequence from P. vivax VCG-I and wrote the authors final manuscript. Competing approved by FIDIC 's ethics committee. Publisher 'sN o t e Springer Nature remains neutral with regard to jurisdictional claims in published Inmunolog\u00eda de Colombia (FIDIC), Carrera 50 No. 26-20, Bogot\u00e1 DC, Colombia.2PhD Programme in Biomedical and Biological Sciences, Universidad del Rosario, Carrera 24 No. 63C-69, Bogot\u00e1 DC, Colombia.3Basic Sciences Department, School of Medicine and Health Sciences, Universidaddel Rosario, Carrera 24 No. 63C-69, Bogot\u00e1 DC, Colombia. Received: 27 October 2016 Accepted: 10 May 2017 References 1. WHO. World malaria report. 2014. 2. WHO. State of the art of new vaccine research and development. 2006.3. Patarroyo ME, Bermudez A, White O, Berriman M, Hyman RW, et al. Genome sequence of mass Berry D, Baum The cellular and molecular basis for malaria parasite invasion of the human red blood J Cell Biol. 2012;198:961 -71. 9. Richards JS, Biol. T, Thonkukiatkul A, Miura K, Otsuki H, et al. Discovery of GAMA, a Plasmodium falciparum : a research Rev Vaccines. 2012;11:1249 -60. 14. Urquiza M, Patarroyo MA, Mari V, Ocampo M, Suarez J, Lopez R, et al. Identification WQ, Gruszczyk J, Lim NT, Lin New Guinean children. PLoS Negl Trop Dis.2016;10:e0005014. 16. Rodriguez LE, Urquiza M, Ocampo M, Curtidor H, Suarez J, Garcia J, et VCG-1 D, selection in Plasmodium vivax .G e n o m eB i o lE v o l . 2014;7:106 -19. 21. Neafsey DE, Galinsky K, Jiang RH, Young L, Sykes SM, Saif S, et al. The population. Malaria J. 2014;13:388. 24. Wang Y, Ma A, Chen SB, Yang YC, Chen JH, Yin MB. Genetic diversity Genet Graur Y, Price N, Azevedo RB, Zufall RA, E. On \"in Freeland DE, Poe AC, Durrego E, Collins WE, et al. A monkey 's tale: the origin of Plasmodium vivax as a human malaria parasite. Proc Natl Acad Sci USA. 2005;102:1980 -5. 27. Edgar RC. MUSCLE: multiple sequence alignment Acids Res. J, Nei M. Positive Darwinian selection after gene duplication in primate ribonuclease genes. Natl Acad Sci after comparison of methods B, et al. of 1137. Moreno-Perez 38. Pico de Coana Y, Rodriguez J, Guerrero E, Barrero C, Rodriguez R, Mendoza M, et al. A method rapid solid-phase synthesis of large numbers of Natl Acad Sci USA. 1985;82:5131 -5. 41. Lu F, Li J, Wang B, Cheng Y, Kong DH, Cui L, et Torres Lde Malaria J. 2013;12:165. 44. Mongui A, Angel DI, Gallego G, Reyes C, Martinez P, Guhl F, et al. Characterization and antigenicity o D, Patarroyo MA. Size polymorphism MA, Taylor JE, Prall SP, Ambu L, Nathan S, et al. Accelerated diversification of nonhuman primate malarias H, Arisue N, Palacpac N, de Oliveira ML, Pathirana S, et al. Lineage-specific positive selection Today. 1991;7:99 -105. 53. Ferreira MU, NM, Wunderlich G. diversity and Martinez P, Suarez CF, Gomez A, Cardenas PP, Guerrero JE, Patarroyo MA. level Jongwutiwes S, Ferreira MU, Kanbara H, Udomsangpetch R, Cui L. global diversity J. 2014;13:495. 59. Pacheco MA, Elango AP, Rahman AA, Fisher D, Collins WE, Barnwell JW, et al. Evidence of purifying selection -7. 61. Cheng Y, Lu F, Wang B, Li J, Han JH, Ito D, Reports. 2016;6:35581. 62. Malleret B, Li A, Zhang R, Tan KS, Suwanarusk R, Claser C, et al. Plasmodium remodeling Wilson K, Heesom KJ, Cogan N, Green C, Toye AM, et al. Comparison of the proteome of adult Proteomics MCP. -46. 64. Ocampo M, Vera R, Eduardo R, Curtidor H, Urquiza M, Suarez Wang Muh F, Nyunt MH, Na S, et Sci Reports. 2016;6:26993. AE, Nakajima R, Liang L, Baum 2015;212:1429 We accept pre-submission inquiries \u0081 and all major indexing services \u0081 Maximum visibility for your research Submit your manuscript at www.biomedcentral.com/submitSubmit your next manuscript to BioMed Central and we will help you at every step:Baquero et al. Parasites & Vectors (2017) 10:251 | bl ood from other stages has been quite restricted. ens from different parasite in its genome. Although these genesmighthavehighgeneticdiversity,conservedfunctio nally-relevantregions(idealfor vaccine development) could diversity patterns and determini ng features make P. vivaxcontrol and elimination a great challenge. Vaccine development has been considered as one of the most cost-eective interventions for controlling malaria. Desi gning a vaccine against this disease has focused on selecting antig ens able to induce an eective immune target cells. be considered when designing an then through proceed to invade red blood cells (RBC), initiat ing the erythrocyte or blood stage. Within RBC Mrz could dierentiate in new Mrz which will infect new RBC or into gametocytes which can be taken by the mosquito vector to star t above, development. the genetic diversity Baquero these regions could therefore be taken into account 2010; Gomez et al., 2006; Garz\u00f3n-Ospina et al., 2010, 2011, 2012, 2014; Dias et al., 2011; Premaratne et al., al., Arnott, 2014; et al., such pattern. These genes or domains antigens other parasite species (Sultan 1997; al., 1999; Matuschewski et et Kariu et al., 2006; Labaied et al., 2007a,b; Moreira et al., 2008; Rosado et a l., 2008; Engelmann et al., 2009; Alba et al., 2011; Curtidor et a l., 2011; Aldrich et al., 2012; Annoura et al., 2014; Ferguson et al., 2014;Jimahetal.,2016;Kublinetal.,2017;Manzonietal.,2 017; et al., 2017a genes are January 2018 | Volume 9 | Article 10Garz\u00f3n-Ospina et al. Sporozoite (Menard, 2001; Castellanos et al., 2007; Barry and Arnott, 2014), and because characterizing antigens from this stage is laborious, this for orthologous induce an response thus these antigens should into account malaria the from The sequences from dierent locations worldwide obtaine d for screened Edgar,2004 number (ENC) and codon level ( Novembre, Tajima (1989) ,Fu and Li (1993) , andFay and Wu (2000) tests were used for evaluating a neutral model of molecular evolution. Repeat regions or those having insertions/deleti natural ion al., ) dierence MEGA v6 software ( Tamura et al., 2013 ) was used for all A (Miller et al., for choosing the evolutionarymodelandBayesiananalysis. Frontiers in Genetics | www.frontiersin.org 3 January 2018 | Volume 9 | Article 10Garz\u00f3n-Ospina et al. Plasmodiumvivax Sporozoite Vaccine taken regarding any RecombinationwasalsoevaluatedusingtheZZestimator( Rozas et al., 2001 ), the minimum number of recombination events (Rm) (Hudson showed that all genes for siap2, which was only present in species infecting primates) had an ortholog in PvPLP1 (perforin-like helix were predicted at helices in PvP36, PvPLP1 and PvSIAP2 could have resulte d from misidentication and they actually been 1 putative domain, whilst PvTRAP and PvTLP had a von Willebrand putative domain. A membrane attack complex/perforin (MACPF) putative domain was found in PvPLP1 and the domain in PvMCP1. A single sexual antigen was 14 Spz P. vivaxgenes to assess any departure from neutral expectations. Six of these 14 genes had an overall negative statistically signicant value for at l east one test (Table3), suggesting that natural selection could have been actingregardingthesegenes; evidence negative tion for genes, except under negative with few codons under positiv e selection. Many codons under negative selection were locat ed in regionsencodingputativedomains(e.g.,thrombospondintype 1 domain, Supplementary Material 2). It present in primate- infecting parasites); the January 2018 | Volume 9 | Article 10Garz\u00f3n-Ospina et al. Plasmodiumvivax Sporozoite Vaccine Candidates TABLE Yes (494-515) No von Willebrand factor type A doma in (44-225) and Thrombospondin type 1 domain (241-284)Secretory/membrane spect Yes (1-19) No No Secretory (1-23) type 1 domain (264-311) and von Willebran d factor type A domain (334-508)Secretory/membrane celtos Yes (1-35) No No - Non cytoplasmic (1-22) No No Elongation factor Tu positive selection ( Sawai et al., 2010 ). Nine of these topologies had lineages (branches) where some sites were having evidence selecti on lead to a particular species, whilst few of them were ancestral lineages(SupplementaryMaterial3). Linkage Disequilibrium Recombination Linkage disequilibrium genes. there suggesting recombination action. Likewise, most of these genes had at l east onerecombinationevent(RM),whiletheZZestimatorjustgave statistically signicant (Supplemen tary 4). It was seen that the most exposed PLP1 region was acquired to malaria parasi tes have multiple stages, a fully-eective vaccine must have sever al conserved parasitestages. Antigen identication is not an easy task due to P. vivax having a complex biology. Most antigens in Genetics | www.frontiersin.org 5 January 2018 | Volume 9 | Article 10Garz\u00f3n-Ospina et al. Plasmodiumvivax Sporozoite Vaccine cases, these regions correspond with regions putative helix was predicted for pvp36andpvsiap2at the 5-end, but this could have been a misleading prediction (i.e., it could actually have b een a TABLE 2 14 P.vivaxsporozoite genes' 0.003 3.91 0.0 070 0.0003 (0.0003) 0.0001 (0.0000) 0.05 0.0002 1.99 0.0 (0.0004) 0.0006 (0.0001) 1.68 0. 0012 DNA, The average amount of nucleotide differences per site between two sequen ces; AA, The average amount of aa differences; AA, standarddeviation. Frontiers in Genetics | www.frontiersin.org 6 January 2018 Volume 9 | Article 10Garz\u00f3n-Ospina et al. Plasmodiumvivax Sporozoite bias tests. Gene Tajima Fu & d N- dS(ES) K N- KS(ES) MKT ENC CBI D N) and synonymous (K S) divergence vivax and the from the blood stage; few genes/proteins from others stages have been characterized. genes are shared amongst Plasmodium species (Carlton et al., 2008), and present in the and could thus be taken into account for vaccine development. Fourteen of the 15 P. falciparum Spz genes found in P. vivax had similar gene/protein structures, suggesting that they design. As P. vivaxgenetic diversity represents an challenge than in P. falciparum concerning vaccine design, the next step in this work was to assess genetic high genetic divers ity (Putaporntip et al., 1997, 2010; Gomez et al., 2006; Dias et al. , 2011; Premaratne et al., 2011; Garz\u00f3n-Ospina et al., 2012, 2014, 2015 ), representing one of the challenges to be overcomewhen desirable fully-eective antimal arial vaccine. Few segregating sites were found at each locus; some were could have resulted from genetic dierentiation worldwide, ). Nevertheless,fully-conservedregionswerealsoidentiabl einall loci.TheobservedpolymorphisminSpzgeneswascomparableto that in the most of the conserved Mrz genes described to date (Putaporntip et al., 2009; Garz\u00f3n-Ospina et al., 2010, 2011, 2015; et al., Chenet et al., 2013; Forero-Rodri its et al., 2006; Dias et al., 2011; Garz\u00f3n-Ospina et al., 2012, ), Spz displayed low diversity. from various evolution ary forces. Taking into account that a low amount of codons for | 7 January 2018 | Volume 9 | Article 10Garz\u00f3n-Ospina et al. Plasmodiumvivax Sporozoite 22 1,200 spect1 - - - - siap2 0.03 0.02 2 - maebl 0.73* 0.16 0 - plp1 0.03 0.01 2 1,275** 0.02 2 - tlp 0.08 0.12 genes' ENC and random Such values were in Mrz reported for the pressure or preferential codon usage.ThelowgeneticdiversityfoundinSpzgeneswastheref ore low genetic diversity i n thesesantigens. Test of neutral molecular evolution (e.i. Tajima, Fu & Li, Fay & Wu) gave negative values, just a few being statisticall y signicant; the neutrality likely (Kimura, 1983; Graur Although some genes had statistically signicant values, some them had specic regions where neutrality could be ruled out, suggesting negative selection was acting in regions. ge nes having signicant negative value in these tests suggested that negative selection was responsib was conrmed frequency spectrum (e.i. Tajima, Fu & Li, Fay & be used to et al., low rates and several codons interact ion and they could have other functions. However, they could be taken into account for P. vivax vaccine development since they had low diversity and were under functional/structura l constraint. The adapt to dierent selection ( Sawai et al., 2010 ). There was evidence of selective sweep in ve P. vivax genes; this pattern has already been observed for some of these genes in previous studies ( Shen et al., 2017 this parasite would thus allow it to adapt to host-switchdecreasinggeneticdiversity. Additionally, phylogenetically-based analysis could provide greater insight into the role of selection (at these loci) du ring a parasite'sevolutionaryhistoryifthiswastheresultofada ptations to new hosts and/or environments ( Muehlenbein 2015 ). There was evidence of episodic positive selection for nine of these 14 antigens. however, few of them wer e ancestral lineages. Since most branches under selection le ad to particular species, episodic selection could have resulted fro m host, for instance, host during speciation recognize a new host receptor. However, this behavior seems t o be common in the Plasmodium genus and not just for monkey- malariaparasites. evolutionary force which It could be acting on Mrz blood-stage gens leading to new haplotypes to arise, being maintained in Genetics | www.frontiersin.org 8 January 2018 | Volume 9 | Article 10Garz\u00f3n-Ospina et al. Plasmodiumvivax Sporozoite Vaccine Candidates of single in characteristics not amount Some arisen in parasite interaction with According to the sliding window for has potential the aforementioned antigens, particular domains were not found in the whole PvSIAP1 sequence. Orthologs for this protein in Plasmodium in Spz exit from as all along the sequence of the gene encodin g this protein. Nevertheless, the C-terminal region was the re gion where most codons were found to be under negative selection and could thus be the region used for P. vivaxinteraction with a particularhost. PLP1 is not required for entry hepatocytes, putative MAC/perforin domain was identied in P. vivaxwhich had a high sequence conservation, several codons under negative selection and a could Moreira et al., 2008 ) and TRAP (Sultan al., 1997 ) are essential for Spz gliding motility (Sultan et ).P. TLP is the most conserved member of the TRAP/MIC2 family and the rst to be seen to play a role traversing cells ( Moreira et al., 2008 ).P. vivaxTLP was one of the most conserved proteins of those evaluated here ; theN-terminalregionwashighlyconservedwithinandamongs t species. Thrombospondin type 1 (TSP1) von Willebrand factor type al., 2010 ); al., 2014); the region is where pftrap al., 2008 similar in P. vivaxand related species; the sliding window for this r the recognition of particular receptors for each host or is the urs in PvDBP ( VanBuskirk et al., correlated with against di sease the sequences vivaxand related specieswerecompared,theTSP1domainwasseentohavea > 1 and few sites under negative selection. On the other hand, t he C-terminalregionseemedtobethisprotein'santigenicregi on. MAEBL has been described as being a Volume 9 | Article 10Garz\u00f3n-Ospina et al. Plasmodiumvivax Sporozoite Vaccine Candidates and seeming a function that of AMA1, given the high sequence similarity ( repeats being responsible for 2015 ). The fact that this repeat region was found to be under negative selecti on suggested an important role, similar to that already reported for CSP (Aldrich et al., 2012; Ferguson 2014 ). A prediction of linear epitopes suggested that the could be antigenic. ). It a characteristic GTP-binding domain ( Nguyen et al., 2001; Romero et al., 2004 ), that is also present in its P. vivax counterpart; in addition, a translation- initiation restricted, being well pathogen-host function. This protein is antigenic infection following experimental ( Nguyen et al., 2009). The region so recognized is the N-terminal region, which had antigenic potential stages. are expressed thus have been responsible for the interaction between P. vivaxSpz and hepatocytes. The by potential; C-terminal r B-epitopes,whilstthePvP38centralregionandC-terminalco uld be antigenic only had This had many sites suggested that immune system, having various potential B-epitopes along its sequence. Its use as vaccine candidate is limited due to its diversity and the l arge amountofhaplotypesfound. specicityforphosphatidicacid(alipidfoundpredominantlyon plasma membrane inner face) and breaks liposomes consisting of phosphatidic acid shown that parasites lacking CelTOS can enter target cells supposes be intracellular, predictive suggested inclusion a vaccine against P. vivax. The antigenic region coincided with the gene's region where various sites under negative selection were found, suggest ing that the CelTOS functional region could be this region. If this regi on is functionally restricted, but is also antigenic poten tial, PvCelTOS has been shown have within P. vivax. The gene encoding this protein in Iran had, 10 January 2018 | Volume 9 | emto abolishallele-specicimmuneresponses;antigensfromdier ent stages must also be included. As most research has been focus ed on the blood stage, new strategies must be implemented for identifying potential from parasit e stages. As genetic diversity is a characteristic to be born i n mind when designing a vaccine, the present work could be taken as a Gomez et et al., 2011; Premaratne al., 2011; and, consequently, they good vaccine candidates, since low genetic ty is Recent the parasite values and codons under negative parts of protein might be thus implicated in function. taken into account for designing a fully eective vaccine are those having a limited geneticdiversity or at least one domain with such pattern. These genes or domains must have a negative selection signal, as well as a <1 (Garz\u00f3n-Ospina et al., 2015 DG-O performed the gener al interpretation of the data and together with SB and AR participated in writing the paper. MP coordinated the study and helped to write the manuscript. All the authors have read and approvedthenalversionofthemanuscript. FUNDING This work was nanced by the Departamento Administrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n throug m whichthisworkwascarriedout. SUPPLEMENTARY MATERIAL The Supplementary Material for this article C., Ploemen, I. H., Sajid, M., Lin, J. W., Vos, M. W., et al. (2014). Two Plasmodium 6-Cys family-related proteins hav e distinct FASEB J. 28, 2158-2170. doi:10.1096/fj.13-241570Baquero, L. A., D., Forero-Rod Barry, A. D., and Patarroyo, M. A. (2016). S ize polymorphism and low sequence H., Silva, J. C., Bidwell, S. L., Lorenzi, H., C aler, E., et al. (2008). Comparative genomics of the Volume 9 | Article 10Garz\u00f3n-Ospina et al. Plasmodiumvivax Sporozoite Vaccine Candidates Castellanos, A., Ar\u00e9valo-Herrera, M., Restrepo, N., Gulloso, L., Corradin Oswaldo Cruz 102, 411-416. doi:10.1590/S0074-02762007005000047 Chan, E. R., Menard, D., David, P. H., Ratsimbasoa, A., Kim, S., Ch im, P., et al. (2012). Whole genome sequencing M. A., Cornejo, O. E., Durrego, E., Stanle y, C. E. Jr., Castillo, A. I., et al. (2016). Evolution of the transmission-block ing vaccine candidates Pvs28 and Pvs25 in Plasmodium Negl. Trop. Dis. 10:e0004786. doi:10.1371/journal.pntd.0004786 Chenet, S. M., Pacheco, M. A., Bacon, D. J., Collins, W. E., Barnw ell, J. W., and Escalante, A. A. (2013). The evolution and diversity of a complexity (1971).ThePrimateMalarias .Bethesda,MD:U.S.NationalInstituteofAllergy Cornejo, E., D., A. A. (2014). Genome- wide patterns of Curtidor, H., Vanegas, M., Patarroyo, M. E. (2011) . 18,4470-4502.doi:10.2174/092986711797287575 Delport, Poon, A. Frost, S. Kosakovsky Pond, S. L. ( 2010). Datamonkey 2010: biology.Bioinformatics 26,2455-2457.doi:10.1093/bioinformatics/btq429 S., , P. Genetic Edgar, R. C. (2004). MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32, 1792-1797. doi:10.1093/nar/gkh340 Egea, R., Casillas, S., and Barbadilla, A. (2008). Standard and ge neralized McDonald-Kreitman test: a website to map. Bioinformatics 21, 1846-1852. doi:10.1093/bioinformatics/bti299 Fay, J. C., Wu, C. I. (2000). Hitchhiking under positive Darw inian selection. Genetics155,1405-1413. Ferguson, D. J., Balaban, A. E., Patzewitz, E. M., Wall, R. J., J., and Patarroyo, M. A. (2012). Genetic Low genetic polymorphism of Evol. 11, 528-531. doi:10.1016/j.meegid.2010.12.002 Gomez, Suarez, C. F., Martinez, P., Saravia, C., and Patarroyo, M. A. (2006). Highpolymorphismin Plasmodiumvivax merozoitesurfaceprotein-5(MSP5). Parasitology 133(Pt6),661-672.doi:10.1017/S0031182006001168 Zheng, Y., Zufall, R. A., and Elhaik, E. 578-590.doi:10.1093/gbe/evt028 Menard, D., Mercereau-Puijalon, O., Barn well, J., Zimmerman, P. A., et al. (2013). De novo assembly of a eld isolate and Kaplan, N. L. (1985). Statistical properties of th e number of recombination events in the of a sample of DNA sequences. Genetics 111,147-164. Hulden, L. Plasmodium vivax life cycleandsurvival. Malar.J.10:90.doi:10.1186/1475-2875-10-90 Hupalo, D. N., Luo, Z., Melnikov, A., Sutton, P. L., Rogov, P., Esc alante, A., et al. (2016). Population genomics identify Jimah, J. R., Salinas, N. D., Sala-Rabanal, M., Jones, N. G., Sible y, L. D., Nichols, C. G., et al. (2016). Malaria parasite CelTOS targets the Elife5:e20621. molecu les,\" in Mammalian Academic Press),21-132. Kall, L., Krogh, A., and co mbined Coppens, J. M., Vaidya, A. B ., and Kappe, S. H. I. (2004). A member doi:10.1016/j.molbiopara.2003.08.009 Kanoi, N., E., M., White, M. T., Palacpac, N . M., Ntege, E. January 2018 Volume 9 | (200 6). CelTOS, a novel malarial protein that mediates transmission to mosquito and vertebrate hosts. Mol.Microbiol. 59,1369-1379.doi:10.1111/j.1365-2958.2005.05024.x Kelly, J. K. (1997). neutrality based on interlocus associ ations.Genetics 146,1197-1206. Kimura, M. (1983). The Neutral Theory of Molecular Evolution. Cambridge; New York:CambridgeUniversityPress.doi:10.1017/CBO97805116234 86 Kolaskar, A. S., and Tongaonkar, P. C. (1990). A semi-empirical L., Frost, S. D. (2005). Not so dierent after all: a comparison S. D., Delport , W., and Scheer, K. (2011). A random Gravenor, M. Camargo, D. Y., Carvalho, B. O., Albrecht, L., Lopes , S. C., Kayano, A. C., et al. (2015). Immunization with the MAEBL M2 domain protects (2009). DnaSP v5: a software for compreh ensive analysis of Bioinformatics Manzoni, G., S., invasion. (2002). Plasmodium sporozoite invasion into insect and mammalian is directed and Schwartz, T. (2010). \"Creating th e CIPRES science gateway for inference trees,\" in Gateway Computing EnvironmentsWorkshop(GCE) (NewOrleans,LA:IEEE),1-8. Mongui,A.,Angel,D.I.,Moreno-Perez,D.A.,Villarreal-Gonzalez,S .,Almonacid, H., Vanegas, M., et al. (2010). ion of the Plasmodiumvivax thrombospondin-relatedapicalmerozoiteprotein. TRAP-LikeProtein(TLP),isinvolvedintissuetraversalbysporozoites. Cell.Microbiol. 273-280. doi:10.1007/BF00175504 Muehlenbein, M. P., Pacheco, M. A., Taylor, J. E., Prall, S. P., Ambu , L., Nathan, S., et al. (2015). Accelerated diversication primate Mueller, I., Shakri, A. R., and Chitnis, C. E. (2015). Development o f vaccines for Plasmodium vivax malaria. Vaccine vsky and Pond, E., Galinsky, K., Jiang, R. H., Young, L., Sykes, S. M., Saif, S., et al. (2012). The doi:10.1038/ng.2373 Nguyen, T. V., Fujioka, H., Kang, A. S., Rogers, W. O., Fidock, D. A., and James, A. A. (2001). Stage-dependent localization of a novel gene produc t of the parasite, Plasmodium falciparum .J. Biol. Chem. 276, 26724-26731. doi:10.1074/jbc.M103375200 Nguyen, T. V., Sacci, J. B. Jr., de la Vega, P., John, C. C., James, A. A., and Kang, A.S.(2009).CharacterizationofimmunoglobulinGantibodiesto Plasmodium L., Mahmud, R., Chen, Y., and Fong, M. Y. (20 13). Cloning, expression, doi:10.1586/erv.12.91 Patarroyo, M. E., Ar\u00e9valo-Pinz\u00f3n, G., Reyes, C., Moreno-Vranich, and Patarroyo, M. S. S. D., and Muse, S. V. (2005). HyPhy: hypothes is testing using | 13 January 2018 | Volume 9 | Article 10Garz\u00f3n-Ospina et al. Plasmodiumvivax Sporozoite Vaccine Candidates Premaratne, P. H., Aravinda, B. R., A., P. (PvDBPII) under unstable transmission low intensity malaria in Sri Lanka. Infect. Genet.Evol. 11,1327-1339.doi:10.1016/j.meegid.2011.04.023 Price, R. N., Douglas, N. M., and Anstey, N. M. (2009). New Kanbara, H., Udomsan gpetch, R., and Cui, L. (2009). Limited global diversity of the Plasmodium vivaxmerozoite L., Rich, S. M., and Ayala, F. J. (2003). Progress in malaria research: the case for phylogenetics. Adv. Parasitol. 54, 255-280. doi:10.1016/S0065-308X(03)54005-2 Richie, T. L., and Saul, A. Progress challenges for malari a vaccines. C., Manzoni, G., Bigor gne, A. E., Briquet, S., et al. (2015). Malaria L. C., Nguyen, T. V., Deville, B., Ogunjumo, O., and James, A . A. (2004). The MB2 gene family of Plasmodium P., Ayres, D. L., Darling , A., H\u00f6hna, S., al. (2012). Gullaud, G., and Aguad\u00e9, M. (2001). DNA v ariation at the rp49 gene region of M., Chen, S. B., Wang, Y., Xu, B., Abe, E. M., and Chen, J. H. (2017). Genome-wide scans for C. , Hannoun, L., et al. Robson, K. J., Crisanti, A. , Nussenzweig, V., et al. (1997). Kumar, S. (2013). MEGA6: molecular evolutionary genetics analysis version 6.0. Mol. Biol. Evol. 30, 2725-2729.doi:10.1093/molbev/mst197 Taylor, J. E., Pacheco, M. A., Bacon, D. J., Beg, M. A., Machado , R. L., Fairhurst, R. M., et al. (2013). The evolutionary history d residues in thePlasmodium vivax Acad. Sci. U.S.A. 101, G. E., Gilson, P. R., Taechalertpaisarn, T., Tham, W. H., de Jo ng, N. W., Harvey, K. L., et al. (2015). Revealing the sequence K. J., Janse, C. J., Bistoni, F., et al. (1999). The A-domain and the thrombospondin-related motif of Plasmodium falciparum 10.1093/emboj/18. 19.5195 Winter, D. J., Pacheco, M. A., Vallejo, A. F., Schwartz, R. S., Are valo-Herrera, M., Herrera, S., et al. (2015). Whole genome sequencing A. S. P., Lopaticki, S., O'Neill, M. T., Erickson, S. M., Dou glas, D. N., Kneteman, N. M., et al. Perwitasari-Farajallah, D., Walter, L., Hodges, J. K., et al. (2007). Molecular phylogeny and evolutionary history of Southeast Asian that the research was conducted in the absence of any commercial or nancial relations hips that could beconstruedasapotentialconflictofinterest. Copyright\u00a92018Garz\u00f3n-Ospina,Buitrago,RamosandPatarroyo.Th isisanopen- access article original author(s) credited an d that the original publication in this journal is cited, in accordance with acc epted academic practice. No use, distribution or reproduction is permitted which doe s not comply with these terms. Frontiers in Genetics | www.frontiersin.org 14 January 2018 | 9 | Article 10fgene-09-00372 September 7, 2018 Time: 10:57 # September 2018 doi: 10.3389/fgene.2018.00372 Edited by: of Vigo, Spain Reviewed by: Eduardo Castro-Nallar, Universidad Andr\u00e9s Bello, Chile Eugenia Lo, University of North Carolina at Charlotte, United States S. Noushin Emami, section of Frontiers in Genetics Received: 25 May 2018 Accepted: 23 2018 Ricaurte-Contreras LA, Noya O and Patarroyo MA (2018) Alejandra Ricaurte-Contreras1, Oscar Manuel A. Patarroyo1,6* 1Department of Molecular Biology and Immunology, de Colombia (FIDIC), Bogot\u00e1, Colombia,2Microbiology Postgraduate Programme, Universidad Colombia, Bogot\u00e1, Colombia,3PhD Programme in Biomedical and Biological Sciences, Universidad del Rosario, Bogot\u00e1, Colombia,4Livestock Sciences Faculty, Universidad de Ciencias Aplicadas y Ambientales, Bogot\u00e1, Colombia,5Instituto de Medicina Tropical, Facultad de Medicina, Universidad Central de Venezuela, Caracas, Venezuela,6School of Medicine and Health Sciences, Universidad del Rosario, Bogot\u00e1, Colombia The RBSA protein is encoded by in natural infections and can bind to target cells, it has been proposed as a potential candidate for an anti- Plasmodium vivax However, challenge overcome for ensuring fully effective vaccine design) has the rbsa gene's evolutionary history is being here forces involved in (which September 2018 | 9 | Article 372fgene-09-00372 September 7, 2018 Time: et al., 2005; Carlton et al., 2013) (although an African origin is also likely, Liu et al., 2014), involving a host-switch from monkeys to humans (Mu et al., 2005) around 1.3-2.9 million years ago (Pacheco et al., 2011), Plasmodium cynomolgi being the most phylogenetically related species (Mu et al., 2005; Pacheco et al., Tachibana et al., 2012). P. vivax then reached countries on the 5 continents through human migration (Rodrigues et al., 2018), currently predominating in Asia and America (Guerra et al., 2010; Gething et al., 2012). This species is considered the second most important human-malaria parasite million cases were attributed to this parasite in 2016 (around 7 million less than in 2010) (WHO, 2017). Despite that, the social and economic burden of malaria in endemic countries (Suh et al., 2004) could still be huge. Even though control measures against this parasite have useful, P. vivax elimination (and/or malarial most relevant challenges for eliminating malaria concern the social and economic conditions of the places most aected by this illness, the social and political conflicts in several endemic areas and the anomalous weather patterns 2017). with and Consequently, new interventions must be designed which can reduce the parasite reservoir, limiting the time that a human (or mosquito) host is infectious (Barry and Arnott, 2014). This goal could be achieved by developing a fully eective antimalarial vaccine which, together with existing control measures, could contribute towards a malaria-free world (Barry and Arnott, 2014; White et al., 2014). Malaria-related vaccine research and development eorts were exclusively focused on Plasmodium falciparum for a long time (Galinski and Barnwell, 2008). During the last few decades, P. vivax research has been increased and more and more groups are studying approaches to an anti- P. vivax vaccine (Galinski and Barnwell, 2008; Chen et al., 2010; et al., 2016). Initial research was based on the knowledge acquired regarding rapid gametocyte al., 2013) since P. falciparum andP. vivax have had dierent evolutionary paths, - exclusive antigens could be relevant. For instance, the Duy antigen, which is not , antibodies; it has been suggested as one of the main P. vivax vaccine candidates (Chen et al., 2016; Ntumngia et al., One et al., 2017) located on Chr 3. The protein product has a signal peptide and two transmembrane by the human immune system in natural infections. It has thus been suggested as a putative vaccine candidate for anti- P. vivax malaria vaccine development et al., 2017). However, since parasite's high genetic Arnott, having limited polymorphism or the conserved functional them (Richie and Saul, 2002). pvrbsa genetic diversity has not been membrane protein and is recognized by the human immune system in natural infection; and between species (Graur et al., 2013; Garzon- Ospina et al., 2015). Consequently, inferring this kind of selection on pvrbsa could be to predict regions samples were informed about the purpose of the study procedures in this study were approved by the ethics committees of the Fundaci\u00f3n Instituto de Inmunolog\u00eda de Colombia (IRB number: ACTA N\u000e037-CEEPA), the Universidad del Rosario (IRB number: CEI-ABN026- 0001061) and the Bioethics' committee from the Instituto de Medicina Tropical \"Dr. F\u00e9lix Pifano\" at the Universidad Central de Venezuela (IRB number: CEC-IMT11/2018). DNA in Genetics | www.frontiersin.org 2 September 2018 9 | Article 372fgene-09-00372 September 7, 2018 Time: dierent n= 39, and Amazonas, 41) and Venezuelan (Bolivar, n= 29 and Venezuela's coastal area, n= following the manufacturer's instructions. A Pure for extracting DNA from Amazon samples from each drop of blood collected on the FTA cards, according to the manufacturer's msp3 allele, suggesting Identifying the rbsa Gene in Plasmodium Monkey (using the 1,506 bp from Sal-I- P. vivax rbsa gene was was then selected using the JModelTest v.2.1.3 (Posada, 2008) the Akaike's information criterion and MEGA v.6 software (Tamura et al., 2013). Phylogenetic were inferred ML and Bayesian (BY) methods, using the GTR and/or the TVM models (selected as the best models). MEGA v.6 software was used for ML analysis and v.3.2 software (Ronquist et al., 2012) and the analysis was run until reaching a lower than 0.01 standard deviation of sump commands were used for posterior probabilities and building a consensus rst reaction involved water, 5.4 mL of HiFi HotStart 50-TTTATTTCATTTTGACGTTGTAACTTG-30and rbsarev : 50-TTAAGAAATGATCCCAACTCG-30) and 1 mL of DNA. The PCR was carried out as follows: one 5 min step at 95\u000eC, a second 35 cycle step for 20 s at 98\u000eC, 15 s at 57\u000eC and 45 s at 72\u000eC, followed by a nal step of 10 min at 72\u000eC. Two mL of the rst PCR product were added to the second PCR reaction containing 7.5 mL of ultrapure water, 12.5 mL of KAPAHiFi HotStart Readymix and rbsa2rev : conditions were the same used the reaction. contained 7.5 mL ultrapure water, 12.5 mL enzyme, 0.3 mM primer (designed taking involved 1 step of 3 min at 95\u000eC, followed by 35 cycles of 20 sec at 98\u000eC, 15 s at 60\u000eC and 15 s at 72\u000eC, and a nal step of 30 s at 72\u000eC. All amplicons were then puried by low-melt agarose gel the Wizard SV Gel and PCR Clean-Up System (Promega) and then sequenced with a BigDye Terminator kit (Macrogen, Seoul, South Korea) in both directions using the second primers and an rbsaintseq : 50-TTTATATTTACACTATTCCTTTGG-30). Singleton PCR amplication. The sequences obtained here were deposited into the each enzyme were used in a 25 mL reaction which was incubated for 1 h at 37\u000eC and then inactivated at 80\u000eC for 20 min. Ligation to pET32bCvector was performed in a 20 mL volume containing 1x T4 buer, 30 U/ mL T4 ligase a 1:3 ratio. The reaction was incubated at 16\u000eC for 16 h and then inactivated at 65\u000eC for 20 min. Each in Genetics | www.frontiersin.org September 2018 | Volume 9 | Article 372fgene-09-00372 September 7, 2018 Time: bio, Colombian 2008; with sequences obtained from several sequencing projects (Chan et al., ambiguous nucleotides); 232 alignments were inferred using the TranslatorX web was Rozas, 2009) was used for calculating the amount of singleton sites (s), of the estimator, \"w) nucleotide (p) for all available sequences (worldwide as well as for the Colombian populations and for the subpopulations within both populations. Departure from the neutral model of molecular evolution was assessed by Tajima (1989); Fu and Li (1993), and Fay and Wu (2000) estimators. These are frequency spectrum-based tests equal. Rejection expectations suggests that selection or a demographic process could be taking place, the Fay and Wu test being suitable for detecting selective sweep (Fay and Wu, 2000). On the other hand, since each new polymorphic site has a high probability of delineating a new haplotype (Depaulis and Veuille, 1998) Similar to frequency spectrum-based tests, departures from neutral expectation could be the consequence of selection or demographic history, Fu's Fs estimator being a more sensitive indicator The methods consider aBSREL method (Smith et al., 2015) was used to test whether positive selection had occurred phylogeny. 1998) Jukes-Cantor correction and Cantor, 1969) al., 2013) to identify signicant statistical values. 1991) was calculated using a web server (Egea (d N/dSand/or K N/KS) was then used for assessing how natural selection acts throughout the gene. The Datamonkey web server (Delport et 2010) was used for assessing codon sites under positive and BYs (Pond et al., 2006), SLAC, REL (Kosakovsky Pond and Frost, 2005), MEME (Murrell et al., 2012) FUBAR (Murrell et N/dSestimation (Anisimova et al., 2003; and Posada, 2010, 2014), the GARD method (Kosakovsky Pond et al., 2006) was considered regarding recombination before running these tests. Linkage disequilibrium was evaluated by calculating Z NS method (Kosakovsky Pond et al., 2006), as well as by ZZ (Rozas et al., 2001) and RM (Hudson and Kaplan, 1985) tests. The degree of genetic molecular variance PvRBSA Protein Whole PvRBSA, A puried, For the protein was expressed for 4 h at 37\u000eC complete PvRBSA) or 30\u000eC (for PvRBSA-A B1 buer (20 Tris-Cl, pH native protein extraction and then lysed by sonication on ice for 3 min 30 s, with 0.2 s pulses ON, 0.2 s OFF, at as control (Baquero et al., 2017; Moreno-Perez et 2017). | September 2018 | 9 | Article 372fgene-09-00372 September 7, 2018 Time: 1:20 (protein:peptide) molar ratio with 2 \u0002107 red blood cells from umbilical cord blood for 1 hour at 4\u000eC et was used as negative control. All cysteine Canto II (Biosciences) cytometer FACSDiva software Statistical Dierences between medians ( m) were compared by Kruskal- Wallis test when comparing multiple groups. Statistical signicance was assessed by comparing m, deviations (SD) were of three independent RESULTS Identifying the rbsa ) the same identity but they did not belong to the same chr; one of the two fragments occurred at the chr3 and the other one at chr10. There was 99.57% identity between these P. cynomolgi DNA fragments. A similar blast search using Sal-I pvrbsa was whole identity at the the rst one placed P. vivax sequences together, the second group clustered P. cynomolgi sequences and in the third, P. Evolutionary Analysis Together with the 167 sequences obtained here, 65 additional sequences recovered from PlasmoDB (Colombia 18, Peru n= 16, Brazil n= 3, Mexico n= 5, Madagascar n= 2, China n= 2, Cambodia n= 2, Thailand n= 8, Papua New Guinea n= 6, India n= 1, North Korea n = 1 and the Sal- I sequences, Supplementary Venezuela modulating the pvrbsa gene diversity observed here. Tests based on a neutral molecular evolutionary were performed for population and subpopulations to population had negative statistically signicant values just for the Fay 2 ) had and test, being statistically signicant (p<0.05) which could have resulted from balancing selection or a decrease in population. The subpopulation had a value Li's F estimator gave Frontiers in Genetics | www.frontiersin.org 2018 9 | Article 372fgene-09-00372 September 7, 2018 Time: rbsa locus was found in parasites from clade, but it was not clear whether the rbsa gene became lost from the or arose exclusively in the as for populations (Colombia and Venezuela) and subpopulations (Amazonas, Choc\u00f3, C\u00f3rdoba, Meta, Bolivar, and mutations was computed signals Meta (Table selection. The region from nucleotide 200-1,100 had &= 0 which is expected under negative selection. Although, the McDonald-Kreitman test did not signicant values, N-KSdierences P. in Genetics | www.frontiersin.org 6 September 2018 | Volume 9 | Article 372fgene-09-00372 September 7, 2018 Time: 2 tests for Colombia, Venezuela, and subpopulations. n Tajima Fu and Li Fay and region gene. (A)A phylogeny tree inferred from pvrbsa CDS analyzed by the method. of the rbsa DNA and the sliding window for the &rate. The &rates within P . (dN/dS) and between the species (K N/KS) are shown. A gene model of the rbsa gene is given below the sliding window, indicating the sites under purifying selection (green) and positive selection (red). Gene model and numbering were based the region between nucleotide 600 - 1,572 (hereinafter called PvRBSA-B). The region between nucleotide 200 - 600 (hereinafter called PvRBSA-A) had a negative Frontiers in Genetics | www.frontiersin.org 7 September 2018 | Volume 9 | Article 372fgene-09-00372 September 7, 2018 Time: PvRBSA-B) and dN-dS(as well as for d another 30 were under negative selection. Several of the negative selected sites were vivax. Population PvRBSA-A (196 - 600 600 9 | Article 372fgene-09-00372 September 7, 2018 Time: using contraction star a lines connecting different mutational and rst belonged to the DMP1 domain and the other to a domain containing a LRR. Recombination is an evolutionary environments the same DNA region) independently arising variants (Perez- Losada et al., 2015). that 2011). Venezuela, H_4) but also amongst subpopulations (Choc\u00f3, C\u00f3rdoba, in Genetics | www.frontiersin.org 9 September 2018 | Volume 9 | Article 372fgene-09-00372 September 7, 2018 Time: inter-population FSTvalues. diagonal correspond (F) and B). The Figure shows each puried molecule analysed by Coomassie blue staining (lines 2, 4, and 6) or Western blot (lines 3, 5, and 7). MW, molecular weight marker Standard deviation is shown for each used as negative control. All peptides were pre-incubated incubating 5 ); that of variation was between populations vivax target CD71 abundantly on &<1) bind to with antibody). PvRBSA-A-derived specic regions within 9 | Article 372fgene-09-00372 September 7, 2018 Time: Malaria remains public health several tropical and subtropical regions worldwide (WHO, 2017). Although an antimalarial vaccine appears to a good cost-eective intervention which would help in controlling malaria, a fully eective vaccine has not been developed yet. Since P. vivax has a complex biology (Galinski et al., 2013) (for instance, it has an antimalarial vaccine slow task (Patarroyo et al., 2012). Several antigens suggested 2011, 2013, Patarroyo andP. dierent features evolutionary paths. Consequently, several antigens could thus be taken into antigen could be specic for invading this kind of host cell and could therefore be considered a vaccine candidate when designing an anti- P. vivax malaria vaccine (Moreno- Perez et al., 2017). However, appears exclusive for P. vivax and P. cynomolgi . A was present in fragile (the most basal species in (Carlton et al., 2013; Muehlenbein et al., 2015), this gene could be present in the ancestor of all monkey-malaria parasites and, because orthologs were not found in P. knowlesi and P. coatneyi , then it has been lost in some species within this clade. The rbsa gene was found as a single copy gene in P. inui (pirbsa ) and P. ), This could the evolution which can homogenize duplicate gene fragments (Nei and Rooney, 2005). However, duplication or found event must therefore vivax P. cynomolgi divergence. A 4,000 bp fragment was duplicated at chr3 in P. vivax (it is present in contrast, both pcrbsa copies were complete in 99.91% identity. chr10. At least a this a dierent chr is not clear. Likewise, it is not yet clear whether the high identity found in pcrbsa and pcrbsap has been due to negative selection acting on both copies or has been due to a recent duplication event. According to the aforementioned results, two independent duplication events must have happened. On the other hand, the pvrbsa gene was amplied in 167 samples from Colombian and Venezuelan populations. The together with 65 sequences from dierent regions around the world. This gene had length polymorphism to repeats located at pvama1 [p= 0.0067 pvmsp10 (p= 2010; Buitrago et al., subpopulations had more diversity than Colombia however, the forces causing such diversity diversity. The negative this kind of selection decreased diversity and could have been a consequence of functional constraint. On the other hand, the 750-940 nucleotide region was under balancing selection, as suggested by 2018 | 9 | Article 372fgene-09-00372 September 7, 2018 Time: A percentage of sites under positive selection were identied in al., 2016; Garzon-Ospina et al., 2016). Evidence of positive selection was found in PvRBSA-B ( Figure 2 and 3 ,4), agreeing test results. All this avoid as has been other (Garzon-Ospina et al., 2012). was lower than 1 in this region, several codons in PvRBSA-A and this region therefore 2B ); one was the DMP1 superfamily domain which is found in dentin acting as transcriptional component in mammals (Narayanan et al., 2003). However, how this domain could act in the parasite is not clear yet. More interesting was the nding of the PRK15370 domain. This domain belongs to the NEL superfamily where family members have an involved pathogen interaction et -B that for the other invasion-related Plasmodium (Chitnis and al., 2005; Arevalo-Pinzon et al., rst located towards the N-terminal domain whilst the other one was at the end of this. Remarkably, this region was found in the PvRBSA repeat region; repeats are in the CS protein (Aldrich et al., 2012; Ferguson et al., 2014). PvRBSA region interaction vivax sequences analyzed here) being critical for binding, meaning that these peptides could be considered in vaccine development. The aforementioned results thus suggest is under diversifying populations structured (Taylor et al., 2013); this pattern has also been observed in other P. vivax antigens in Colombia (Forero- Rodriguez et al., 2014a,b; Buitrago et al., 2016), hence migration was the last force evaluated here. The haplotype network inferred by dierent countries, even the world. Several haplotypes found on the American continent were dierent P. vivax introductions to America by human migration (Rodrigues al., haplotypes have reached dierent American counties. A structured haplotype network was inferred. In fact, several haplotypes were shared between Colombia as amongst all subpopulations was computed. This could the consequence of limited gene flow amongst Colombian subpopulations or due to local adaptation. Synonymous and non-synonymous mutations were analysed independently to try to determine which event(s) led to this structure ( Supplementary Data Sheet 3 Since typically silent, they are considered to follow neutral expectations and, therefore, they could represent the demographic history (migration). On the other hand, non-synonymous mutations are subject to natural selection and could consequently represent local adaptations. The synonymous data set showed that Bol\u00edvar and Venezuela's coastal area in Venezuela as well as the Choc\u00f3, C\u00f3rdoba, Amazonas and Meta departments in Colombia seem to be found. However, the non-synonymous set showed all (except Bol\u00edvar and Venezuela's coastal area as well as Choc\u00f3 and dierent. Frontiers in Genetics | www.frontiersin.org 12 September 2018 | Volume 9 | Article 372fgene-09-00372 September 7, 2018 Time: lineage species. The encoding have been present in the last monkey-malaria parasite common ancestor and it then became lost in some species (i.e. P. knowlesi and P. coatneyi ). An independent et al., 2012, 2014); this diversity is modulated by natural selection, recombination and migration (the latter for Venezuela but not for Colombia). According to Tajima, Fu and Li, K N-KSand codon-based tests the RBSA 's C-terminal end (PvRBSA-B) is under balancing (or diversifying) selection, likely due to region being in immune response evasion whilst manuscript. ON and MP coordinated the study and helped to write the manuscript. All the authors have read and approved the nal version of the manuscript. FUNDING This work was nanced by the Departamento Administrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n (COLCIENCIAS) through grant RC # 0309-2013. ACKNOWLEDGMENTS We would like to thank the Instituto de Ciencia, Biotecnolog\u00eda e Innovaci\u00f3n en Salud (IDCBIS) in Bogot\u00e1 for supplying the umbilical cord blood and Jason Garry for translating and reviewing the manuscript. SUPPLEMENTARY MATERIAL The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fgene. 2018.00372/full#supplementary-material REFERENCES Abascal, F., Zardoya, R., T., Bistoni, F., Crisanti, A., et al. (2012). Roles of the amino terminal region and repeat region and Y ang, Z. (2003). Eect of recombination on the accuracy of the acid sites. 1229-1236. recombination. Genetics 184, (2014). \"The influence of recombination on the estimation of selection from coding sequence alignments, \" in Natural Selection: Methods and Applications ed. M. A. Bermudez, vivax rhoptry neck G., H., J., and L. Understanding the population genetics of is essential 11, 14. doi: 10.1186/1475-2875-11-14 Bandelt, D., Forero-Rodriguez, J., Ortiz-Suarez, in Genetics | 9 | Article 372fgene-09-00372 September 7, 2018 Time: Barry, A. E., and M. A. (2016). Size polymorphism and Carabali-Isajar, L., M., Rodriguez, D. C., Vanegas, M., Curtidor, H., Patarroyo, M. A., et al. (2018). doi: 10.1016/j.bmc.2018.03.044 Carlton, J. M., Adams, J. H., Silva, J. C., Bidwell, S. L., Lorenzi, H., Caler, E., et al. (2008). Comparative genomics of the neglected 455, Carlton, J. A., and Escalante, A. A. (2013). Genomics, population genetics and 205, 1003-1035. doi: Chan, E. R., Menard, D., David, P. H., Ratsimbasoa, A., Kim, S., Chim, P., et al. (2012). Whole Chen, E., Salinas, N. D., Huang, Y., Ntumngia, F., Plasencia, M. D., Gross, M. L., et al. (2016). Broadly neutralizing epitopes doi: 10.1073/pnas.1600488113 Chen, J. H., Jung, J. W., Wang, Y., Ha, K. S., Lu, F., Lim, C. S., et al. (2010). Immunoproteomics proling of blood 10.1021/ Chitnis, C. E., A. F., Frost, and Kosakovsky Pond, S. L. (2010). Datamonkey 2010: a suite Neutrality based on the distribution of haplotypes under model. Mol. Biol. Evol. 15, 1788-1790. 10.1093/oxfordjournals.molbev.a025905 Edgar, C. (2004). with high accuracy Acids Res. 1792-1797. doi: 10.1093/nar/gkh340 Egea, R., and Barbadilla, A. (2008). Standard and generalized McDonald-Kreitman test: a website A., Cornejo, O. E., Freeland, D. E., Poe, A. C., Durrego, E., Collins, W. E., et al. (2005). A monkey's tale: the origin of Plasmodium vivax as a Laval, G., and Schneider, S. (2007). Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol. Bioinform. Online 1, 47-50. Fay, J. C., and Wu, C. I. (2000). Hitchhiking under positive Darwinian selection. Genetics 155, 1405-1413. Ferguson, D. J., Balaban, A. E., Patzewitz, E. M., Wall, R. J., Hopp, C. S., Poulin, B., et al. (2014). The repeat region of the circumsporozoite protein is critical S., Kappe, S. H., Narum, D. L., VanBuskirk, K. M., and Adams, J. H. Erythrocyte-binding activity Plasmodium 117, 49-59. 10.1016/S0166-6851(01)00326-7 Fu, Y. X. (1997). Statistical tests of neutrality of mutations against population growth, hitchhiking and background selection. Genetics 147, 915-925. Fu, Y. X., and Li, W. H. (1993). Statistical tests of neutrality of mutations. Genetics 133, 693-709. Galinski, M. R., and J. Galinski, M. E. V., and Barnwell, J. W. (2013). Plasmodium vivax : modern strategies to Forero-Rodriguez, and Patarroyo, Patarroyo, M. A. (2012). Genetic the Plasmodium (2011). Low genetic polymorphism of Elyazar, I. R., Moyes, C. L., Smith, D. L., Battle, K. E., Guerra, C. A., et al. (2012). A long neglected world malaria map: Plasmodium Y., Price, N., Azevedo, R. B., Zufall, R. A., and Elhaik, E. (2013). On the immortality of television sets: \"function\" in the human E., Patil, A. P., Gething, P. W., Van Boeckel, T. P., Temperley, W. H., et al. (2010). The international limits and population at risk of Plasmodium vivax Ganguli, I., Perera, L., Premaratne, P. H., et al. (2007). Genetic diversity the Plasmodium S., and Przeworski, M. (2003). A neutral explanation for the correlation of diversity with recombination rates 1527-1535. doi: 10.1086/37 5657 Hester, J., Chan, E. R., Menard, D., Mercereau-Puijalon, O., Barnwell, J., Zimmerman, P. A., et al. (2013). De novo assembly of a eld isolate 9 | Article 372fgene-09-00372 September 7, 2018 Time: pvrbsa Genetic Diversity Hudson, R. R., and Kaplan, N. L. (1985). Statistical properties of the number of recombination events in the history of a sample of DNA sequences. Genetics 111, 147-164. Huijben, S., evolution elimination: winning Melnikov, A., Sutton, P. L., Rogov, P., Escalante, A., et al. (2016). Population Jukes, and Cantor, protein molecules, \" in Mammalian Protein (New York, NY: Academic Press). doi: 10.1016/B978-1-4832-3211-9.50009-7 Kato, K., Mayer, D. C., Singh, S., Reid, M., and Miller, L. H. (2005). Domain III of Plasmodium falciparum apical J., interlocus associations. Genetics 146, 1197-1206. Kosakovsky Pond, L., and Frost, S. D. (2005). Not so dierent after all: a comparison of methods D., Gravenor, M. B., Woelk, C. H., and Frost, S. D. Automated J., Bennett, S. M., Fitzpatrick, C. L., and Noor, M. A. (2008). Fine- scale mapping of recombination P., and Rozas, J. (2009). DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics 25, 1451-1452. doi: 10.1093/ bioinformatics/btp187 Liu, W., Li, Y., Shaw, K. S., Learn, G. H., Plenderleith, L. J., Malenke, J. A., et al. (2014). African origin of the parasite Plasmodium vivax .Nat. Commun. 5:3346. doi: 10.1038/ncomms4346 Zhang, R., Tan, K. S., Suwanarusk, R., Claser, C., et al. (2015). Plasmodium Khuntirat, B., Sattabongkot, J., Y an, G., Escalante, A. A., et al. (2005). Molecular evolution and intragenic recombination of the McDonald, J. H., and Kreitman, M. (1991). Adaptive protein evolution at the Drosophila .Nature 351, 652-654. doi: 10.1038/351652a0 Moreno-Perez, D. A., Baquero, L. A., Patarroyo, M. M. D. A., Duan, J., Huang, Y., Carlton, J., Walker, J., et al. (2005). Host switch leads to emergence of Plasmodium 10.1093/molbev/msi160 Muehlenbein, M. P., Pacheco, M. A., Taylor, J. E., Prall, S. P., Ambu, L., Nathan, S., et al. (2015). Accelerated diversication of nonhuman primate malarias Kosakovsky Pond, FUBAR: K., Ramachandran, A., Hao, J., He, G., Park, K. W., Cho, M., et al. (2003). Dual functional roles of dentin matrix protein 1, implications gene Neafsey, D. E., Galinsky, K., Jiang, R. H., Young, L., Sykes, S. M., Saif, S., et al. (2012). The M., and Rooney, A. P. (2005). Concerted and birth-and-death evolution of 10.1146/annurev.genet. 39.073003.112240 Nobrega de Sousa, T., Carvalho, L. H., and Alves de Brito, C. F. (2011). Worldwide genetic variability of the 0022944 Ntumngia, F. B., Pires, C. V., Barnes, S. J., George, M. T., Thomson-Luque, R., Kano, F. S., et al. (2017). An engineered vaccine of the 10.1038/s41598-017-13891-2 Pacheco, M. A., Battistuzzi, F. U., Junge, R. E., Cornejo, O. E., Williams, C. V., Landau, I., et al. (2011). Timing the origin of human M. A., Elango, A. P., Rahman, A. A., Fisher, D., Collins, W. E., Barnwell, J. W., et al. (2012). Evidence of purifying selection on merozoite surface protein 12, 978-986. doi: 10.1016/j.meegid.2012.02.009 Pacheco, M. A., Ryan, E. M., Poe, A. C., Basco, L., Udhayakumar, V., Collins, W. E., et al. (2010). Evidence for negative selection on the gene encoding rhoptry-associated protein 1 A. (2012). Vaccines against Plasmodium vivax : 10.1586/erv.12.91 Perez-Losada, Gonzalez-Candelas, F. (2015). D., Grossman, Z., Gravenor, M. B., Richman, D. D., and Brown, A. J. (2006). Adaptation to L., Valecha, N., Nosten, F., Baird, J. K., and White, N. J. (2014). Global extent of chloroquine-resistant Plasmodium vivax : a 14, 982-991. doi: 10.1016/S1473- 3099(14)70855-2 Rao, Y., Sun, L., Nie, Q., and Zhang, X. (2011). The influence of recombination on doi: 02210.x L., Saul, A. (2002). Progress and challenges for malaria vaccines. Nature 415, 694-701. doi: 10.1038/415694a Rodrigues, P. T., Valdivia, H. O., de Oliveira, T. C., Alves, J. M. P., Duarte, A., Cerutti-Junior, C., et al. (2018). Human migration and the spread of malaria parasites to the New World. Sci. Rep. 8:1993. doi: 10.1038/s41598-018-19554-0 Ronquist, F., Teslenko, M., van der Mark, P., Ayres, D. L., Darling, A., Hohna, S., et al. (2012). Aguade, M. (2001). DNA variation the rp49 gene 2018 | 9 | Article 372fgene-09-00372 September 7, 2018 Time: pvrbsa Genetic Smith, M. D., Wertheim, J. S., Murrell, B., Scheer, K., and Kosakovsky Pond, S. N., (2004). Malaria. CMAJ 170, 1693-1702. doi: 10.1503/cmaj.1030418 Tachibana, S., Sullivan, S. A., Kawai, S., Nakamura, S., Kim, H. R., Goto, N., et al. (2012). Plasmodium cynomolgi genome sequences 44, 1051-1055. doi: 10.1038/ng.2375 Tajima, F. (1989). Statistical method by DNA polymorphism. 123, 585-595. Peterson, and Kumar, S. (2013). MEGA6: molecular evolutionary Biol. Evol. 30, 2725-2729. doi: 10.1093/molbev/mst197 Taylor, J. E., Pacheco, M. A., Bacon, D. J., Beg, M. A., Machado, R. L., Fairhurst, R. M., et al. (2013). The evolutionary history The malERA Consultative L. A., Escalante, A. A., Arevalo-Herrera, M., et al. (2011). Polymorphism from Pacic coast of Am. J. Trop. Med. Hyg. 84, 64-70. doi: 10.4269/ajtmh.2011.09-0517 Valencia, S. H., Rodriguez, D. C., Acero, D. L., Ocampo, V., and Arevalo- Herrera, M. (2011). Platform for Plasmodium vivax doi: 10.1590/ S0074-02762011000900023 Wang, Y., Ma, A., Chen, S. B., Y ang, Y. C., Chen, J. H., and Yin, M. B. (2014). Genetic diversity and natural selection for the MHC with PCR-SSP. Rev. Immunogenet. 1, 157-176. White, N. J., Pukrittayakamee, S., Hien, T. T., Faiz, M. A., Mokuolu, O. A., and Dondorp, A. M. (2014). Malaria. Lancet 383, 723-735. doi: WHO (2017). World Malaria Report 2017 . Geneva: World Health Organization. Zhang, J., Rosenberg, H. F., and Nei, M. (1998). Positive darwinian selection after gene duplication in primate the research was conducted in the absence of any commercial or nancial relationships that could be construed as open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Frontiers in Genetics | www.frontiersin.org 16 September 2018 | Volume 9 | Article 372 "}